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ABSTRACT 
Vaccination of C57BL/6 mice with irradiated cercariae of Schistosoma mansoni 
results in the generation of up to 70% resistance to challenge infection. Protection is 
dependent on the development of CD4+ Th I cells in the skin draining LN, and 
recruitment of these cells to the lungs post-vaccination (Mountford et al., 1992). The 
effector mechanism operates in the lungs and consists of the formation of foci, rich in 
CD4 +T cells and macrophage, around migrating challenge parasites. Inflammatory 
cytokines play an important role in this model. Furthermore, resistance is IFNy 
dependent, as demonstrated by a 90% abrogation of immunity upon ablation of this 
cytokine (Smythies et al., 1992b). 
The cytokine expression levels in lung and lymph node tissue following exposure 
to the irradiated vaccine have been investigated at a semi-quantitative and 
quantitative level by reverse transcription-PCR. Analysis of total RNA isolated from 
the skin draining LN after vaccination has demonstrated that an early Thl response 
occurs, closely followed by increases in the expression of Th2-type cytokines. 
Following challenge of previously vaccinated mice, the level of IFNy and IL-2 
expression in LN tissue is much reduced. In contrast, IL-4 expression increases 
sharply above the level detected post-vaccination, displaying a strong anamnestic 
response. 
Lung tissue shows a mixed Th I /Th2 response after vaccination with all cytokines 
under test peaking at day 2 1. Post-challenge, it is the inflammatory cytokines, such 
as IFN7, TNFa, IL- 12 and IL- I P, which increase to levels approaching those 
detected post-vaccination. Although Th2 cytokines are detectable, expression is 
much lower than before challenge resulting in a higher ThI: Th2 cytokine ratio than 
that observed following vaccination. The kinetics of the effector response were 
further analysed by the sampling of a synchronous challenge time course. The data 
obtained in this experiment confirmed the profiles of cytokine expression detected 
after percutaneous challenge. In addition, these samples showed significant 
expression of inducible nitric oxide synthase (NOS), the enzyme responsible for 
nitric oxide production, at the time of peak inflammatory cytokine expression. 
The induction responses were further investigated by the vaccination of BALB/c 
and C57BL/6 mice and the cytokine mRNA detected in lung and LN tissue of both 
strains compared. Results indicate that BALB/c mice show a tendency to develop a 
more Th-2-biased cytokine response upon vaccination, compared to the mixed 
response seen in C5713L/6 animals. The higher Th2 cytokine profiles parallel the 
lower resistance measurements obtained for the former strain. In addition, 
vaccination of IFN7R-/- mice has demonstrated that these animals show an increased 
Th2 cytokine profile compared to wild type animals of the same and C57BL/6 
strains, corresponding to a reduction in resistance. The cytokine profiles obtained for 
all the above systems are described and related to immunity in the irradiated 
Schistosoma mansoni vaccine model. 
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CHAPTER ONE 
Introduction 
Part 1. Immunity to Schistosomiasis 
1.1 Background to the Disease 
Schistosomiasis is a widespread parasitic disease caused by trematode blood flukes 
of the genus Schistosoma. There are now 76 countries in which schistosomiasis is 
endemic, resulting in an estimated 200 million infected people (Cheever, 1993, 
Bergquist et al., 1994) and 1 million deaths annually (Warren, 1989). Three main 
species of Schistosoma are responsible for infection in man: S. mansoni is prevalent 
in Africa, South and Central America; S. japonicum, which is limited to Asia; and S. 
haematobium, responsible for schistosomiasis in Africa and the Middle East. The 
first two species reside in the mesenteric veins of their host and release eggs into the 
gut tissues. From here the eggs pass through to the gut lumen and are excreted. The 
third parasite inhabits the vesical plexus of the bladder and eggs are released in the 
urine. 
The schistosome life cycle involves primary mammalian and intermediate fresh 
water molluscan hosts. Free swimming miracidia hatch from eggs excreted into 
water, releasing the stage infective to snails. In the snail, asexual reproduction 
occurs and results in the release of a second free swimming stage, the cercaria, in 
response to light. Cercariae infect their primary host by skin penetration, upon which 
their swimming tails are shed and transformation into the migratory stage, the 
schistosormilum, takes place. These larvae migrate via an intravascular route, 
possibly using secretions from the acetabular and head glands to cross the dermis and 
access blood vessels, to the hepatic portal system or the bladder (Wilson, 1987). 
Once in the liver the worms mature, pair up and migrate to their final destination in 
the mesenteric veins of the gut (S. mansoni, S. japonicum), or vesical plexus of the 
bladder (S. haematobium). Here oviposition of 300 to 3000 eggs per day, depending 
on species, commences. 
The presence of worm pairs in the host causes little pathology; it is the host's 
immune response against the eggs, of which over half get trapped in local tissues or 
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washed away with blood flow, which results in the characteristic pathology of the 
disease (Von Lichtenberg, 1987). In S. mansoni infections eggs are trapped in the 
pre-sinusoidal portal venules (Cheever, 1993), where the release of antigen from 
mature eggs results in an intense local inflammatory response and the formation of 
fibrous lesions, or granulomas (Boros and Warren, 1970). As egg burden in the liver 
increases with repeated high level infection, portal hypertension, hepatomegaly and 
oesophageal varices form, eventually leading to liver failure (Warren, 1972). 
Various control measures have been implemented in attempts to clear infection in 
endemic populations (Mott, 1987). Stategies such as improving sanitation and health 
education have had limited success, mainly due to the economic costs involved. The 
use of molluscicides, besides damaging the local environment, is expensive and can 
lead to the development of resistant snails and reinvasion of a cleared area. There are 
chemotherapeutic drugs available for widespread treatment, and these have been 
effective in reducing prevalence in some areas (Mahmoud et al., 1983). Drugs such 
as Praziquantal (broad range) and Oxamniquine (S. mansoni only) eliminate worm 
burdens but do not reverse existing pathology or prevent reinfection, and therefore 
successive doses are required to control infection (WHO Report, 1989). The cost and 
practical problems of repeated treatment make it impractical to control infection 
significantly in third world countries with chemotherapy. Hence the preferable long 
term solution is the development of an economically viable vaccine able to prevent 
infection with a single dose. 
Research into potential vaccines is centred on the study of the host immune 
response to parasite antigen candidates and attenuated models. Although the use of a 
live vaccine in humans may have dangerous implications, an understanding of the 
immune mechanisms required for resistance can only aid in the design of an antigen- 
based vaccine. Development of age-related protective immunity does occur in 
human populations (Butterworth et al., 1988), and the differences in reinfection 
levels of children and adults cannot simply be accounted for by exposure patterns 
alone (Butterworth, 1994). However, the mechanisms of human resistance are not 
known, and since manipulation of this system is impossible the majority of research 
is carried out on animal models. 
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1.2 Experimental Models of Schistosomiasis 
Various animal models exist for the laboratory study of immunity to 
schistosomiasis. Different species are used depending on the nature of the research, 
each host having a distinct relationship with the parasite. Non-human primates 
provide a model close to that of human infection. However, for practical reasons, the 
majority of research is based on rodents. Both rats and mice can support human- 
infective species of Schistosoma, but mice are permissive hosts and display similar 
pathology to human infection (McLaren and Smithers, 1987). In contrast, rats are 
semi-permissive hosts and eliminate S. mansoni worms around 28 days post- 
infection. S. mansoni is the most prevalent of the human-infective species and its 
life cycle can be easily maintained in laboratory conditions. This makes 
schistosomiasis mansoni the most researched form of the disease. The following 
studies will focus exclusively on the immunity induced in the murine host following 
exposure to S. mansoni. 
1.3 Infection of Mice with Normal Parasites 
1.3.1 Migration and Development 
Between 30% and 50% of the numbers of cercariae penetrating the skin will 
survive to reach maturity in the hepatic portal vasculature (Miller and Wilson, 1980). 
During penetration of the mammalian host skin the cercariae lose their tails and begin 
transformation into schistosomula. This process takes less than I hour to complete in 
vivo (Cousin and Stirewalt, 198 1), and involves changes in respiration and tegument 
(outer membrane) structure (Hockley and McLaren, 1973). Once in the skin, the 
epidermal base is reached within 30 minutes (Wheater and Wilson, 1979) but the 
basement membrane provides a barrier which takes longer to cross (Wilson and 
Lawson, 1980). The majority of parasites locate and penetrate post-capillary venules 
and migrate to the lungs via the vasculature (Miller and Wilson, 1978). However, 
10% to 20% leave the skin by entering the lymphatics and join the blood circulation 
via the thoracic duct (Wheater and Wilson, 1979, Mountford et al., 1988). The 
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duration of stay in the skin is estimated, on average, to be between 2 and 5 days 
(Miller and Wilson, 1978). 
By day 4 post-infection the first parasites can be found in the lungs (Miller and 
Wilson, 1980). During the next few days the schistosomula undergo a period of 
elongation accompanied by rhythmic extension and contraction (Wilson et al., 1978), 
and loss of mid-body spines (Crabtree and Wilson, 1980), thought to aid passage 
through the lung capillary beds. The larvae exit the lungs through the pulmonary 
vein, are carried to the left ventricle of the heart and are distributed to the systemic 
organs in proportion to cardiac output (Wilson et al., 1986). Those parasites 
reaching the hepatic portal system lodge there and mature into blood feeding adult 
schistosomes. Parasites distributed to other organs negotiate the capillary beds, 
return to the lungs and repeat the process of systemic migration. The trapping 
efficiency of the liver for schistosomula is 72% to 86% (Wilson and Coulson, 1986) 
and it is estimated, by portal perfusion, that the entire recoverable adult population 
can accumulate in two to three circuits of the blood system (Wilson, 1987). 
Accumulation in the liver is complete by day 21 post-infection (Wilson et al., 1986). 
The signals responsible for termination of migration are probably envirom-nental, the 
hepatic vessels having a low blood pressure and providing nutrient-rich 
surroundings (Wilson et al., 1978). Between 28 and 35 days post-infection the 
parasites in the hepatic portal system pair and migrate to the mesenteric veins 
(Wilson, 1987); here egg laying begins with production of approximately 300 eggs 
per worm pair per day. The immune response resulting in the formation of 
granulomas around eggs trapped in the liver will be discussed in section 2.8. 
1.3.2 Maturation 
The fate of the 50% to 70% of parasites which penetrate the skin but fail to mature 
was the subject of fierce debate until the advent of autoradiographic tracking 
techniques. Extraction of skin phase parasites by mincing and incubation suggested 
that up to 65% of penetrating cercariae died in the skin (Clegg and Smithers, 1968, 
Smithers and Gammage, 1980). However, parasites could not be detected in the skin 
in significant numbers by histological methods after migration through this organ is 
complete (Wheater and Wilson, 1979). Furthermore, 63% of skin penetrants were 
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present in the lungs, as detected by quantitative histology 6 to 7 days post-infection 
(Mastin et al., 1983). Compressed organ autoradiography proved to be the most 
accurate method for following the migration of previously labelled parasites, since 
whole organs can be assayed for radioactive counts without the need for a parasite 
extraction step. This technique demonstrated that up to 78% of skin parasites can be 
detected in the lungs by day 7 post-infection (Mangold and Dean, 1983) and, by day 
14,90% of penetrating parasites can be detected in organs other than the skin 
(Wilson et al., 1986). Thus it would seem that the majority of parasite loss during 
primary infection of naive mice occurs after migration from the skin. 
The lungs are now generally accepted as the major site of schistosomulurn attrition 
in naive mice (Mangold and Dean, 1986). The number of parasites eventually 
maturing in the hepatic portal system is much lower than the number detected in the 
lungs during migration (Georgi et al., 1983), and hence elimination could occur in 
the lungs, during migration to the liver or in the liver itself The latter possibility was 
ruled out by injection of lung stage schistosomula directly into the hepatic portal 
system (Mangold et al., 1986, Coulson and Wilson, 1988). High levels of maturation 
were obtained indicating that this organ provides a stable environment for worm 
development. Final evidence for the lungs being the major site of parasite loss came 
with whole body autoradiography (Wilson et al., 1986). When all tissues were 
sampled at day 2 1, after recruitment is complete, parasites detected in organs other 
than the portal system, were distributed in the ratios 3.9 : 1.9 :I in the lungs, 
systemic organs and skin respectively. 
The method of parasite trapping in the lungs is thought to be a non-specific 
mechanism. Histological and ultrastructural examinations of the lungs over the 
migratory period have indicated that the first schistosomula to arrive are intravascular 
and attract little inflammatory response (Mastin et al., 1983, Crabtree and Wilson, 
1986a). However, with time more parasites can be found in the alveoli, presumably 
by rupturing the capillaries as they try to migrate alongside the delicate blood/air 
barrier. Each parasite entering the alveoli attracts an inflammatory focus (Von 
Lichtenberg et al., 1985, Crabtree and Wilson, 1986b). The trapped parasites are not 
damaged by the immune response, and if extracted from the lung tissue and 
introduced into the hepatic portal system of naive mice are capable of full maturation 
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(Coulson and Wilson, 1988). Conversely, parasites recovered from donor mice and 
introduced via the trachea into the lungs of naive mice have difficulties in crossing 
the alveolar barrier to complete their migration through the vasculature. Hence 
parasite attrition in the lungs of mice exposed to a normal infection would appear to 
be due to the inability of schistosomula to re-enter the vasculature once diverted into 
the alveoli, leading to probable death by starvation. 
1.3.3 Concomitant Immunity 
Concomitant immunity is the term used to describe the phenomena by which 
secondary infections in mice with existing adult worm burdens fail to reach maturity 
in the liver (Smithers and Terry, 1969). This acquired resistance of up to 100% 
(Dean et al., 198 1 c) would seem to indicate an immune mechanism which can 
eliminate migrating parasites but leave the resident adult worm population unharmed. 
Further work indicated that resistance correlated closely with egg burden (Dean et 
al., 1978a), and that single sex infections failed to give protection (Dean et al., 
1978b, Bickle, 1982 Wilson et al., 1983). These findings led to the 'leaky liver' 
hypothesis (Wilson et al., 1983, Wilson, 1990) in which the impaired integrity of the 
liver, due to pathology in chronically infected mice, results in the accumulation of 
parasites in locations unfavourable to schistosomula maturation, for example the 
lungs. It has been shown that mice with chronic infections develop altered hepatic 
vasculature (Cheever and Warren, 1964) which results in a reduced trapping ability 
of the liver. Thus there is no increase in hepatic worm burden, giving the impression 
of immunity. It should be noted that even the lowest infection possible in a mouse of 
one worm pair is equivalent to a heavy worm burden in man (McLaren and Smithers, 
1987). This condition also accounts for the seemingly innate resistance of 129 strain 
mice to schistosome infections (Mitchell et al., 1984). A high proportion of these 
mice have natural portal shunts which, following infection with S mansoni, result in 
the direction of liver stage worms to the lungs (Coulson and Wilson, 1989). In 
conclusion, concomitant immunity in the mouse is most likely not an immune 
effector mechanism, but rather a consequence of liver pathology caused by the 
immune response against eggs produced from an already resident adult population. 
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1.4 The Irradiated Cereariae Vaccine 
1.4.1 Parasite Attenuation 
A major advance towards a vaccine for schistosomiasis occured when it was 
discovered that cercariae, attenuated by gamma irradiation, were incapable of 
maturing (Villella et al., 1961). Vaccination of mice with these parasites induced 
resistance without the danger of liver pathology. Several different methods of 
attenuation have been used including chemicals (Bickle and Andrews, 1983), 
ultraviolet light (Dean et al., 1983), and X-rays (Hsu et al., 198 1). However it is 
gamma radiation from a 60Cobalt source which has proved most popular. The dose 
of radiation is vital in inducing resistance (Minard et al., 1978a); a low dose will 
allow migration to the liver and possible pathology, a high dose may prevent entry to 
the vasculature completely. Although the optimal dose of irradiation in the UK is 20 
krads (Bickle et al., 1979a), in the USA a higher dose of 50 krads is preferred. This 
discrepancy may be due to differences in parasite maintenance or irradiation 
conditions. However, a recent report in the USA has found that parasites attenuated 
with 15 krads of irradiation give higher protection than those exposed to the original 
50 krad dose (Reynolds and Ham, 1992). 
The resistance induced using attenuated parasites varies from 30 to 80% depending 
on the strain of mouse (James et al., 198 1). Strains such as C57BL/6 routinely 
develop around 70% resistance to reinfection after a single vaccination. Multiple 
vaccination of mice results in little increase above this limit (Minard et al., 1978, 
Bickle et al., 1979b, Dean, 1983). The ceiling limit on protection may be due to 
many immunological factors and will be discussed later. The optimal radiation dose 
appears to be one which leads to termination of migration in the lungs (Mastin et al., 
1983). Following a single percutaneous vaccination of C57BL/6 mice with 500,20 
krad irradiated parasites, resistance peaks between days 17 and 24, and persists at a 
high level for at least 15 weeks (Ratcliffe and Wilson, 1991, Minard et al., 1978a). 
1.4.2 The Effects of Optimal Irradiation on Parasite Development and Maturation 
The ability of attenuated parasites to impart resistance has been investigated 
without finding any major differences between irradiated and normal larvae. Early 
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ultrastructural studies concluded that there were no morphological variations between 
normal and irradiated lung stage worms (Mastin et al., 1985a). Furthermore, no 
differences in the antigens secreted by 3 hour schistosomula derived from normal and 
irradiated cercariae have been detected (Simpson et al., 1985). Recent studies on 
UV-attenuated parasites have shown modification of some carbohydrate antigens on 
newly transformed cercariae (Wales et al., 1992) and inhibition of early protein 
synthesis. Although these effects have not been described for gamma irradiation 
techniques as yet, the comparison of in vivo and in vitro cultured parasites attenuated 
in this way has highlighted some minor changes in neuromuscular function (Harrop 
and Wilson, 1993). Scanning electron microscopy of lung stage parasites revealed 
muscular constrictions along the length of the worms and reduced motility which 
may account for the truncated migration of attenuated larvae. 
The main difference between normal and attenuated larvae is the slower migration 
of vaccinating parasites (Mangold and Dean, 1984). Only 13% of healthy parasites 
are left in the skin by day 5 post-infection, whereas 43.4% of the irradiated larvae 
remain after vaccination (Mountford et al., 1988). Normal parasites also negotiate 
the skin-draining lymph nodes (sdLN) quicker than their irradiated counterparts, 3% 
of the former remaining at day 7 compared to 10.4% of the latter. Although the 
vaccinating parasites can remain in the LN for up to 2 weeks, death in this site is 
negligible and most of the attenuated larvae eventually reach the lungs. Quantitative 
histological studies have shown that 57% of irradiated larvae reach the lungs by day 
7 and persist there until day 21 post-vaccination, by which point 81% are dead 
(Mastin et al., 1983). Thus it would seem that protection is induced by persistence in 
the skin-draining LN and lungs, these migration characteristics being the major 
difference between normal and attenuated parasites. The increased exposure of LN 
cells to parasite antigen in an environment geared towards antigen processing and 
presentation may generate an effective immune response. The detection of a 
proportionally greater amount of parasite antigen in the LN of vaccinated mice 
compared to mice with normal infections (Mountford et al., 1988) supports this 
theory. 
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1.5 Induction of Immunity 
1.5.1 The Nature ofImmunity 
The immune response induced by vaccination and challenge has been an area of 
intense research over the last 10 years. Early experiments demonstrated that 
immunity was transferable to a naive partner during parabiosis (Dean et al., 1981 a), 
and that resistance is usually only effective against challenge with the same species 
of schistosome (Cheever et al., 1983, Bickle et al., 1985). Thus immunity is based 
on transferable factors, such as cells and antibodies, specific for parasite antigens. 
By investigating mouse strains deficient in certain types of immune response the role 
for various cell types in protection has been demonstrated. Vaccinated athymic 
(nu/nu) mice show no resistance to challenge with S mansoni (Sher et al., 1982) but 
can be reconstituted with thymus grafts. Thus T lymphocytes would appear to play a 
pivotal role in protection. Confirmation of this finding came with the ablation of 
CD4 +T cell population by in vivo administration of an antibody directed against this 
subset of T lymphocytes (Kelly and Colley, 1988, Vignali et al., 1989), a treatment 
which completely abrogated immunity. It is interesting to note that anti-CD4 
treatment only reduces resistance by 70% in animals vaccinated twice before 
challenge (Vignali et al., 1989), and immunity is not diminished at all in mice 
vaccinated five times (Kelly and Colley, 1988). This would seem to indicate a 
changeover from cell-mediated to antibody-mediated immunity with multiple 
vaccinations. 
Evidence for T cell and macrophage involvement in immunity came from 
vaccination of the PN strain mouse which shows poor resistance upon reinfection 
(James and Sher, 1983). These mice have normal antibody titres but are unable to 
activate macrophages due to a defect in T cell ftinction and lack of IFN7 production 
(James et al., 1986). The importance of this one cytokine, IFN7, was further 
demonstrated by ablation experiments in which anti-IFN7 antibody administered 
during challenge abrogated immunity by up to 90% (Sher et al., 1990a, Smythies et 
al., 1992b). An increase in eosinophilia in the lungs with this treatment suggested 
that these cells play no role in resistance. Furthennore, ablation of the Th2 cytokines 
IL-4 and IL-5 result in the reduction of serum IgE and eosinophilia, but has no effect 
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on immunity implying that these factors are not vital components of protection (Sher 
et al., 1990a). 
A role for B lymphocytes in protection has also been implied after depletion of this 
cell type, via administration of an anti-ýt chain antibody, resulted in reduced 
resistance (Sher et al., 1982). However, it was later found that this antibody could 
also deplete specific and non-specific T cell responses (Kim el al., 1984), and thus 
these results are inconclusive. The advent of B cell-deficient mice (Kitamura et al., 
1991) may provide the answer to B cell involvement. Humoral responses have been 
shown to play a less important role than CD4+ T cells in the single vaccination 
regime. Schistosome-specific antibody titres show no correlation to host immunity, 
and serum from mice exposed to a single vaccination cannot mediate protection 
when transferred to naive recipients (James et al., 1981, Roberts et al., 1988). In 
contrast, administration of immune serum from animals receiving multiple 
vaccinations to naive animals results in some resistance to infection (Mangold and 
Dean, 1986, McLaren and Smithers, 1988). Furthermore, the IgGl isotype, which is 
frequently associated with humoral immune responses, seems especially important in 
this model (Delgado and McLaren, 1990). An increase in the production of 
interleukin-4 (IL-4) and IL-5 in the skin-draining LN of multiply-vaccinated mice is 
consistent with the presence of IgG1 antibody in the serum, all the above being 
components of a Th2 type response (see section 2, Caulada-Benedetti et al., 1991, 
Finkleman et al., 1990). However, splenocytes from multiply-vaccinated mice can 
still produce IFN7 and activate macrophages, indicative of the presence of a Thl cell 
population and implying compartmentalisation of T-helper responses (Caulada- 
Benedetti et al., 1991). Thus the type of immune mechanism responsible for 
protection appears to shift from a cell-mediated to humoral response upon multiple 
exposure to irradiated parasites. 
1.5.2 Site and Exposure Time Requirements in the Induction ofImmunity 
In order to determine the in vivo exposure time necessary for live parasites to 
induce immunity in the host, several approaches have been used. Terminating the 
vaccinating infection by drug treatment at various times post-exposure has 
demonstrated that resistance is decreased if the parasites do not survive for at least 7 
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to II days (Bickle et al., 1982). In addition, removing the exposure site, either the 
ear (Bickle et al., 1982), or tail (Mangold and Dean, 1984), has also shown that the 
presence of the vaccination site is needed for at least 4 days, and for maximum 
resistance should be left intact for 8 to II days. Conclusions drawn from this work 
suggest that the presence of live parasites is required during the first 2 weeks of a 
vaccinating infection for induction of the protective response. 
The parasite stage required for induction has also been investigated. Dermal 
innoculation of 8 day lung schistosomula, extracted from donor mice, induces equal 
resistance to percutaneous vaccination with irradiated cercariae (Coulson and 
Mountford, 1989). This indicates that cercarial antigen is not necessary for 
successful vaccination. However, vaccinating intradermally with 3 to 4 week old 
schistosomula results in lower resistance than skin or lung stage parasites (Sher and 
Benno, 1982, Dean et al., 198 1 b), possibly due to the loss of migratory potential. 
1.6 Immune Responses Following Vaccination 
1.6 1 The Skin-draining Lymph Nodes 
As described above, the two key sites considered to be necessary for successful 
vaccination are: the lymph nodes through which a minority of parasites migrate and 
persist, and the lungs where migration terminates. Vaccinating parasites persist 
longer in the skin and LN than their normal counterparts (Mangold and Dean, 1984, 
Mountford et aL, 1988). The dependence of the protective response on parasite 
migration through the LN was demonstated by administering parasites into mice via 
routes which bypass the nodes (Coulson and Mountford, 1989). Vaccination by the 
intravenous injection of day 8 schistosomula imparted a much reduced level of 
protection compared to parasites injected intradermally. In addition, excising the 
draining LN five days prior to vaccination decreased immunity by 60%, the residual 
resistance presumably being due to other mechanisms operating independently of the 
LN (Mountford and Wilson, 1990). Furthermore, lymphadenectomy at various 
timepoints post-vaccination resulted in higher resistance the later this operation was 
performed, indicating that the LN play an early role in induction. Vaccination with 
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hyper-irradiated (80 krad) cercariae induces no resistance, even though small 
numbers of parasites reach the draining LN and elicit a transient response similar to 
that produced by normal larvae (Constant et al., 1990). In contrast to 20 krad 
irradiated larvae, these weaker parasites do not migrate as far as the lungs. 
Combining a vaccination with 80 krad irradiated cercariae and intravenous injection 
of day 8 schistosomula eight days later results in the induction of protection, even 
though independently the two regimes have little effect (Coulson and Mountford, 
1989, Mountford et al., 1992). Thus it would seem that both antigen presentation in 
the LN and parasite migration to the lungs are vital for the generation of a protective 
response. 
Analysis of the axillary LN cell populations has revealed that cell numbers peak at 
day 14 post-vaccination, with a 13.5 fold increase over the cell number detected in 
naive mice (Constant et al., 1990). Proliferation also peaks at this time and is higher 
in vaccinated mice compared to normal infection controls. These observations could 
be explained by the persistence of parasites in the nodes, and hence the increased 
amounts of antigen present (Mountford et al., 1988). Further, there is an increase in 
B cell proliferation and recruitment to the axillary LN which leads to a dramatic 
change in the T: B cell ratio from 4: 1 to 1: 1 (Constant and Wilson, 1992). By 
comparing the total numbers of T and B cells to their individual proliferation values, 
it can be concluded that there is a higher proportion of T cells proliferating even 
though there is an increase in B cell number. Upon ftirther investigation into the LN 
cellular composition it was discovered that this increase in B cells is caused by 
recruitment and retention, as suggested by low B cell numbers in the efferent LN 
vessels (Constant and Wilson, 1992). The role of this cell type during induction is 
unclear, but B cells may act as antigen presenting cells (APCs) for development of 
the immune response in the LN (Janeway et al., 1987). 
Research into the immune response induced by vaccination took a new direction 
after the discovery that CD4+ T cells exist in two distinct subsets, termed T-helper 
(Th) I and Th2, each of which secretes different cytokine patterns and results in the 
development of contrasting immune mechanisms (see section 2 for a full description, 
Mosmann and Coffman, 1987). Fundamental to the distinction of these subsets is the 
production of IFNy by Thl cells and IL-4 by Th2 cells. Ablation experiments 
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directed against CD4+ and CD8+ cells during vaccination have demonstrated that the 
majority of IFN7 is secreted by the CD4+ cell population in the axillary nodes 
(Pemberton et al. 1 1991). IFN7 protein secretion peaks 
in cultures of sdLN cells at 
day 5, when the maximum number of parasites and parasite-released material are 
present. The decrease in IFN7 release after day 5 may be explained by a fall in 
parasite material and an influx of B cells into the nodes. However, a second peak of 
IFN7 secretion occurs around day 18, possibly stimulated by the release of antigens 
from dead or dying parasites (Pemberton et al., 199 1). In comparison with normal 
infection, cultured LN cells from vaccinated mice secrete higher levels of IFN7. In 
addition, the increased numbers of the CD4+ cell type present in the LN of vaccinated 
mice compared to control animals (Pemberton et al., 199 1, Constant et al., 1990) 
results in an overall 24 fold increase in the capacity for IFN7 production at day 22 
post-vaccination. Vaccinated nodes also produce IL-2, IL-3, IL-4 and IL-10 in 
response to secondary in vitro stimulation with specific antigen (Pemberton et al., 
1991, Pemberton and Wilson, 1995). In contrast, cells from control animals given a 
normal infection secrete little IL-4 and IL-3, but do produce significant levels of IL- 
2. Thus the cytokine profiles are not clearly of Thl or Th2 phenotype, but consist of 
a mixed, or ThO type response (see section 2) in which the high levels of IFN7 may 
promote the generation of Th I -like memory cells (Pemberton et al., 199 1, Coulson 
and Wilson, 1993, Mountford et al., 1992). 
The response elicited in the sdLN varies depending on the exposure regime. 
Repeated infection, either multiple vaccinations or vaccination and challenge, on the 
same area leads to the generation of a Th_2 type response, characterised by IL-4 and 
IL-5 production (Pemberton and Wilson, 1995, Caulada-Benedetti et al., 1991). 
Alternatively, a single exposure appears to favour a ThO/Thl profile. Vaccination 
and challenge on the same site leads to downregulation of the IFN7 production in 
nodes previously secreting high levels of this cytokine, and an increase in IL-4, an 
effect reversed by the neutralisation of IL- 10 (Pemberton and Wilson, 1995). Thus 
the absence of any anamnestic Thl response in the LNs may be due to the effects of 
IL-10, acting via antigen presenting cells to anergize the Thl population whilst 
leaving the Th2 response free to develop (Fiorentino et al., 1991 a, Flores Villanueva 
et al., 1993, Gajewski et al., 1994). 
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1.6 2 The Lung and Mediastinal Lymph Node. 
Footpad inflammation assays have demonstrated that a schistosome-specific 
lymphocyte pool present in the circulation expands between day 10 and day 17 post- 
vaccination (Menson and Wilson, 1989, Ratcliffe and Wilson, 1991). The peak 
response to schistosome antigen after vaccination occurs at day 17, and decreases 
again by day 35. The peak response to lung-stage parasites is weaker and occurs 
earlier at day 10 (Ratcliffe and Wilson, 199 1), and both responses can be abrogated 
by prior in vivo administration of anti-CD4 monoclonal antibody. These results 
correspond with data showing that mononuclear cell recruitment to the lungs occurs 
between days 10 and 16 post-vaccination, thus coinciding with the decrease in 
peripheral responses detected by DTH footpad assays (Ratcliffe and Wilson, 199 1). 
Irradiated parasites start arriving in the lungs from day 4 post-vaccination onwards, 
and terminate their migration here (Mangold and Dean, 1984, Mastin et al., 1983, 
1985a). Cell accumulation around the worms can be detected between days 13 and 
21 post-vaccination (Mastin et al., 1983,1985b) as cells are recruited from the 
circulation to parasites trapped in the alveolar spaces. 
Broncho-alveolar lavage (BAL), which samples cells present in the airways of the 
lung, has shown that mononuclear infiltration into the alveoli begins at day 14 and 
peaks at day 21 post-vaccination (Aitken et al., 1988, Menson et al., 1988). The 
influx of cells results in a6 fold increase in macrophage recovery and a 58 fold 
increase in lymphocyte numbers (Menson et al., 1988), as compared to a baseline 
comprising of 90% macrophages in naive mice (Aitken et al., 1987). The recruited 
cell populations persist for at least 10 weeks post-vaccination (Aitken et al., 1988). 
A transient pulmonary eosinophilia also occurs, peaking at day 2 1, when these cells 
account for 30% of the leucocyte influx (Menson et al., 1988). Although there is no 
difference in the cell number recovered at 2 weeks post-infection by BAL from mice 
exposed to vaccinating and normal parasites (Aitken et al., 1988), by week 5 the 
absolute cell numbers recovered from vaccinated mice are much higher, reflecting 
the transient nature of the pulmonary response in a normal infection. 
Cytokine protein production by BAL cells is very limited and appears to be 
derived from the Th I subset of CD4+ T cells (Smythies et al., 1992a and b, 
Mountford et al., 1992). Neutralisation experiments have defined CD4+ cells as 
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producers of the increased levels of IFNy detected in culture supernatents post- 
vaccination. These cells also produce IL-3, but little IL-2 or IL-4, and appear 
incapable of proliferation (Smythies et al., 1992a, Wilson et al., 1996). In contrast, 
splenocytes from vaccinated mice taken at day 14 or 21 can respond to antigen by 
proliferating (Mountford et al., 1992, Smythies et al., 1992a), but display different 
kinetics of cytokine production. IFNy secretion is only detectable in splenocyte 
cultures after 72 hours, compared to 24 hours for BAL cells. Thus it seem 
splenocytes cannot mount a strong recall response upon secondary stimulation in 
vitro, unlike cells recovered from the lungs. This may be explained by the absence of 
parasites or antigen in the spleen after vaccination (Mountford et al., 1988) and 
demonstrates the local, as opposed to systemic, nature of the induced immune 
response. 
Further evidence demonstrating the recruitment of schistosome specific T cells to 
the lungs was obtained by analysis of cells recovered by lavage for the expression of 
memory characteristics (Coulson and Wilson, 1993). BAL cells from the lungs of 
vaccinated mice are capable of mounting a stronger response to mitogen or 
schistosome antigen than splenocytes from the same individual. This observation is 
explained by the upregulation of the p55 subunit of the IL-2 receptor on the surface 
of these cells, indicative of previous activation. In addition, higher numbers of cells 
recovered from the airways express CD44, a marker associated with the memory 
phenotype, compared to LN or peripheral blood lymphocytes, which show only a low 
percentage of memory cells. In contrast, the reverse is true for CD45RB expression, 
a marker which is lost upon activation, demonstrating the naive status of the majority 
of LN and circulating lymphocytes. Therefore the lymphocyte population recruited 
to the lungs post-vaccination appears to be of the memory/effector phenotype. 
Flow cytometric analysis of the alveolar macrophages recovered by BAL has 
demonstrated an increase in la (MHC 11) expression and a decline in F4/80 between 
days 14 and 21 (Menson and Wilson, 1990). These expression profiles are indicative 
of macrophage activation, and indeed alveolar macrophages are capable of mounting 
an oxidative burst between days 14 and 21 post-vaccination (Menson and Wilson, 
1989). This upregulation of macrophage activity coincides with IFNy production 
from Th cells recovered from the mediastinal LN, and from day 21 BAL cells, 
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restimulated in vitro with schistosomal antigen (Menson and Wilson, 1990, Smythies 
et al., 1992a). Indeed, the above cytokine has been implicated as a major activation 
signal for macrophage cytotoxic functions and inflammatory cytokine release, both in 
vitro and in vivo (Murray et al., 1985). 
The results obtained from BAL cells are confirmed by analysis of lymphocyte 
populations extracted from the LN draining the lungs. Peak proliferation in the 
mediastinal LN occurs at day 21 and persists until after day 35 post-vaccination 
(Constant et al., 1990, Constant and Wilson, 1992). This coincides with detectable 
levels of parasite protein (Mountford et al., 1988), and increased secretion of IFNY 
from cultured cells at day 22 (Pemberton et al., 1991). In summary, lymphocytes 
which are recruited to, and persist, in the lungs appear to be of the short term 
memory/effector Th I phenotype capable of elevated IFNy secretion, and may act to 
arm this organ against further infection. 
1.7 Immune Responses Following Challenge 
1.7.1 Immune Responses in the Skin-draining IN after Challenge 
The involvement of the LNs draining the exposure site appear less important after 
challenge than during vaccination (Lewis and Wilson, 1982). There is no anamnestic 
Th I type response, and the increase in IL-4 and IL-10 cytokine release from cultured 
LN cells indicates a tendency towards Th2 development (Pemberton and Wilson, 
1995). Indeed, the circulating T cell population can be depleted by whole body 
irradiation (Vignali et al., 1988, Aitken et al., 1987) with no deleterious effects on 
resistance. This implies that any cell populations which may be elicited in the LN, 
and recruited to the lungs after challenge, are not required for effective challenge 
elimination (Aitken et al., 1987). 
1.7.2 The Site ofParasite Elimination 
The organ in which challenge parasites are eliminated has been in dispute for 
many years. There are two main contested theories, involving attrition in the skin 
and lungs, with evidence available supporting both (reviewed by McLaren, and 
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Wilson and Coulson, respectively, 1989). However, it is agreed that the elimination 
target is the lung stage worm (Ward and McLaren, 1988). With the development of 
more accurate techniques the data supporting lung phase immunity has overwhelmed 
that of skin phase and a brief resume of the experiments leading to the current 
opinion will be described. 
Mincing and incubation studies have detected equal numbers of parasites in the 
lungs of previously vaccinated and control mice (Minard et al., 1978). In addition, 
histological studies indicate that there is no difference between the numbers of 
parasites leaving the skin of vaccinated or control mice (Mastin et al., 1983), and that 
parasites detected in the skin of previously vaccinated animals show no damage 
(Mastin et al., 1983, Von Lichtenberg et al., 1985). Intravenous injection of 
challenge parasites into the lungs gives little or no reduction in resistance (Dean et 
al., 1981b), and 30-50% of injected worms are eliminated in the lungs (Mangold et 
al., 1986, Dean et al., 1981b). These data imply that it is the lungs which represent 
the major migratory hazard for larvae. In support of this, injection of schistosomula 
downstream of the lungs, into the superior mesenteric vein, results in 80% maturation 
of challenge parasites (Mangold et al., 1986). 
Histological sections of lung tissue from vaccinated and challenged mice have 
demonstrated the presence of focus formation around migrating parasites (Von 
Lichtenberg et al., 1985), with no visible damage to the actual worm trapped in the 
centre. Autoradiographic tracking studies have provided information on the timing 
of parasite arrival in the lungs following challenge. Equal numbers of challenge 
parasites reach the lungs of vaccinated mice as in naive controls (Dean et al., 1984, 
Wilson et al., 1986). However, in the former group migration is delayed and fewer 
parasites leave the lungs to continue systemic migration and portal accumulation 
(Wilson et al., 1986). By day 21, when normal migration would be complete, a large 
proportion of challenge parasites can still be detected in the lungs. Challenge 
elimination is thought to start around days 7-12 and continue until at least day 35 
(Wilson et al., 1986). 
Although some parasite attrition may occur in the skin, the data described above 
indicate that the majority of challenge elimination takes place in the lungs. In 
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accordance with this current consensus of opinion, the immune response upon 
challenge will be described for lung phase immunity only. 
1.7.3 The Pulmonary Effector Mechanism 
On the arrival of challenge parasites in the lungs of previously vaccinated mice an 
anamnestic inflammatory response occurs, rich in CD4+ T cells and macrophages, 
resulting in focus formation around each parasite (Kambara and Wilson, 1990, 
Crabtree and Wilson, 1986b, Aitken et al., 1988). Increases in cell numbers 
recoverable by BAL have been reported (Aitken et al., 1988), although other studies 
find no such influx (Menson et al., 1988, Ratcliffe and Wilson, 1992) and the effects 
of whole body irradiation described above suggest no further recruitment is necessary 
for protection. 
Cytokine assays on recoverable BAL populations have implicated IFN7 as the 
major cytokine involved in the effector mechanism. Peak IFN7 secretion occurs at 
day 14 post-challenge and returns to baseline levels by day 22 (Smythies et al., 
1992a). At peak response, this protein can be detected by ELISA without the need 
for secondary stimulation, but at no time can IL-2 or IL-4 be detected in culture 
supernatants by bioassay. However, more recent ELISA data demonstrates a low 
level of IL-4 production (Smythies et al., 1993, Smythies et al., 1996a). Proliferation 
levels were also reduced in BAL cell cultures post-challenge, comparable to levels 
detected after vaccination. Coincidental with peak IFN7 release, alveolar 
macrophages show increased MHC 11 expression (Menson and Wilson, 1990) and are 
capable of mounting an oxidative burst, consistent with cell activation (Menson and 
Wilson, 1989). These immunological effects occur over a period of time 
corresponding to challenge parasite retention in the lungs (Wilson et al., 1986). In 
comparison, inflammation in challenge control mice is delayed by around I week and 
thus materialises too late to prevent worm migration and maturation. 
As described earlier (section 1.5.1), anti-IFN7 antibody administered from days 4- 
16 post-challenge can reduce resistance by 90% (Smythies et al., 1992b). BAL cell 
populations from these treated mice show increased numbers of eosinophils at day 
14, although this cell type has previously been shown to play no role in resistance 
(Sher et al., 1990a). The foci around migrating parasites in IFN7-ablated mice were 
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larger, but looser in composition, and contained many giant cells. It is possible that 
the increase in maturation of challenge parasites following anti-IFNy treatment is 
caused by the ablity of parasites to navigate through the loose foci to continue 
migration. Thus IFN7 may play a role in adhesion molecule (such as LFA- I and 
ICAM-1) upregulation, reducing the ability of cells in IFNy-neutralised animals to 
adhere and form a compact focus (Smythies et al., 1992b, Dustin et al., 1986, Dustin 
and Springer, 1988). 
As mentioned above, parasites arriving in the lungs attract a focus of inflammation 
(Von Lichtenberg et al., 1985). By day 11 post-challenge these foci have increased 
in size and surround schistosomula trapped both in the capillaries and alveoli, in 
contrast to normal infection where only parasites in the alveolar spaces attract foci, 
(Crabtree and Wilson, 1986b). With time, more parasites can be found in alveoli, 
possibly due to the large foci blocking migration routes. Although macrophages 
have the ability to kill schistosomula in vitro (reviewed by James, 1986), these 
studies often involve peritoneal macrophages and newly, mechanically transformed 
parasites, and do not reflect the true in vivo situation in the lungs. However, 
C57BL/6 macrophages are capable of larvacidal activity against skin phase and post- 
lung stage worms (James, 1986, Pearce and James, 1986, James and Glavem, 1989, 
James and Hibbs, 1990). More recently, nitric oxide (NO) synthesis by macrophages 
has been shown to kill newly transformed parasites in vitro (James and Nacey, 
1993). No reports as yet demonstrate the killing of lung stage worms in vitro, and in 
support of this, an experiment blocking NO synthesis in vivo after challenge reported 
no effect on resistance (Smythies et al., 1996b). However, a possible requirement for 
NO release during challenge elimination has been reported recently when prolonged 
suppression of NO synthase activity in vivo resulted in an increase in worm burden of 
12-22% (Wynn et al., 1994a). Furthermore, inducible nitric oxide synthase (iNOS) 
expression can be detected in situ in the foci surrounding the parasites (Wynn et al., 
1994a). 
Although these observations may indicate a role for macrophage larvicidal activity 
in vivo, evidence in support of the theory that parasites trapped in the lungs are 
resistant to the cytotoxic environment surrounding them is strong. Ultrastructural 
studies show no visual damage to the parasites, and no evidence of worm death up to 
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day 35 post-challenge (Crabtree and Wilson, 1986b). Furthermore, trapped parasites 
extracted from the lungs at day 17 are able to migrate and fully mature when 
introduced into a naive host (Coulson and Wilson, 1988, Wilson and Coulson, 1989). 
This would suggest that the effector mechanism is unable to harm trapped parasites, 
and elimination occurs through an indirect mechanism which prevents completion of 
migration and maturation (Smythies et al., 1993). 
1.8 Summary of the Induction and Effector Mechanisms Leading to Protection 
Protective immunity appears to be mediated by two major migration 
characteristics of optimally irradiated cercariae. The slower, truncated migration of 
these parasites and their persistence in the skin-draining LN results in increased 
antigen exposure in the LN during vaccination, compared to a normal infection. The 
cytokine profiles induced during this extended stay in the LN are Th I in phenotype, 
and more intense than those observed following exposure to normal parasites. The 
cell population elicited in the LN is recruited to the lungs, presumably attracted by 
parasites unable to migrate further, and arms that organ against the subsequent arrival 
of challenge parasites. Thus, upon secondary infection the schistosome-specific Thl 
cell population can react quickly to antigenic stimulation. This interaction stimulates 
the release of IFN7 from the CD4+ cell population, resulting in macrophage 
activation. Further secretion of inflammatory cytokines by macrophages and T cells 
might be responsible for the observed rapid focus formation, and hence blocking of 
the exit route from the lungs. 
Trapped parasites probably eventually die by starvation, although cytotoxic 
mechanisms may play a role at later times. In this model the actual cause of death 
would appear to be irrelevant, it being the focus itself that prevents worm migration 
and maturation into an adult, egg laying population. It should be noted that the 
vaccination regime does not provide 100% immunity; some parasites manage to 
negotiate the lungs and proceed with migration to the portal system. The factors 
influencing the differentiation pathways of T-helper subsets, and the effect of the 
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subsequent release of cytokines on the immune response to parasitic infection will be 
discussed in detail in the next section. 
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Part 2. Thl and Th2 Cell Subsets: Cytokine Secretion and Related 
Function. 
2.1 Background 
In 1968 it was found that lymphocyte cell populations fall into two separate 
categories: B cells and T cells, maturing from the bone marrow and thymus 
respectively (Mitchell and Miller, 1968). Subsequently, in 1975, the T cell 
compartment was further divided into two types recognisable by different cell surface 
markers (Cantor and Boyse, 1975). Cells bearing the CD8 suface marker (originally 
designated lyt-2 in the mouse) displayed a cytolytic function and thus were termed 
cytotoxic T (Tc) cells. Cells positive for CD4 (formally lyt-1 and then UT4 in the 
mouse) were designated T-helper (Th) cells due to their ability to aid antibody 
production by B cells. 
In 1986 cellular immunology took a further major step forward when two distinct 
cellular subsets were described for murine CD4+ T cell clones (Mosmann et al., 1986, 
Mosmann and Coffman, 1987, Mosmann and Coffman, 1989). These subsets, named 
Th I and Th2, cannot be distinguished by any surface marker but only by their 
differing patterns of cytokine secretion. Thl clones produce predominantly IFNy, 
IL-2 and TNFP upon secondary stimulation in vitro (Mosmann and Coffman, 1987, 
Mosmann and Coffman, 1989, Cherwinski et al., 1987, Mosmann et al., 1991, 
O'Garra and Murphy, 1994) leading to delayed-type hypersensitivity reactions 
usually indicative of cell-mediated immunity (Cher and Mosmann, 1987). Th2 
clones secrete IL-4, IL-5, IL-6, IL- 10 and the recently discovered IL- 13 (Cherwinski 
et al., 1987, Fiorentino et al., 1989, Doherty et al., 1993). This combination of 
cytokines induces the humoral side of immunity involving B cell help for antibody 
production and immediate hypersensitivity reactions such as those responsible for 
allergic inflammation (Tony et al., 1985, Kim et al., 1985). 
Although initially Th subsets were only described for murine T cell clones, cells 
displaying Th I- and Th2-type characteristics have now been reported in vivo in both 
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man and mouse (Romagnani, 1991,1994, Scott, 199 1, Scott and Kaufman, 199 1). 
When Th I and Th2 secretion patterns were first reported, human clones did not show 
the clear distinctions observed with cells isolated from mice. Primary analysis of 
human clones revealed a mixed cytokine profile involving cytokines from each 
subset expressed by the same population. However, later screening of a panel of 
human T cell clones did detect segregation of cytokine production into patterns 
similar to those seen in mouse T cell populations (Romagnani, 1991,1994). The 
initial results implying that T-helper subsets are a murine phenomenon may have 
arisen due to differences in the methods used to derive T cell clones in mice and man. 
Murine clones are obtained after vigorous immunization and manipulation; these 
procedures are impossible to carry out in humans and thus clones are established 
from normal, healthy individuals. Thus early clones were not derived from cells 
undergoing an intense immune response. However, a panel of human clones 
displaying T-helper subset characteristics was isolated from patients previously 
exposed to Mycobacterium tuberculosis or Toxocara canis, resulting in Thl clones 
specific for purified protein derivative (PPD), or Th. 2 clones responding T Canis 
excretory/secretory antigen respectively (Del Prete et al., 199 1, Romagnani, 199 1, 
1994). 
The discovery of the existence of either Thl or Th_2 extremes in vivo promoted the 
theory that each subset has the ability to cross-regulate the other, resulting in the 
generation and dominance of very different immune responses. Many murine 
models of human disease are now studied to gain insight into the development and 
role of Thl/Th. 2 polarisation in vivo. Thus the cytokine profiles exhibited during the 
induction and execution of a mechanism to deal with various invading organisms 
have been segregated into Thl and Th2 responses. However, evidence is now 
emerging to suggest that this dogma is too rigid and should be relaxed to take into 
account cytokine production patterns observed in CD8+ T cells, and the mixed 
cytokine profiles produced by individual Th cells (Kelso, 1995, Asserimacher et al., 
1994, Mosmann and Sad, 1996). It is becoming clear that the involvement of T- 
helper subsets in infection is not as simple as initially thought, although there are 
some systems which demonstrate clear cut Thl and Th2 dichotomy. The following 
sections aim to provide a current review of T-helper cell immunology and its relation 
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to infection, the investigation of which provides the basis of the research carried out 
in this thesis. 
2.2 Cytokine Secretion by Other Cell Types 
Although cytokines are thought to originate predominantly from CD4+ T cells, it is 
becoming increasingly clear that many other cell types can produce the cytokines 
necessary for Th cell development. The production of cytokines early in an immune 
response may be vital in influencing the direction of T-helper cell development, and 
hence the outcome of infection. With this in mind, intense investigation into the cell 
types responsible for cytokine production during the initial stimulation and 
differentiation of T cell subsets has shown that many cells other than CD4+ can 
secrete a wide range of cytokine profiles. rNIVE 
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The cytotoxic arm of the T cell compartment can secrete a Th I -like profile of 
cytokines such as IFN7, GM-CSF, IL-3, TNFP and TNF(x (Kelso and Glasebrook, 
1984, Taguchi et al., 1990). Although some clones derived from CD8+ cells also 
produce IL-2, this is not found universally. The expression of this range of cytokines 
can induce a similar type of DTH response to that observed upon CD4+ T cell 
polarisation into a Thl population (Fong and Mosmann, 1990). Furthermore, CD8+ 
cells have recently been shown to secrete IL-4 and IL-5 in comparable amounts to 
Th2 cells under certain in vitro conditions (Taguchi et al., 1990, Salgame et al., 
1991, Seder et al., 1992). These data indicate that CD8+ T cells might also segregate 
into Type I and Type 2 subsets, as defined by their cytokine secretion profiles. 
2.2.2 B Cells 
Normal and Ly-l+ (CD5) B cells have been found to express IL-10 mRNA 
(O'Garra et al., 1990, Murphy et al., 1993, Velupillai et al., 1994). Message levels 
were most abundant in the Ly- I subset, and cytokine expression from this cell type 
may be responsible for B cell-mediated immunoregulation or suppression (O'Garra 
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et al., 1990). In addition to IL- 10, murine peritoneal B cells have been shown to 
express IL-6, TNFcc and TNFP (O'Garra et al., 1990). Furthermore, both human and 
murine B cells can express the p3 5 and p40 components of IL- 12 to produce 
biologically active protein (D'Andrea et al., 1992, Mengel et al., 1992) although B 
cells are not considered to be the major producers of this cytokine in vivo 
(Trinchieri, 1995). 
2.2.3 Monocytes and Macrophages 
Both human and murine monocytes have been shown to produce IFNY, IL-1, 
TNF(x, IL- 10 and IL- 12 (Essner et al., 1989, de Waal Malefyt et al., 199 1). These 
cytokines are released coincident with macrophage activation; hence this cell type 
plays a central role in the development of DTH and inflammatory responses. IL- 12 
production is both spontaneous and inducible in adherent human peripheral blood 
mononuclear cell populations (D'Andrea et al., 1992), the effect of which can 
stimulate IFNy production and proliferation in natural killer (NK) and T cells (Chan 
et al., 199 1, Perussia et al., 1992). Thus monocyte-derived IL- 12 might play an 
initial role as the stimulus for Thl differentiation (see section 2.4). Macrophage 
secretion of IL- 10 appears to be later than the typical DTH cytokines such as IFNy 
and TNFa (de Waal Malefyt et al., 199 1). This IL- 10 release is partially inhibited 
(70%) by IL-4, as are other macrophage-derived cytokines (Essner et al., 1989, te 
Velde et al., 1990). In addition, endogenous IL- 10 can depress expression of IL- 1, 
IL-6, IL-8 and TNFa as well as its own message (de Waal Malefyt et al., 1991). 
Thus macrophages appear to posess an inbuilt, self-regulatory inhibitor which is 
produced once the inflammatory response has established, presumably as a means of 
regulating the potentially host-damaging molecules produced during a DTH reaction. 
More recently, macrophages have been shown to secrete IL- 15, an IL-2-like 
cytokine which can stimulate T and NK cell proliferation (Doherty et al., 1996). IL- 
15 expression is more resistant to inhibitors of macrophage cytokine release such as 
IL-4 and IL- 13, and IL- 10 appears to have no effect on production of this cytokine. 
2.2.4 Mast Cells and Basophils 
Murine and human mast cells and basophils are capable of secreting IL-4 and have 
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long been thought of as the driving source of this cytokine behind Th2 development 
(Bradding et al., 1992, Plaut et al., 1989, Ben-Sasson et al., 1990a). However, 
cytokine expression in mast cells appears to require cross-linking of surface Fc 
receptors and thus IL-4 production may not occur early enough to provide naive cell 
priming. In addition to IL-4, murine mast cells can express IL-3, IL-5 and TNF(x 
when triggered by IgE or IgG cross-linking (Latour et al., 1992). 
2.2.5 Natural Killer Cells 
Natural killer cells can release significant quantities of IFN7 and TNF(x, which may 
contribute to Th I -like responses (Aste-Amezaga et al., 1994). The secretion of IFN7 
is stimulated by IL-12 from macrophages (see above), and is thought to provide the 
early source of IFN7 required for Thl differentiation. 
2.2.6 Eosinophils 
Eosinophils have been associated with IL-5 mRNA expression in a human tissue 
from patients with Coeliac disease (Desreumaux et al., 1992). This cytokine may be 
acting as an autocrine differentiation and activation factor, since IL-5 has been shown 
to induce eosinophil differentiation and proliferation (Yamaguchi et al., 1988). 
Furthermore, IL-5 can activate cytotoxic mechanisms in this cell type resulting in the 
release of mediators (Lopez et al., 1988). In addition to IL-5, human eosinophils 
appear to secrete an increasing list of cytokines. At present these include: IL-3 (Kita 
et al., 199 1), IL-6 (Hamid et al., 1992), TNFcc (Costa et al., 1993) and IL-4 (Moqbel 
et al., 1995). Many of these cytokines have been associated with lung inflammatory 
conditions, and research into expression by murine eosinophils is still somewhat 
incomplete in comparison. 
2.3 Functions of Thl and Th2 Subsets as a Result of Their Respective Cytokine 
Secretion 
2.3.1 B cell help 
Cytokine secretion from Th2 cells positively regulates B cell function and the 
27 
production of antibodies, predominantly of the IgGl, IgE and IgA isotypes (Tony et 
al., 1985, Kim et al., 1985, Coffman et al., 1986, Finkelman et al., 1988, reviewed 
by Mosmann and Coffman, 1989, Finkelman et al., 1990). Thl cells and IFN7 can 
also provide some help for antibody production; however, the help is restricted to 
switching to IgG2a isotype production (Snapper and Paul, 1987, Finkelman et al., 
1990). Furthermore, this switch is not solely dependent on IFN7 since antibody 
ablation of this cytokine in vitro only partially inhibits the generation of an IgG2a 
response (Snapper and Paul, 1987, Coffman et al., 1988, Finkelman et al., 1990), and 
IFNy added to Th2 cell cultures is not sufficient to change antibody isotypes from 
IgG1 to IgG2a. 
One of the major cytokines responsible for antibody production, especially the 
induction of IgE, is IL-4. This cytokine can have an effect on the function of B cells, 
T cells, mast cells and macrophages (Mosmann et al., 1986, Mosmann and Coffman, 
1987, Finkelman et al., 1990). The dependence of IgE isotype switching upon IL-4 
has been established both in vivo and in vitro (Coffman and Carty, 1986, Coffman et 
al., 1986,1988, Finkelman et al., 1990) and correlates with an increase in IgG1 
production (Isakson et al., 1982). The presence of these isotypes during an immune 
response is now generally regarded as a marker of Th2 subset activation. However, 
the production of IgG I is less dependent on IL-4 than IgE switching, and ablation of 
IL-4 has little effect on the isotype (Mosmann and Coffman, 1989). In addition, 
IgG I can be produced during a Th I response, whereas IgE is rarely present in these 
situations. 
Thus Thl and Th2 subsets show some degree of characteristic isotype regulation; 
Th I responses leading to IgG2a production and Th2 cytokines promoting switching 
to IgE with IgGl. In general, immune responses involving high antibody titres are 
regarded as polarised towards the Th2 phenotype, with IgE production indicating the 
presence of high IL-4 levels and little IFN7 and Th I -related cytokine expression. 
2.3.2 TO Cell Function 
The cytokines released by Th2 cells, namely IL-4, IL-5, IL- 10 and IL- 13, lead to 
an increase in IgE, mastocytosis and eosinophilia, and an inhibition of macrophage 
activation (Mosmann et al., 1986, Mosmann and Coffman, 1989, Fiorentino et al., 
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199 1 b, Doherty et al., 1993). This combination of immune mechanisms results in an 
immediate type hypersensitivity response similar to that seen in allergy and asthma 
(Romagnani, 1994), with high antibody titres (see above section) and inflammation 
caused by eosinophil and mast cell degranulation. 
2.3.3 Thl Cell Function 
The major response associated with the cytokines released during Th I subset 
activation is classed as DTH (Cher and Mosmann, 1987, Mosmann et al., 199 1). 
Only Thl cell clones can elicit the footpad swelling characteristic of DTH when 
injected with antigen, and many inflammatory responses in vivo correlate with Thl 
cytokine production (reviewed by Romagnani, 1991). Cytokines involved in 
inflammation include IFN7, IL- I P, TNFcc and TNF P, which can be produced by Th I 
-type T cells and macrophages, with the exception of IL- IP which is only produced 
by the latter cell type (Mosmann, 1988). IFN7 is a principal activator of macrophage 
cytotoxicity, affecting the production of nitric oxide which in turn inactivates the 
enzymes critical for DNA replication, the citric acid cycle and mitochondrial 
respiration (James and Hibbs, 1990, Gazzinelli et al., 1992a). The release of 
inflammatory cytokines from activated macrophages and Thl cells can be severely 
downregulated by the Th2 cytokines IL-4, IL-10, IL-13 and TGFP (see cross 
regulation section). 
A important factor in the development of a DTH response is the accumulation of 
cells at the site of infection. Recent studies into the possible mechanisms reponsible 
for the recruitment of Th I cells to the area of inflammation have implicated 
RANTES (Regulated upon Activation of Normal T cells Expressed and presumably 
Secreted, Rathanaswami et al., 1993) as an important chemokine in human DTH 
reactions. This chemokine is a selective recruiter for human monocytes and memory 
T cells (Schall et al., 1990, Rathanaswami et al., 1993, Devergne et al., 1994), yet its 
role in murine responses has not been fully evaluated. RANTES is released by 
macrophages, possibly acting as a self-perpetuating factor for granuloma formation 
by those macrophages already at the site (Dervergne et al., 1994) . In addition, 
endothelial cells, activated T cells, epithelial cells (Schall et al., 1990) and fibroblasts 
(Rathanaswami et al., 1993) can all secrete this chemokine. RANTES expression is 
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upregulated by the Th I cytokines IFNy and TNF(x, which are produced by 
macrophages and T cells, and IL- 10 from macrophages (Rathanaswarni et al., 1993, 
Arend et al., 1989, Donnelly et al., 1991). In contrast, RANTES is not expressed in 
tissues undergoing a humoral immune response, and is downregulated by IL-4 
directly, and by IL-4 and IL- 10 indirectly via inhibition of IL- I P, TNF(X and IFNy 
release by macrophages and Thl cells (Essner et al., 1989, te Velde et al., 1990, 
Rathanaswami et al., 1993). RANTES has also been shown to attract eosinophils in 
vitro, but since these cells are not usually present in natural DTH reactions this effect 
may be inhibited by other factors in vivo (Alam et al., 1995). Moreover, it has 
recently been demonstrated that human eosinophils can express and secrete 
RANTES, and thus an autocrine role for this chemokine in allergic inflammation 
might yet be defined (Ying et al., 1996). 
2.3.3 CD8+ T Cell Help 
Both Thl and Th2 cells can release cytokines that provide help for cytotoxic T 
cells and cause an upregulation in the expression of MHC class 11 on some APCs 
(Mosmarm and Coffman, 1987,1989). Most notably, IL-2 provides help for CD8+ 
cell expansion and upregulation, a cytokine which is absent or expressed at very low 
levels by CD8+ T cells themselves. 
2.4 Differentiation of Thl and Th2 Cell Populations. 
Early studies involving T cell clones in both murine and human systems found that 
some clones could not be segregated into either Thl or Th2 types, but secreted a 
mixed cytokine profile (Romagnani, 1991,1994, Mosmann and Coffman, 1987, 
1989). It was later proposed that these clones might be displaying an earlier 
phenotype of Th I /Th2 differentiation than established clones, and at this stage IFN7, 
IL-2, IL-4 and IL-5 can all apparently be secreted by the same cell (Firestein et al., 
1989, Gajewski and Fitch, 1988, Openshaw et al., 1995). These mixed T-helper type 
cell populations were designated ThO, and since their discovery the search for the 
factors and conditions necessary to promote their development into a primary 
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response of the Thl or Th2 type has been intense. Basic questions to be addressed 
included whether both Th I and Th2 cells differentiate via a ThO phenotype but 
segregate due to differing cytokine and APC exposure, or if naive cells are 
precommitted as precursor Thl and Th2 cells (ThIp and Th2p) to become one subset 
or the other upon maturation (Mosmann and Coffman, 1989). The factors leading to 
the dominance of one T-helper subset over the other and the proposed differentiation 
pathways are intricate, hence an overview of the current hypothesis is described 
below. 
2.4.1 Growth Requirements of Th Cell Clones 
Investigations into the growth of T cell clones in vitro have indicated differences 
in the timing and responsiveness of the two cell subsets to IL-2 and IL-4, the 
cytokines produced by Thl and Th2 cells respectively. Both types of clone can 
proliferate vigourously in response to IL-2, and to a lesser extent IL-4. However, the 
Th I response to IL-4 is low, and weakens with time. In contrast, Th2 cells respond 
to the effects of IL-4 longer than Th I cell clones but still require IL-2 for growth 
(Fernandez-Botran et al., 1986,1988). The dependence of CD4+ T cells on IL-2 for 
proliferation has been further demonstrated by the generation of transgenic mice 
containing the Herpes Simplex Virus thymidine kinase (HSV-tk) gene linked to the 
IL-2 promotor (Minasi et al., 1993). Culture of cells from these animals in the 
presence gancyclovir to prevent the production of endogenous IL-2 results in 
abrogation of proliferation in response to superantigen. 
The response of T-helper subsets to their own cytokines may indicate that 
proliferation is under autocrine control at the population level ( Mosmann and 
Coffman, 1989, Ferriandez-Botran et al., 1988). In addition to cytokine stimulation, 
costimulatory molecules play an important role in primary growth responses. 
Signalling through the B7/CD28 pathway is required for naive T cell development 
both in vitro and in vivo, although the addition of IL-2 appears to bypass the need for 
accessory cell presence during primary stimulation (Seder et al., 1994). The 
importance of costimulation in the differentiation of Th cell subsets is described in 
section 2.4.5 
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2.4.2 The Role of Cytokines in Th Cell Differentiation 
Two main approaches have been used to investigate the development of Th cells 
from naive precursors. The first involved in vitro culture of naive T cells or ThO 
clones in the presence of mitogen and various cytokines or anti-cytokine antibodies. 
However, recent transgenic mouse technology has permitted the development of 
animals with a modified (xp T cell receptor (TCR) specific for an antigen that the 
animal would not normally encounter in vivo, for example ovalburnin (Hseih et al., 
1993, O'Garra and Murphy, 1994 , Seder et al., 1992, Scott, 1993a). This results in 
the isolation of true naive cells which can then be stimulated either in vitro or in vivo, 
reproducing a more natural pathway of activation in the presence or absence of 
various cytokines. 
The major cytokines implicated in T-helper cell differentiation are IL-4 with 
regard to Th2 cell development (Swain et al., 1990, Croft and Swain, 1995, LeGros 
et al., 1990, Seder et al., 1992a, O'Garra and Murphy, 1994), and IFNy and IL- 12 for 
Thl development (GaJewski and Fitch, 1988, Hsieh et al., 1993, Seder et al., 1993, 
Manetti et al., 1993,1994). The cell types responsible for the initial production of 
these cytokines required for subset differentiation have also been extensively studied. 
The Leishmania major infection model in mice has proved an ideal system in which 
to analyse the development of T cell subsets due to the two extremes of response 
seen in mice infected with the parasite. Self-healing strains produce a strong DTH 
response with Thl cytokine secretion, whereas non-healing mice die due to disease 
exacerbation as a result of Th2 cytokine profiles (Heinzel et al., 1989,1993b, Scott, 
1993a, Reiner and Locksley, 1995). This model will only be discussed with strict 
relevance to the cytokine factors necessary for subset development in this section, the 
model as a whole will be discussed more thoroughly in section 2.6. 
2.4.3 IL-4 and Th2 Development 
As mentioned above, IL-4 is crucial to the development of a Th2 cell population in 
both in vitro and in vivo systems (Swain et al., 1990, LeGros et al., 1990, Scott, 
1993a and Vella et al., 1992, Vella and Pearce, 1992). The cell type acting as the 
primary source of this cytokine is still not clear, although possiblities include T cells 
themselves, mast cells and basophils. There is some evidence to suggest that naive T 
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cells (CD44 LO) can spontaneously produce IL-4, especially if repeatedly stimulated 
with antigen (Vella et al., 1992, Croft and Swain, 1995). This contradicts earlier 
findings that only CD44H' cells can produce cytokines other than IL-2 (Budd et al., 
1987), although these differences may be due to differing levels of sensitivity in the 
cytokine assays. However, mast cells and basophils can both secrete IL-4 and may 
provide the initial burst of the cytokine to initiate Th2 development (Ben-Sasson et 
al., 1990a, Mosmann et al., 1991, Bradding et al., 1992, Scott, 1993a, Mosmann and 
Sad, 1996). Furthermore, a population of cells bearing the markers NKL 1, CD4, and 
CD44 has been isolated which can produce IL-4 without the requirement for initial 
IL-4 presence (Yoshimoto and Paul, 1994). 
Although the development of both Th2 and Thl cell populations requires IL-2, 
exogenous IL-4 directs development towards a Th2 phenotype and decreases the 
number of IFN7 and IL-2 producing effectors (Swain et al., 1990, LeGros et al., 
1990, Macatonia et al., 1993). The presence of high levels of IL-4 in primary culture 
conditions can reduce the number of IFN7 producing cells, resulting a population 
displaying predominantly Th2 characteristics (Swain et al., 1990, LeGros et al., 
1990). In addition, studies involving the in vitro stimulation of naive CD4+ T cells 
from up TCR transgenic mice have shown that the presence of IL-4 determines the 
development of these cells into IL-4-secreters (Seder et al., 1992a, Macatonia et al., 
1993). Thus it is generally accepted that IL-4 is critical for the polarisation of naive 
CD4 +T cells into an IL-4-producing Th population. 
2.4.4 IFNr, IL-12 and Thl Development 
Although the direct involvement of IFNy in the generation of Thl cell populations 
has been more difficult to demonstrate than the role for IL-4 in Th2 development, 
there is some evidence to suggest that this cytokine can promote Thl cell polarisation 
by inhibition of Th2 proliferation (Gajewski and Fitch, 1988, Seder et al., 1993). 
IFNy has been reported to drive naive T cells towards a Thl pattern of cytokine 
secretion in some instances, but is ineffective at activating resting memory cells 
(O'Garra and Murphy, 1994). Furthermore, addition of IFNy to primary cultures of 
ocP TCR transgenic T cells is not sufficient for the development of a Thl cytokine- 
secreting cell population (Hseih et al., 1993). More recently, IL- 12 has been 
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implicated as the Thl equivelent to IL-4 (Hsieh et al., 1993, D'Andrea et al., 1992, 
Sher et al., 1993). IL- 12 is produced by macrophages, dendritic cells and B cells 
(D'Andrea et al., 1992, Trinchieri, 1995), and can act to stimulate IFNy production 
from T cells and NK cells so driving development towards a Thl population 
(Perussia et al., 1992, Seder et al., 1993, Manetti et al., 1993,1994, Hsieh et al., 
1993). The association between IL-12 and Thl cell induction may have developed 
through innate response mechanisms, since it has been shown that pathogens which 
induce Th I -like profiles upon infection also induce IL- 12 production upon infection, 
for example in Staphylococcus aureus (D'Andrea et al., 1992) and Toxoplasma 
gondii (Sher et al., 1993). 
The macrophage is thought to be the major cellular source of IL- 12 during the 
initiation of a primary response (reviewed by Scott, 1993b, Trinchieri, 1995). IL- 12 
produced from macrophages can act synergistically with TNFoc and IL- I P, which are 
also produced by these cells, to give optimal proliferation of Th I cells (Trinchieri 
and Scott, 1994). In addition, IL- 12 might act both directly through receptors on the 
T cell itself, and indirectly via IFNy production by NK cells (Scharton and Scott, 
1993, Hsieh et al., 1993). Acting independently of IFNy, IL- 12 can reduce IgE levels 
by Th. 2 stimulated B cells and can suppress Th2 development in vivo (Manetti et al., 
1993). IFNy from NK and T cells can stimulate a positive feedback mechanism for 
more IL- 12 production from macrophages (reviewed by Trinchieri, 1995). 
Furthermore, there is some evidence to suggest that IFNy may be required for the 
initial stimulation of IL-12 secretion from macrophages (Trinchieri, 1993,1995) and 
can upregulate transcription of both the p35 and p40 subunits required for 
biologically active IL- 12 (Ma et al., 1996). 
Although IFNy appears to have a positive effect on the expression of IL-12, the 
ability of IFNy gene-disrupted mice to produce IL- 12 would seem to indicate that this 
cytokine is not an absolute requirement (Wynn et al., 1995b). Furthermore, addition 
of IL-12 to primary cultures of naive T cells results in the development of Thl 
clones independently of accessory cell presence (Seder et al., 1993, Macatonia et al., 
1993). In contrast, IFNy appears to have little effect in either APC-dependent or 
independent priming. Further evidence supporting the proposal that macrophages 
provide the initial burst of IL- 12 comes from studies involving primary stimulation 
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of T cells in the presence of various APCs. If B or dendritic cells are used as the 
APCs, exogenous IL-12 is required to promote Thl development whereas 
macrophages require no additional cytokine presence (Hsieh et al., 1993). IL-12 
produced by macrophages has also been shown to stimulate cytokine production by 
NK cells independently of T cell presence, either alone, or in combination with 
TNFa and IL-2 (Gazzinelli et al., 1993). 
IL- 12 secretion can be inhibited by IL-4, IL- 10 and TGF P, presumably through the 
downregulatory effects of these cytokines on macrophage cytokine expression 
(Fiorentino et al., 199 1 b, Tripp et al., 1993, D'Andrea et al., 1993). IL-4 appears to 
have a dominant role over IL-12, since Th2 development can occur in the presence of 
IL- 12 (Trinchieri, 1993, Trinchieri and Scott, 1994, Reiner et al., 1994, Reiner and 
Locksley, 1995). Moreover, combining IL-12 and IL-4 in primary cultures leads to 
development of a Th2-like population (Seder et al., 1993, Hsieh et al., 1993). 
With human T cell lines, clones which usually develop into Th2 cytokine 
producers upon in vitro culture can be induced to produce more IFNY and reduced 
levels of IL-4 if derived in the presence of IL- 12 (Manetti et al., 1993). Th I -type 
clones derived in the presence of anti-IL-12 display a ThO phenotype, whereas 
transient IFNy production can be observed in established Th2 clones cultured with 
IL-12, although the Th2 phenotype is not permanently reversible (Manetti et al., 
1994). 
Finally, an alternative early source of IFNy for Th I development might be 76 T 
cells, which have been detected within the first three days of Listeria innoculation 
into the peritoneal cavity (Hiromatsu et al., 1992). Furthermore the presence of these 
cells in lesions induced by infection with Leishmania maj . or implies that they may 
contribute to an early burst of IFNy to increase IL-12 expression and hence Th I 
polarisation (Scott, 1993b). 
2.4.5 The Influence of Costimulatory Molecules and Antigen Presenting Cells on 
ThIlTh2 Development 
The interaction of APC with naive T cells is thought to play an important role in 
the determination of the outcome of primary stimulation. The factors responsible for 
stimulation include: the primary engagement of the TCR with MHC class II 
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displaying antigen, and a secondary signal from costimulatory molecules present on 
the surface of the APC. The importance of accessory signals during the in vivo 
induction of an immune response is becoming evident from numerous studies on 
costimulatory molecules such as the B7 family, ICAM- I and some cytokines 
(reviewed by Linsley and Ledbetter, 1993, Jenkins, 1994, Linsley, 1995, Allison and 
Krummel, 1995). 
In vitro studies have indicated that naive T cells require interaction with 
professional APCs displaying high levels of costimulatory molecules for activation 
(Larson et al., 1994, Murphy et al., 1994, Croft et al., 1994, Croft and Swain, 1995, 
Kawamura and Furue, 1995). Thus dendritic cells, Langerhans cells and activated 
macrophages and B cells can act as superior APCs for naive T cells, whereas resting 
macrophages and B cells are inefficient at promoting expansion (Croft and Swain, 
1995). 
Although the involvement of B7 on APCs and CD28 on T cells was thought 
initially to be a simple model of primary stimulation, the discovery of families of 
receptors and ligands with differing affinities and expression profiles has revealed a 
more complicated mechanism. There are now two known members of the B7 family, 
137-1 and B7-2, with a possible third under investigation (Kawamura and Furue, 
1995). B7-1 and 137-2 are expressed by macrophages, dendritic and Langerhans 
cells, and B and T lymphocytes (Hathcock et al., 1994); both these molecules can 
provide costimulatory signals for naive T cells independently of each other. Further, 
137-2 is constitutively expressed on most APCs and can be upregulated to high levels 
by IL-4 and IFNy (Kuchroo et al., 1995, Kawamura and Furue, 1995, Morokata et 
al., 1995, Larsen et al., 1994). In contrast, B7-1 is expressed upon cell activation and 
is upregulated in vitro by the action of IL-4, and inhibited by IFNy (Kawamura and 
Furue, 1995). Both 137-1 and B7-2 are downregulated by IL-10, possibly explaining 
the inhibitory effects this cytokine has on the capacity of macrophages to act as 
APCs (Ding et al., 1993, Kawamura and Furue, 1995). 
Similarly there are two main receptors for these ligands on T cells, CD28 and 
CTLA-4. CD28 is expressed constitutively at high abundance, but has a low affinity 
for both 137-1 and 137-2 (Linsley, 1995, Allison and Krummel, 1995, Kuchroo et al., 
1995). In contrast, CTLA-4 is highly inducible but has low abundance before 
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activation, and binds B7-1 and 137-2 with a greater affinity than CD28. Thus it 
initially appeared that CD28 and CTLA-4 may cooperate in the activation of T cells. 
However, recent research into the functions of the components of this costimulatory 
pathway has highlighted an inhibitory role of CTLA-4 on T cell expansion. The 
main evidence for this has come from the generation of CTLA-4 gene-disrupted mice 
(Waterhouse et al., 1995). These animals exhibit extensive lymphoproliferation, 
with infiltration of activated lymphocytes into the major organs of the body. It 
would therefore seem that CTLA-4 acts as a natural negative regulator of the T cell 
response (Allison and Krummel, 1995). Furthermore, overlap between the function 
of CD28 and CTLA-4 also appears unlikely due to the observation that CTLA-4 
cannot compensate for the reduced levels of stimulation in CD28 gene-disrupted 
mice (Shahinian et al., 1993). These animals have some limited T cell activation and 
DTH responses, however, reduced IL-2 levels appear to correlate with diminished T 
cell help for antibody class switching. 
The roles of B7-1/-2 and CD28/CTLA-4 in the induction of the primary immune 
response has been investigated in vitro and in vivo. Some published data describe the 
development of Th2-like cells following in vitro stimulation of naive or ThO cells in 
the absence of costimulatory signals (Gajewski et al., 1994, Croft and Swain, 1995). 
Populations displaying ThO cytokine secretion profiles lose the ability to secrete Thl 
cytokines such as IL-2, and progress to develop Th. 2 characteristics (IL-4 and IL-5 
release) when stimulated by TCR cross-linking alone (GaJewski et al., 1994). 
Furthermore, this population subsequently becomes Th2-like in the calcium levels 
required for intracellular signalling pathways. Th I cells typically show an increase 
in Ca 2+ when activated via the TCR. However, Th2 clones exhibit higher basal 
levels of Ca 2+ and cytokine synthesis appears relatively insensitive to changes in this 
ion (Gajewski et al., 1989,1994, Quill and Schwartz, 1987). 
Repeated stimulation, or the presence of high levels of antigen can overcome the 
need for costimulation or exogenous cytokine presence (Croft and Swain, 1995). 
Naive T cells stimulated in vitro under these conditions appear able to produce 
enough endogenous IL-4 to facilitate the development into a Th. 2 population. In 
contradiction to this in vitro finding, in vivo manipulation of the B7 costimulation 
pathway has demonstrated that Th2 cell development is more dependent on accessory 
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molecules than Th I (Corry et al., 1994). Administration of CTLA-41g ftision protein 
to block B7 interaction with T cells can abrogate susceptibility to Leishmania major 
infection in BALB/c mice if given in the first week. However, this treatment has no 
effect on the development of a protective response in C57BL/6 animals. Other in 
vivo evidence supporting the requirement of costimulation for Th2 cell polarisation 
includes: the observation that CTLA-41g transgenic mice, which express extremely 
high levels of soluble CTLA-4, develop diminished Th2 populations, and the reduced 
ability of CD28 knockout animals to mount antibody-mediated responses (Ronchese 
et al., 1994, Corry et al., 1994, Shahinian et al., 1993). 
Alternative pathways in the in vitro stimulation of naive T cells have been reported 
which do not encompass costimulation with CD28/137, but depend on the addition of 
exogenous cytokines. Cell populations displaying Th2 characteristics can be derived 
in vitro by culturing with exogenous IL-2 (Seder et al., 1994). Furthermore, APCs 
deficient in CD28 can provide priming for Th2 differentiation if additional IL-2 and 
IL-4 are incorporated into the culture medium, or the addition of IL-2 alone can 
result in the generation of Thl cells (Seder et al., 1994). 
Much of the investigation into T cell costimulation has been carried out in vitro on 
naive ThO cell clones and established Th I /Th2 cell lines. Thus the conditions and 
outcome of manipulation may not reflect the true in vivo situation. Some reports 
have described the induction of anergy in Thl clones stimulated in the absence of 
costimulatory molecules (Gajewski et al., 1990, Jenkins, 1994). In contrast, 
established Th2 clones are reported to require no costimulation if cultured at high 
density, and can rapidly secrete ThO-Iike cytokine profiles upon the engagement of 
the TCR alone through the autocrine production of IL- I (Zubiaga et al., 199 1, Croft 
and Swain, 1995). Thus cytokine secretion from memory-type cells may not require 
the same high costimulatory signals as naive T cell activation, and APCs displaying 
lower levels of B7, such as resting macrophages and B cells, may be able to provide 
all the signals necessary for reactivation (Croft et al., 1994). However, this is 
disputed by other data detailing the induction of anergy in both murine and human 
Thl and Th2 cells stimulated in the absence of B7/CD28 (Yi-qun et al., 1996, 
Gimme et al., 1993), although recently activated murine T cells seem able to forego 
costimulation (Yi-qun et al., 1996). 
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The differential regulation of Thl and Th2 activation by costimulatory molecules 
has been reported with reference to the timing of the secondary signal. In the 
activation of Thl clones, CD28 engagement induces autocrine IL-2 production and 
cell expansion. In contrast, Th2 cells require IL-4 for activation. However, in order 
to respond to increased IL-4 levels the cells require IL- 1, presumably derived from 
the APC (McArthur and Raulet, 1993). Thus in Th2 clones costimulation results in 
the increased responsiveness to IL-4, and B7/CD28 is not required if exogenous IL- I 
is added to the cultures. Optimal stimulation of human and murine Th I clones can 
be achieved with the addition of IL- 12 into the culture medium (Murphy et al., 1994, 
Kubin et al., 1994). Thus IL- 12 appears to synergise with costimulatory signals 
through the B7/CD28 pathway in the stimulation of Thl development. 
Finally, investigations into the possible differential roles of the costimulatory 
molecules have shown that 137-1 and 137-2 can induce Thl and Th. 2 differentiation 
respectively (Kuchroo et al., 1995). The addition of anti-137-1 antibody during in 
vitro stimulation results in the generation of a Th2-like population with IL-4 
secretion, whereas anti-137-2 results in IFNy secretion. This has been confirmed in 
vivo by the abrogation of encephalomyelitis with the administration of anti-137-1 to 
reduce Thl development and promote healing Th2 cytokine secretion (Kuchroo et 
al., 1995). 
2.4.6 Thl and Th2 Development: The Hypothesis 
The current dogma for differentiation of T-helper phenotypes involves 
progression of T cells through various stages of activation and cytokine secretion. 
Upon primary stimulation of naive T cells, IL-2 is the only cytokine produced, 
closely followed by low levels of IL-4 secretion, both these cytokines are required 
for T cell proliferation and growth (reviewed by Mosmann and Coffman, 1989, Croft 
and Swain, 1995 Mosmarm and Sad, 1996). This stage in development has been 
summarised as a T-helper precursor cell (Thp). The next stage of differentiation is 
characterised by secretion of a mixed Thl/Th2 profile of cytokines including IL-2, 
IL-3, IL-4, IL-5, IL- 10 and IFN7 with cells designated as possessing a ThO phenotype 
(Firestein et al., 1989). This pattern of secretion appears to be short-lived, especially 
in vivo, and the cell population rapidly progresses into Th I- or Th2-type secretors, 
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secretors, depending on the cytokine environment, type of APC and costimulation 
signal. Thl and Th2 cells can return to the restricted IL-2 secreting phenotype when 
they become memory cells with the cell markers CD45RB'O, CD44 hi , L-Selectinio 
(Mosmann and Moore, 1991). Memory cells can be directed to develop into Th I or 
Th2 populations rapidly upon secondary stimulation with APC and antigen, possibly 
with less restricted costimulatory requirements. 
Based on the similarity in intracellular Ca 2+ profiles upon activation, some reports 
have suggested that precursor Thp cells can develop directly into Th I -type 
populations (Gajewski et al., 1994). ThO cells show an intermediate calcium profile 
between that for Thp and Th2 cells, indicating that ThO may represent a step in Th2 
development rather than a stage between Th I and Th2 differentiation. The 
precommitment of Thp cells to either Th I or Th2 subtypes before primary 
stimulation was a convincing hypothesis for immune response development, but has 
recently been disputed by analysis of transgenic animals with the HSVtk gene 
situated behind the promoter for the IL-4 gene (Kamagowa et al., 1993). When cells 
from these mice are activated in vitro in the presence of gancyclovir any cell 
producing IL-4 is eliminated, and thus the role of IL-4-producing cells in T cell 
differentiation can be defined. Results from these investigations have indicated that 
IL-4- and IFNy-secreting cells originate from the same precursors which can express 
IL-4, implying that Thl and Th2 cells may differentiate from the same cell 
population. 
2.5 Cross Regulation of the Thl and Th2 Responses 
Thl and Th2 subsets represent the extremes of CD4+ T cell polarisation, resulting 
in DTH or antibody-based immune responses respectively. These responses are 
mutually exclusive, which implies that a counter regulatory mechanism must exist 
between them. IFN7 has been found to inhibit Th2 effector function by suppressing 
proliferation of this subset (Gajewski and Fitch, 1988). However, it appears that 
IFN7 has no effect on cytokine secretion from Th2 cells, and hence the decreases 
observed in cytokine secretion are due to the reduction in cell number rather than 
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inhibition of gene transcription. IL-12 may also have the capability to reduce IL-4 
levels and thus inhibit Th2 population development (Manetti et al., 1993, Finkelman 
et al., 1994, Trinchieri, 1995), although it has recently been observed that murine 
Th2 cells lose the ability to respond to IL-12 receptor signalling and thus any effect 
must occur early during differentiation (Szabo et al., 1995). 
In response to the regulation of Th2 populations by IFN7 and IL-12, the Thl 
subset can be downregulated by IL-4 produced by Th2 cells, and IL- 10 produced by 
Th2 cells and macrophages (reviewed by Mosmann and Moore, 1991, Mosmann and 
Coffman, 1989, Moamann and Sad, 1996). IL- 10 is thought to be the major 
regulatory cytokine involved in modulating the Th I and inflammatory immune 
responses, and can execute this affect via a variety of mechanisms. This cytokine can 
suppress Thl activity by inhibiting the production of IFNy and IL-2, seemingly via 
inhibition of macrophages and their inflammatory cytokine release (Fiorentino et al., 
1989,1991a, 1991b, Moore et al., 1990). The in vitro downregulation of Thl 
populations only occurs when macrophages are the acting APC; there is no effect 
when the macrophages are replaced with B cells. The ability of macrophages to 
induce a Th2 response is not impaired, and therefore IL- 10 may be acting on the 
expression of costimulatory molecules and independently of TCR-MHC interactions 
(Fiorentino et al., 199 1 a, Ding et al., 1993, Kawamura and Furue, 1995). This 
observation might explain the lack of effect on Th2 cell induction, a process thought 
to require less costimulation than Thl populations (Croft and Swain, 1995). Not all 
inhibition by IL- 10 can be attributed to macrophages; inhibition may also affect other 
APC populations such as dendritic cells. However, B cells are not inhibited by IL- 
10, and indeed the Ly- I /CD5 subset of this population has been shown to produce 
this cytokine (O'Garra et al., 1990, Murphy et al., 1993). IL- 10 inhibition of T cell 
proliferation has also been reported in human systems (Taga and Tosato, 1992), 
although the production of this cytokine by both human Thl and Th2 cells implies 
that a more general suppression of the immune response occurs rather than regulation 
solely of Thl popularions (Romagnani, 1994). 
It is well documented that IFNy can act as a potent upregulator of macrophage 
activation and the resulting inflammatory cytokine release (Fiorentino et al., 1991 a, 
1991 b, Gautharn et al., 1992, Gazzinelli et al., 1992a). IL- 10, and to a lesser extent 
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IL-4, can inhibit IL-I, IL-6 and TNFa production in macrophage cell lines and 
peritoneal macrophages (te Velde et al., 1990, Essner et al., 1989, Fiorentino et al., 
1991 a and 199 1 b). The downregulation of TNFa may also act to inhibit the Th I 
response, since TNFcc is a cofactor for the production of IFNy from murine T and NK 
cells, which in turn is thought to be important in the polarisation of a Thl population. 
IL- 10 inhibition of IFN7 production can be overridden by the addition of exogenous 
TNFcc (Fiorentino et al., 199 1 a, 199 1 b). However, TNF(x stimulation of human T 
cells is insufficient to stimulate the secretion of IFN7, and thus it is unlikely that the 
major inhibitory effect of IL-10 acts via the downregulation of TNFcc (D'Andrea et 
al., 1993). An effect of IL- I 0-mediated downregulation of IFN7 is the inhibition of 
NO production by macrophages, so reducing microbicidal activity (Gazzinelli et al., 
1992b). 
IL- 10 can also inhibit IL- 12 production by macrophages and dendritic cells 
(D'Andrea et al., 1993, Trinchieri and Scott, 1994). This in turn will downregulate 
the production of IFNy. Thus, in conjunction with the downregulatory effects upon 
the costimulatory family of B7 molecules and cofactors TNFcC and IL- I (Kubin et 
al., 1994), IL- 10 can inhibit IFN7 release and hence Th I development. IL- 10 
suppression can be overridden in human systems by addition of IL-12 and IL- I 
(D'Andrea et al., 1993). 
The ability of IL- 10 to depress the inflammatory response has been put to good 
use by the Epstein Barr Virus (EBV), which contains an open reading frame in the 
viral genetic code homologous to IL- 10 (Moore et al., 1990). When translated, this 
protein can inhibit IFNy production in vitro by both isolated murine T cells and 
human PBMC, mainly from NK cells in the latter population (Hsu et al., 1990). 
Thus production of this IL- 10 homologue by B cells infected with the virus may 
protect these cells from host attack during viral replication (Mosmann and Moore, 
1991). In addition to depressing cytokine production by macrophages and CD4+ T 
cells, IL-10 can also act to downregulate Thl -like cytokine production from murine 
CD8 + (Mosmarm and Moore, 199 1) and NK cells (Sher et al., 1992) resulting in 
suppression of all sources of Thl-like cytokines. 
IL-4 is the other major Th2 cytokine thought to exert control over Thl responses 
and thus enhance the expansion of Th2 cells. This cytokine can downregulate IFN7 
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synthesis and T cell proliferation (Peleman et al., 1989, Vercelli et al., 1990, 
Martinez et al., 1990) and inhibit macrophage cytotoxic functions and cytokine 
expression (Essner et al., 1989, te Velde et al., 1990, Sher et al., 1992, Oswald et al., 
1992, Gautharn et al., 1992). In addition, IL-4 can regulate IL- 12 production, and 
thus the development of a Thl response, via the inhibition of cytokine release from 
monocytes and macrophages (Doherty et al., 1993, Trinchieri, 1993,1995). Hence 
IL-4 has become the major marker for Th2 cell polarisation and ongoing antibody- 
mediated effector responses. 
A recently discovered cytokine with IL-4 properties, IL- 13, has also been found to 
have suppressive effects on cell-mediated immunity (Minty et al., 1993, Doherty et 
al., 1993). This cytokine is produced by Th2 cells and inhibits both murine and 
human macrophage cytotoxicity and inflammatory cytokine release. In addition, 
human IL- 13 can upregulate IgE production from B cells, although this function has 
not been described in the mouse (McKenzie et al., 1993). Murine IL- 13 suppresses 
monokine release in response to IFNy or LPS (lipopolysaccharide) stimulation, thus 
decreasing IL- 12 and NOS production at the transcription level (Doherty et al., 
1993). This reduction in cell activity has been illustrated by enhanced survival of 
Leishmania major parasites in macrophages cultured in vitro in the presence of IL- 13 
(Zurawski and DeVries, 1994). 
Finally, TGFP produced by macrophages, T and B cells can have a general 
downregulatory effect on macrophage cytokine production, lymphocyte proliferation 
and NK cell effector function (Silva et al., 1991). This cytokine can act on many 
components of the immune response, but in contrast to early in vitro studies 
suggesting that TGFP can promote Thl cell expansion (Swain et al., 1991), recent 
data has implied that the converse is true (Schmitt et al., 1994). In fact, TGFP can 
strongly inhibit IFN7 production in response to IL- 12 stimulation, and prevent IL- 12- 
induced Thl development. Furthermore, TGFP can inhibit NK cell activity; thus 
depletion of this cytokine in mice infected with Leishmania major can lead to 
enhanced Th 1 responses and resistance in susceptible strains (Su et al., 199 1, Barral- 
Netto et al., 1992). 
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2.6 Models of Parasitic Disease: The Relevance of Thl. and Th2 Subsets 
2.6 1 Introduction 
By the very nature of parasitic infections, the immune response against the 
invading organism is strong and sustained. This provides the stimulation necessary 
to make parasitic models ideal in vivo systems in which to study the induction, 
polarisation and cross-regulation of T-helper subsets. The ease of manipulation 
provided by animal models has permitted the detailed examination of induction and 
effector mechanisms generated upon infection, and allowed the development of 
various vaccination strategies. During these investigations, an abundance of 
information on the immunology of T-helper cells has been described. Many parasitic 
infections have been found to provoke the development of one Th subset over the 
other. This has lead to the general observation that intracellular invaders such as 
protozoa, bacteria and viruses induce cell-mediated Th I -type responses, whereas 
multicellular organisms such as helminths lead to the development of humoral Th2 
responses (reviewed by Scott and Kaufman, 1991, Scott et al., 1989, Sher et al., 
1992, Sher and Coffman, 1992, Romagnani, 1994). The immune mechanism 
generated upon infection is not always in the best interest for survival of the host, the 
inappropriate production of cytokines sometimes leading to pathology rather than 
cure. This section will briefly discuss the induction of T-helper subsets following 
infection with various pathogens, with special emphasis on the induction and effector 
mechanisms employed in the murine models of leishmaniasis and schistosomiasis. 
Both these systems have provided valuable information on the mechanisms 
underlying Thl and Th2 polarisation. In fact, exposure of mice to Leishmania major 
remains the most defined model of T-helper subset differentiation during parasite- 
induced immune responses. Hence this model has become the paradigm against 
which Th I /Th2 segregation during other infections is compared. 
2.6 2 Infections Resulting in the Generation of Th2 profiles 
Typical immediate hypersensivity responses induced by the promotion of Th2 
cytokines occur with helminths such as Nippostrong3dus brasiliensis, Trichinella 
spiralis and Trichuris muris (Svetic et al., 1993, Scott and Kaufmann, 1991, Else et 
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al., 1991,1994, Finkelman et al., 1991). These parasites promote high serum IgE, 
and blood and tissue eosinophilia via increased IL-4 and IL-5 levels respectively 
(Coffman et al., 1989, Finkelman et al., 1991, Cox and Liew, 1992), and the 
generation of a Th2-based mechanism is responsible for protection. In some cases, 
blocking Th2 cytokine production with anti-cytokine antibodies, or administering 
Thl-promoting cytokines such as IL-12, leads to the abrogation of resistance. For 
example, in Heligosomoides polygyrus, T spiralis and T muris infections, ablating 
IL-4 increases worm survival and renders resistant strains susceptible (Else et al., 
1994, Sher and Coffman, 1992). Similarly, administration of IFNy or IL-12 early 
after infection with N. brasiliensis can exacerbate infection (Finkelman et al., 1994, 
Sher and Coffman, 1992). The induction of a Th2 response following patency of 
Schistosoma mansoni infection in mice will be described in detail in section 2.8. 
2.6.3 Infections Resulting in the Generation of Thl Responses 
The majority of research into the differentiation of Th I populations during 
parasitic infection has been carried out in association with the development of 
protection following exposure of mice with Leishmania major (Scott, 1989,1991, 
Locksley and Scott, 1991, Reiner and Locksley, 1995). The effects of this parasite 
on the host are directly related to the type of Th response induced, and this will be 
discussed as a model for the investigation of T-helper subsets in detail below. Other 
infections known to generate strong cell-mediated immunity include Mycobacterium 
tuberculosis and leprae (Scott and Kaufmann, 1991, Walker et al., 1992, Mosmann 
and Sad, 1996) and Toxoplasma gondii (Sher and Coffman, 1992, Mosmann and Sad, 
1996). In these infections parasite control and killing is mediated by IFN7 activation 
of macrophages and the release of toxic compounds (Liew et al., 1990,1991, 
Gazzinelli et al., 1992a, 1992b, 1993, Oswald et al., 1994c), and blocking either 
IFN7 or IL- 12 can have a deleterious effect on the outcome of disease (Scott et 
al., 1989, Gazzinelli et al., 1993, Walker et al., 1992, Yamamura et al., 1991). 
There are cases when the nature of the immune response generated to cope with 
the invading parasite causes severe consequences for host survival. Human infection 
with falciparurn malaria can result in TNF(x levels elevated to such an extent that 
they become lethal, an effect also observed in murine malaria (Grau et al., 1987, Sher 
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and Coffman, 1992). Similarly, following S. mansoni infection, the Th2 immune 
response mounted against eggs deposited in the liver results in the formation of 
granulomas, which in turn leads to liver damage (reviewed by Sher and Coffman, 
1992). It is also important to note that some infections rely on the production of 
Th I -like cytokines from CD8+, rather than CD4+, T cells, since depletion of this cell 
population during infection results in reduced protection, for example T gondii and 
Trypanosoma cruzi (Gazzinelli et aL, 1991, Tarleton, 1990, Sher and Coffman, 
1992). 
2.7 Leishmaniasis 
2.7.1 Background 
Leishmaniasis is a protozoal disease transmitted by the bite of the sandfly when 
the promastigote stage present in the saliva invades host macrophages. The 
infectious stage transforms into an amastigote within the macrophage, and undergoes 
a period of replication before rupturing the cell and infecting other macrophages in 
the vicinity. The resulting disease mainfests itself as various types of cutaneous 
tissue necrosis, and the most invasive strain, L. donovani progresses internally to 
cause visceral leishmaniasis. This latter infection in humans is closely mimicked by 
the infection of mice with L. major. The study of this disease in mice has led to the 
discovery of strains resistant and susceptible to infection, with phenotypes which 
correlate closely to the type of T-helper cell response mounted (reviewed by Scott, 
1989, Reiner and Locksley, 1995). Self-healing strains include C57BL/6, B 10 and 
C3H/HeN, in which infection progresses no further than a cutaneous lesion and heals 
with no treatment. Susceptible strains such as BALB/c cannot control infection, and 
the cutaneous lesion progresses into the visceral tissues to become lethal. 
The very different responses to infection have been associated with the induction 
of different cell populations. Ablation of the CD4+ T cell type with specific antibody 
in susceptible mice results in the ability of these animals to self-heal (Heinzel et al., 
1989, Scott, 1989). In contrast, neither the CD8+ or NK cell compartments are 
crucial for disease resolution in C5713L/6 mice. The following two sections describe 
46 
the cytokines involved in resistance and susceptibility to murine infection with 
Leishmania major. 
2.7.2 The Th I Response and Resistance to L. major 
In resistant animals, healing of lesions is concomitant with high IFNy production 
at both the mRNA and protein level, and low or undetectable levels of IL-4, from LN 
cells (Heinzel et al., 1989). Administration of recombinant IL-4 or anti-IFNy can lead 
to exacerbation of the disease, temporarily or permanently respectively (Chatelain et 
al., 1992, Belosevic et al., 1989, Sadick et al., 1990). To ablate the IFNy response 
and affect the outcome of the disease, the antibody treatment has to be given within 
the first week of infection, indicating that it is the differentiation of the Thl 
population that must be altered (Scott, 1991). Likewise, suppression of macrophage 
activation by IL-4 treatment later in infection is not sufficient for reversal of 
protection in resistant animals (Scott, 1989, Scott et al., 1989, Sadick et al., 1991, 
Reiner and Locksley, 1995). 
Although it has been shown that early IFNy is required for resistance, C57BL/6 
mice do not produce high levels of this cytokine during the first week of infection but 
are nonetheless resistant (Reiner et al., 1994). Thus research has concentrated on 
possible differences between healer and non-healer strains in an attempt to define the 
crucial step in induction of immunity which is absent in BALB/c mice. In some 
strains, such as C3H/HeN, NK cells have been shown to provide an early source of 
IFN7 (Scharton and Scott, 1993). However, BALB/c mice have a low NK cell 
response, possibly due to downregulation by early IL-4 and TGFP. The presence of 
IL- 13 in both resistant and susceptible mouse strains during the first 4 days of 
infection may also enhance IFN7 release from NK cells. This cytokine has properties 
similar to IL-4, with the surprising exception that it can promote some IFN7 
production from murine NK cells (Doherty et al., 1993). 
The protection afforded by the Thl response has been associated with the 
activation of macrophages to a state capable of killing the amastigote parasites 
(Nathan et al., 1983, Green et al., 1990, Liew et al., 1990,1991). This is ftirther 
demonstrated by the ability of IL-4 and TGFP to inhibit macrophage activation, 
consequently leading to increased levels of parasitaemia (Barral-Netto et al., 1992). 
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Studies into the cytotoxic nitrogen products released by activated macrophages have 
highlighted the importance of NO in amastigote killing (Green et al., 1990, Liew et 
al., 1990, Reiner and Locksley, 1995). Although the crucial difference in the survival 
pattern of BALB/c and B 10 mice is the release of NO in the latter (Hsieh et al., 
1995), these differences do not appear to correlate with an early production of either 
Thl or Th2 cytokines, which are similar in resistant and susceptible strains (Reiner et 
al., 1994). Furthermore, BALB/c macrophages are capable of releasing NO when 
driven by a Thl population generated by the addition of exogenous cytokines (Reiner 
et al., 1994, Hsieh et al., 1995). Thus, the differences in the outcome of infection 
observed between these strains are apparently due to the eventual default pathway of 
Th subset differentiation; self-healing mice producing a Thl response resulting in 
macrophage activation and NO production, and non-healers producing a Th2 reponse 
rich in IL-4 and IL-10 resulting in inhibition of macrophage activation. The 
dependence of resistant mice upon the production of NO was proved beyond doubt 
with the generation of iNOS-deficient mice (Wei et al., 1995). These mice, on the 
MF I background, are normally resistant to infection with L. major. However, upon 
exposure of animals with a deleted portion of the inducible NOS gene, and hence a 
non-functional enzyme, the lesions become visceral and lethal. Thus, it can be 
concluded that this macrophage product is essential for control of parasitaernia and 
self-cure in murine leishmaniasis. 
2.7.3 The Th2 Response and Progression of Disease 
The cytokine responses of susceptible mice to infection correspond to a 
characteristic Th2 phenotype: high IL-4 and IgE antibody titres, low IFN7 and no 
DTH reaction. LN tissue sampled from infected BALB/c mice displays high levels 
of IL-4, IL- IP and IL- 10 expression with little IFN7 message (Heinzel et al., 1989, 
1991). Furthermore, a single dose of anti-IL-4 administered to susceptible mice at 
the time of infection results in the healing of cutaneous lesions, self-cure and 
protection against further infection (Chatelain et al., 1992). Presumably the long 
lasting effects of an antibody which only has a half-life of 4.5 days is due to the 
suppression of IL-4 during a crucial stage of Th2 development, allowing the 
expansion of the Th I subset which subsequently remains as a memory population. 
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The administration of recombinant IFNy leads to temporary improvement in the 
progression of leishmaniasis in susceptible hosts, but the effects are not permanent 
(Scott, 1991). In addition, the administration of T cell clones of either Thl or Th2 in 
nature, and specific for leishmanial antigen can either cure or exacerbate disease in 
BALB/c mice respectively (Scott et al., 1988), again demonstrating the complete 
dependence of pathology on the expression of Th2 cytokines. 
The high level of IL-2 secretion in susceptible mice has initiated research into this 
non-Th2 cytokine and its role in disease exacerbation. IL-2 is required for the 
development of both Thl and Th2 subsets (LeGros et al., 1990, Ben-Sasson et al., 
1990b), and ablation of this cytokine results in self-healing of 80% of infected mice 
(Heinzel et al., 1993a). Moreover, during this treatment an increase in the level of 
IFN7 and a reduction in IL-4 production by LN cells is observed. Furthermore, the 
IFN7 secretion can be traced to both CD4+ and CD8+ cell populations, an effect not 
observed in anti-IL-4 treated BALB/c mice. The IL-2 production is limited to B cells 
in BALB/c mice, in contrast to C57BL/6 animals where both T and B cells produce 
this cytokine (Heinzel et al., 199 1). This production of IL-2 may explain the reversal 
of progressive disease when B cells are ablated. Ablation of IL-2 in resistant mice 
has no effect on the development of Th I cells, possibly due to the lower levels of IL- 
2 required by Thl cells for proliferation, and the synergistic effect of small amounts 
of IL-2 with IL- 12 in promoting Th I expansion (Heinzel et al., 1993 a, 1993 b). 
Contrary to earlier studies which reported the complete segregation of IFN7 and 
IL-4 mRNA expression in resistant and susceptible strains using the Northern blot 
technique (Heinzel et al., 1989), more recent research has indicated that both types of 
mice produce a ThO response during the first week of infection (Morris et al., 1992, 
Scott, 199 1, Reiner et al., 1994). A high percentage of IL-4-producing T cell clones 
can be derived from BALB/c mice at I week post-infection, and this value continues 
to rise up to week 8. A similar panel of clones is obtained at week I from self- 
healing mice. However, by week 8 the proportion of clones expressing a Th2 
phenotype has fallen and those cells secreting IFNy are dominant (Morris et al., 
1992). Furthermore, this cytokine production has been shown to originate from the 
CD4 +T cell compartment in both strains of mice (Scott et al., 1989, Scott, 1991). 
Analysis of the mRNA production in LN tissue from susceptible and resistant strains 
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demonstrated that both types of mice produce IFNy, IL-2, IL-4, IL- 10 and IL- 12 
within the first 4 days of infection (Reiner et al., 1994). Resistant mice then start to 
downregulate the Th2 cytokine synthesis whereas non-healing mice do not, despite 
the production of IL-12, resulting in the development of a strong Th2 response. 
A possible explaination for this observation is proposed by a recent report indicating 
that BALB/c mice lose the ability to generate IL-12-induced Thl responses (Goler et 
al., 1996). As infection progresses the capacity of susceptible mice to respond to IL- 
12 is reduced, presumably allowing upregulation of Th2 cytokine expression. This 
data is supported by the finding that Th2 cells are unable to respond to IL- 12 at the 
intracellular signalling level (Szabo et al., 1995). The onset of IL- 12 
unresponsiveness may also account for the inability of this cytokine to alter an 
established Th2 response in BALB/c mice when administered after the first week of 
infection (see section below, Heinzel et al., 1993a). 
2.7.4 The Importance of IL-12 in Leishmania Infection 
After the discovery of IL-12 and its role in the differentiation of Th I populations, 
the effect of administering or blocking this cytokine in both susceptible and resistant 
strains of mice infected with L. major was investigated. Recombinant IL- 12 given 
early to BALB/c mice can lead to complete cure (Heinzel et al., 1993a, Sypek et al., 
1993), whereas anti-IL- 12 can exacerbate the diseased state of the resistant mice if 
given at I week post-infection (reviewed by Trinchieri and Scott, 1994, Scott, 1993b, 
Locksley, 1993). 
There is some debate as to whether IL- 12 is required only during the early 
response, or is also important at later time points. As mentioned above, 
administration of IFNy cannot reverse the outcome of infection in susceptible mice 
on a permanent basis (Sadick et al., 1990). However, IL- 12 appears able to do so, 
suggesting that it is manipulation of T-helper subset differentiation which is 
important. An early role for IL-12 in the development of protection is contradicted 
by the ability of promastigotes to evade induction of pro-inflammatory cytokine 
mRNA upon initial infection (Reiner et al., 1994). Furthermore, in vitro culture of 
macrophages with L. major parasites fails to result in IL- 12 production. Although 
stimulation of murine peritoneal macrophages in vivo by injection of parasites into 
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the abdominal cavity followed by cell harvesting and in vitro stimulation can induce 
the release of IL- 12, this may reflect the effect of secondary activation rather than 
primary interaction with promastigotes (Vieira et al., 1994). The discrepancies 
between in vivo and in vitro systems may reflect the lack of costimulatory molecules 
during artificial stimulation. Alternatively, delayed expression of IL-12 may only be 
detected when the second round of macrophage infection with amastigotes occurs 
(Reiner et al., 1994, Vieira et al., 1994). It has been shown that a lipopolysaccharide 
produced by promastigotes can inhibit IL-12 production by macrophages in vitro. In 
fact the timing of IL-12 production, around day 7 post-infection, coincides with 
amastigote release from ruptured cells and the reinfection of further macrophages 
(Reiner et al., 1994). Thus this parasite stage may be more resistant to cellular attack 
and not require immune evasion strategies. Finally, due to the effectiveness of IL-12 
in the induction of Thl responses and protection, its role as an adjuvant in 
vaccination has been investigated. Administration of IL-12 and leishmanial antigen 
has been shown to increase NK cell activity and IFNy release, and as such this 
cytokine has potential in the development of a vaccine (Afonso et al., 1994). 
2.8 Schistosomiasis 
2.8.1 Introduction 
Infection of mice with Schistosoma mansoni has ftirther highlighted the crucial 
effect of T-helper subset polarisation on the outcome of parasitic exposure. Several 
models are currently under investigation, each resulting in the induction of very 
different cytokine profiles. The three major models include liver granuloma 
formation following normal infection, the development of synchronous egg 
granulomas in the lungs, and the irradiated vaccine model. Each of these systems 
will be discussed below in relation to the cytokine profiles produced during the 
immune response. The polarisation of Th I and Th. 2 subsets in these models is not as 
extreme as that observed during Leishmania major infection. Thus the results 
obtained are often contradictory and difficult to interpret, and further research is 
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required to unravel the complicated interplay of the Thl and Th2 cytokines in 
schistosomiasis. 
2.8.2 The Formation ofLiver Granulomas Following Normal Infection 
Following infection of mice with normal cercariae, a strong Th2 cytokine response 
develops which appears to be induced by the deposition of eggs in the liver (Pearce et 
al., 1991, Grzych et al., 1991). Typical characteristics of this response include high 
serum IgE, eosiniphilia, and a seemingly Th2-associated pathology around eggs 
trapped in the liver (reviewed by Scott et al., 1989, Sher and Coffman, 1992). It has 
been reported that prior to worm maturation and the onset of egg laying, a response 
rich in Thl cytokines develops (Pearce et al., 1991). However, after oviposition this 
response is downregulated, presumably by the enhanced levels of Th. 2 cytokines 
which can be detected (Pearce et al., 1991, Gryzch et al., 1991, Sher et al., 1992). 
The majority of research into the immune response induced by normal infection 
has concentrated on characterising the cytokines involved in the granulornatous 
response against eggs trapped in the liver. This consequence of schistosome 
infection results in the pathology associated with the disease, and hence an 
understanding of the immune response may aid the development of a vaccine to 
prevent the damage caused by granuloma formation. Approximately half the eggs 
produced by an adult worm pair get washed downstream to the liver by blood flow. 
There they attract a small focus of CD4+ T cells (Mathew et al., 1986), which in turn 
promotes cellular recruitment and formation of a granuloma comprising of CD4+ T 
cells, CD8+ T cells, macrophages, eosinophils, neutrophils, giant cells, mast cells, 
fibroblasts and some B cells (Moore et al., 1976). The developmental progression of 
granuloma formation can be divided into a distinct sequence of events with respect to 
growth and cytokine profiles (Boros, 1994): a primary response, peak granuloma 
formation, and immunomodulation of the responses. 
a) Primary Granuloma Development 
Primary responses in the liver begin around week six of infection with a switch 
from Th I to Th2 cytokine production (Pearce et al., 1991, Grzych et al., 1991). The 
stimulus for this change in response appears to be the onset of oviposition, although 
52 
there are conflicting reports concerning the involvement of Th I -type cytokines in the 
formation of the liver granulornatous response (reviewed by Boros, 1994). Some 
studies have demonstrated that single sex infections result in the induction of a mixed 
Thl/ThO response with production of IFNy, IL-2 and IL-4 and only marginal 
secretion of the other Th2 cytokines (Grzych et al., 1991, Vella and Pearce, 1992, 
Chensue et al., 1993). This would suggest that it is the presence of egg antigen 
which promotes the expression of Th2 cytokines; an observation supported by the 
rapid expression of IL-4 in a CD4 -ve cell population upon egg injection into the 
peritoneal cavity (Sabin and Pearce, 1995). Furthermore, two oligosaccharides 
derived from eggs have been shown to induce IL- 10 and prostaglandin E2 production 
by B cells in vitro, both of which can downregulate the Thl response (Velupillai and 
Ham, 1994). 
By six to eight weeks post-infection, IL-4 and IL-5 mRNA can readily be detected 
in liver tissue and isolated granulomas (Grzych et al., 1991). In addition, egg antigen 
stimulates higher Th2 cytokine responses than adult worm antigen from splenocytes 
in culture. Cytokines predominant in the development of granulomas at this early 
stage include IL-4, IL-5, IL- 10, TNFcc, IL- I P, TGF P and low levels of IFNy (Wynn 
et al., 1993, Boros, 1994), with message for all these cytokines readily detectable and 
IL-4, IL-5 and IL- 10 displaying the highest levels of expression (Wynn et al., 1993). 
IFNy production declines around week eight post-infection. However, this cytokine 
appears to maintain a regulatory role in the granulornatous response, since the 
administration of an anti-IFNy antibody results in the exacerbation of granuloma 
development. In contrast, treatment with recombinant IFN7 can reduce the size of 
established granulomas (Chensue et al., 1992, Boros, 1994). 
b) Peak Granuloma Development 
Eight to twelve weeks after infection, granuloma development peaks, coinciding 
with high levels of IL-4 and IL-5 which promote increased levels of serum IgE and 
eosinophilia respectively (Grzych et al., 1991). During this vigorous stage there is 
little IFNy release; IL-4 is the dominant cytokine detectable at this time and may act 
to downregulate the IFNy and Thl cell responses (Henderson et al., 1991, Chensue et 
al., 1992). Administration of anti-IL-4 antibody can reduce granuloma growth, and 
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somewhat surprisingly causes a reduction in IL-2 levels (Chensue et al., 1992, Boros, 
1994). The involvement of this Thl cytokine has been under much debate due to 
conflicting reports. The advent of the reverse transcription-polymerase chain 
reaction (RT-PCR) has permitted the detection of this cytokine during the acute stage 
of granuloma formation (Wynn et al., 1993). Although Northern blot analysis has 
repeatedly failed to detect any trace of IL-2 in the liver (Henderson et al., 1991), this 
is probably due solely to the lower sensitivity of this technique compared to RT- 
PCR. Furthermore, a role for this cytokine in granuloma formation is supported by 
the finding that anti-IL-2 antibody treatment results in a reduction in granuloma size 
and fibrosis (Cheever et al., 1992), and that IL-2 can exacerbate lesion development 
in CD4+-ablated mice (Mathew et al., 1990). Repressed granuloma development 
after anti-IL-2 treatment corresponds to a reduction in IL-5 levels and eosinophilia, 
an observation supported by data describing IL-2-dependent eosinophilia 
(Yamaguchi et al., 1990). However, the reduction in this cell type is not responsible 
for the reduced size of the granulomas, since anti-IL-5 treatment has no effect in this 
model (Sher et al., 1990b). Recent studies on the infection of IL-4 gene-disrupted 
mice have implied that this cytokine is not responsible for hepatic pathology (Pearce 
et al., 1996). Infection of these knockout animals did not result in the expected 
reduction in granuloma development, contradicting earlier studies involving ablation 
of this cytokine with anti-IL-4 antibody (Chensue et al., 1992). Possible 
explainations for the discrepancies observed between the two experimental systems 
might include compensation for gene loss by the operation of redundant mechanisms 
in knockout animals. 
In summary, expression of the Th2 cytokines is dominant during peak granuloma 
development. However, in addition there is a requirement for IL-2 in the vigourous 
growth of the lesions. The association of IL-2 and IL-4 release is perhaps not so 
surprising in that IL-2 is a requirement for the development of Th2 responses 
(LeGros et al., 1990, Ben-Sasson et al., 1990b, Cheever et al., 1992). In addition, 
IFNy appears to play a control function in the granulomatous response at this stage, 
since ablation of this cytokine with specific antibodies results in exacerbation of 
granuloma development and an increase in Th2 cytokine production (Chensue et al., 
1992,1994). 
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c) Immunomodulation of the Egg Granuloma 
During the period of sixteen to twenty weeks post-infection, the granulomatous 
response becomes immunomodulated and existing granulomas reduce in size 
(Stadecker, 1992, Boros et al., 1975). IL-4 and IL-2 production from the granuloma 
is greatly reduced at this stage, along with increased expression of IFNy (Chensue et 
al., 1993, Henderson et al., 1992). The source of IFNy remains unclear, although 
CD8 + cells may be responsible for the production of cytokines able to inhibit the Th2 
response in the absence of a Th I CD4+ cell population. During this period of 
suppressed activity, the administration of IL-4 results in an upregulation of 
granuloma formation around new eggs arriving in the liver, a response similar to that 
seen upon injection of IL-2 (Mathew et al., 1990, Yamashita and Boros, 1992, Boros, 
1994). In addition, recombinant TNF(x treatment in immunomodulated animals leads 
to vigorous granuloma formation, and both IFNy and IL-2 can enhance production of 
TNFa from granuloma macrophages (Joseph and Boros, 1993). High levels of IL- 10 
can be detected in splenocytes isolated from immunomodulated mice and may 
possibly be acting in its capacity as a downregulatory molecule, especially in the 
inhibition of macrophage cytokine and toxic mediator production (Gazzinelli et al., 
1992b, Sher et al., 1992, Mosmann and Moore, 1991). 
In contradiction to the above data suggesting that Thl cytokine release may be 
responsible for immunomodulation, macrophages isolated from mice displaying 
downregulated responses are unable to stimulate schistosome antigen-specific Thl 
cell clones, resulting in anergy (Flores Villanueva et al., 1994, Stadecker, 1992). In 
contrast, egg antigen presentation to Th2 clones is unaffected. This observation 
implies that granuloma APCs become suppressive to Thl clones, promoting the 
development of a Th2 response during this late stage of the granuloma development. 
This effect may be caused by inhibitory cytokines such as IL- 10, or via costimulation 
in the absence of B7/CD28, and can be reversed by the introduction of IL-2 into the 
cultures (Flores Villaneuva et al., 1994). Thus these data disagree with Thl- 
mediated immunomodulation in two ways. Firstly, these results imply that it is Thl 
cytokine secretion which induces granuloma formation, and that immunomodulation 
is the result of downregulation of these cytokines. Secondly, that Th2 cytokines are 
responsible for the immunomodulation of the Thl response, and hence the reduction 
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in granuloma development and size. However, IL-4 gene-disrupted mice are capable 
of immunomodulation, hence arguing against a role for this Th2 cytokine in the 
suppression of the granulomatous response (Pearce et al., 1996). 
2.8.3 The Synchronous Lung Egg Granuloma Model 
The analysis of granuloma development in the lungs has increased in popularity 
over the last few years because it permits the study of the kinetics of cytokine 
release. Thus the sequential expression of cytokines upon injection of a standard 
number of eggs and their subsequent arrival in the lungs has been determined. RT- 
PCR studies at day one after intravenous injection can detect IFNy, IL- IP and IL-6 
mRNA in lung tissue, coincident with small influxes of mononuclear cells (Wynn et 
al., 1993). By day three, IL-2, IL-4 and IL-10 mRNAs are detected and mononuclear 
cell accumulation begins. The last cytokines found to be upregulated in this study 
are IL-5 and TNFoc, coincident with peak expression of the earlier cytokines and 
preceding maximum granuloma formation by eight days (Wynn et al., 1993). As 
with liver granuloma formation, administration of anti-IL-4 or anti-IL-2 antibodies 
leads to diminished granuloma size, a reduction in IL-4 and IL-5 expression, and 
increased IL- 10 production, possibly due to the removal of IL-4 inhibition of 
macrophage cytokine production. In contrast, ablation of IL- 12 or IFNy with specific 
neutralising antibodies leads to an enhanced Th2 response and a subsequent increase 
in granuloma size (Wynn et al., 1994b). The study of this model has shown that the 
induction of IL- 12 can be blocked by ablating IFNy or NK cells, implying that IL- 12 
expression is dependent upon the presence of IFNy (Wynn et al., 1994b, Gazzinelli 
et al., 1993). In addition, ablation of this cell type results in reduced IFNy mRNA 
and an increase in granuloma size. Thus the source of early IFNy required for IL- 12 
expression may be NK cells, and possibly macrophages themselves (de Waal Malefyt 
et al., 199 1, Scharton and Scott, 1993). 
Administration of recombinant IL-12 with either a primary or secondary egg 
infection inhibits granuloma formation, and correlates to increased levels of IFNy, 
IL-2, IL- 12 and, surprisingly, IL- 10 at the mRNA level (Wynn et al., 1994b). The 
other Th2 cytokines, IL-4, IL-5, IL-6 and IL- 13, all decrease presumably due to the 
suppressive effects of the upregulated Thl response upon Th2 cytokine secretion 
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(GaJ ewski and Fitch, 198 8, Seder et al., 1993). Increases in IL- 10 mRNA associated 
with upregulation of Thl cytokine expression have been reported numerous times 
(Wynn et al., 1993,1994a, 1995a, 1995b, Finkelman et al., 1994). This may be 
explained by the downregulation of inhibitive Th2 cytokines, and the corresponding 
activation of cytokine production from macrophages. Thus IL-10 may be 
upregulated as a consequence of general upregulation of cytokine secretion by 
activated macrophages. Alternatively, the detection of mRNA for IFNy and IL-10 in 
the same CD4+ T cell may account for the observed link in expression of these 
cytokines (Assenmacher et al., 1994). In addition to the above egg model, IL- 12 has 
also been shown to reduce Th2 responses induced upon egg injection into the 
footpads of mice, if given at early time points (Oswald et al., 1994b). 
Injection of eggs into athymic mice has highlighted the T cell-independent 
production pathways of IFN7, IL-6, IL- 10 and IL- 12 mRNA (Wynn et al., 1993). 
Granuloma development in these animals is virtually absent, even in the presence of 
high levels of TNFoc, indicating that this cytokine alone is not sufficient for the 
induction of the granulomatous response. The above cytokines may be expressed by 
macrophages, NK cells and 78 T cells, all of which are present in athymic mice 
(Yoshikai et al., 1992, Rocha et al., 1992). However, the production of IL-4 and IL- 
5 is completely absent, demonstrating that these cytokines have a solely T cell source 
in this model. 
A recent study of egg-induced lung granuloma formation in IFN7 gene-disrupted 
mice has investigated the ability of IL-12 to stimulate T cells directly in the absence 
of endogenous IFN7 (Wynn et al., 1995b). Surprisingly, IL- 12 administration to 
these animals results in exacerbation of the Th2 response and granuloma formation. 
Following infection, TNF(x, TNFP and IL-2 message are all upregulated in IFN7 -/_ 
mice, along with the IL- 12 p40 chain. This implies that IL- 12 does not require IFN7 
for self regulation or Th I cytokine induction and can act directly on T cells, an 
observation supported by other reports (Seder et al., 1993, Macatonia et al., 1993). 
The increase in expression of the Th2 cytokines may be IL-2 driven in the absence of 
IFN7 inhibition, resulting in an increased granulomatous response. This correlates 
with observed increases in eosinophilia and IgE levels, indicative of the requirement 
of IFN7 for the IL- I 2-driven downregulation of these factors (Wynn et al., 1995b). 
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In support of this work, CD4+ T cells have been shown to default to the Th2 
developmental pathway in IFNy gene-disrupted mice (Wang et aL, 1994). 
2.8.4 The Attenuated Vaccine Model 
The kinetics of basic cytokine secretion in the attenuated vaccine model have 
already been established at the protein level and described in sections 1.6 and 1.7. 
However, the manipulation of this system in immunological research, and relevance 
to Thl and Th. 2 subset development will be discussed below. Murine exposure to S. 
mansoni has provided a system for the investigation of Th cell subsets due to the 
segregating cytokine profiles observed following normal or a vaccinating infection. 
Patency of a normal infection induces a Th2 environment not favourable to resistance 
and resulting in pathology, as described above in section 2.8.2. In contrast, exposure 
to irradiated cercariae results in the development of a Th I response capable of 
arming against exposure to normal parasites. Although this system appears to 
generate dichotomy superficially similar to that observed following infection with 
Leishmania major, the polarisation of cytokine profiles into Thl and Th2 subsets is 
not as extreme, and the exact mechanism of resistance not as well understood. 
a) The Cytokine Phenotype Required for the Induction of a Protective Response 
The protective response induced with the attenuated vaccine model is dependent 
upon the generation of an IFNy-producing population of CD4+ T cells in the skin- 
draining LN (Pemberton et al. 1 199 1, Mountford et al., 
1992). As a proportion of the 
applied parasites migrate through the LN draining the exposure site, high levels of 
IFNy can be detected in culture supernatents from cells stimulated in vitro. However, 
no IL-2, and only minimal levels of IL-4 and IL-10 protein, are detectable post- 
vaccination (Pemberton et al., 1991, Pemberton and Wilson, 1995). 
Following vaccination, the cytokines most readily detectable after culture of cells 
washed from the lung airways are IFNy and IL-3; there are very low detectable levels 
of IL-2, IL-4 or IL-5 protein (Smythies et al., 1992a, Wilson et al., 1996). In 
addition, the lack of proliferation observed in this isolated cell population upon 
secondary stimulation would indicate that these cells are of the Thl memory/effector 
phenotype (reviewed by Smythies et al., 1993). In fact, this was later shown to be 
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the case, with cells washed from the airways of vaccinated mice bearing high levels 
of the surface maker CD44 and low levels of CD45RB, a phenotype associated with 
short term memory cells (Coulson and Wilson, 1993). 
The administration of IL-12 during vaccination has been shown to increase the 
expression of Th I cytokines and induce an elevated level of immunity compared to 
vaccination alone (Wynn et al., 1995a). The increase in IFNY and IL-12 expression 
corresponds to a decrease in the levels of IL-4 and IL-5 mRNA, as detected by RT- 
PCR. Although IL- 12 administered during challenge infection has no effect on the 
already raised resistance and Thl message levels obtained by the early treatment, the 
residual amounts of Th2 cytokine mRNA are lower than those seen in the group 
given recombinant cytokine with vaccination only. Thus IL-12 may exert its effect 
by directing the induction response and by reducing any IL-4 inhibition of the 
effector mechanism. There is no effect on disease outcome if this cytokine is 
administered during a normal infection (Wynn et al., 1995a). 
b) The Cytokines Involved in the Effector Mechanism 
Post-challenge, the efficiency of the effector mechanism can be almost completely 
abrogated by the neutralisation of IFNy (Sher et al., 1990a, Smythies et al., 1992b). 
This results in increased Th2 cytokine expression and reduced Th I and IL-10 mRNA 
levels in treated mice (Wynn et al., 1993,1994a). In contrast, immunity is not 
affected by the ablation of IL-4 or IL-5 (Sher et al., 1990a). These ablation 
experiments support data describing the high level of IFNy protein secretion during 
the effector response (Smythies et al., 1992a). The inflammatory cytokine TNFcc, 
produced by Thl cells, Th2 cells, and macrophages appears to have no influence in 
the protection mechanism since specific ablation of this cytokine has no effect on 
resistance (Smythies et al., 1993). 
Analysis of the lung effector response at the RT-PCR level has uncovered a more 
complicated picture than previously described by protein studies. Not only do 
vaccinated and challenged mice express higher levels of IFNy, IL-2 and TNFcc 
mRNA than challenge control animals, but IL-4, IL-5, IL- 10 and IL- 13 expression is 
also elevated above the naive baseline(Wynn et al., 1994a). In addition, IL-10 and 
IL- 13 mRNA can be detected at higher levels in previously primed mice than in 
59 
naive animals upon challenge infection. The major difference observed between 
infection of vaccinated and naive mice is the timing of the Thl and Th2 responses. 
Vaccinated and challenged mice mount earlier IFN7 and IL-2 responses compared to 
the control group, with IL- 10 following the IFN7 expression profile and not behaving 
like a Th2 cytokine, as reported previously (Wynn et al., 1993,1994a, Finkelman et 
al., 1994). This increased expression of IL- 10, an inhibitor of inflammatory cytokine 
release from macrophages and Thl cells, may possibly be due to the increased 
activation of macrophages in the presence of IFN7. Thus IL- 10 may be expressed as 
a consequence of general macrophage activation, also indicated by the increase in 
TNFoc and IL- IP expression in the effector response (Wynn et al., 1994a). 
The upregulation in the expression of cytokines required for macrophage 
activation and cytokine release in lung tissue from vaccinated and challenged mice 
might indicate that the toxic intermediate nitric oxide, also produced by 
macrophages, plays a role in the effector mechanism. It has been shown that IFN7, 
IL- I P, IL-2 and TNF(x can all act to upregulate the expression of the iNOS gene, the 
enzyme responsible for NO production from L-arginine (Oswald et al., 1994a, 
1994c). All these cytokines are present in the lungs post-challenge and thus NO 
might be expected to play a role in parasite elimination. Indeed, iNOS mRNA is 
upregulated above baseline values at day 17 post-challenge (Wynn et al., 1994a), at a 
time when parasites are trapped in the lungs (Coulson and Wilson, 1988). In 
addition, blocking NO production by the administration of an arginine analogue 
results in an overall increase in worm burdens of 33% (Wynn et al., 1994a). The 
importance of NO in this model is discussed further in chapter four. 
In conclusion, vaccination of mice with optimally irradiated cercariae of 
Schistosoma mansoni leads to the generation of a predominantly Th I -type response. 
This can be manipulated to develop further towards Thl or Th2 polarisation by the 
administration of IL-12 or ablation of IFN7, respectively. Norinal infection 
progresses towards a Th2 polarisation quicker than a vaccinating exposure in which 
IFN7 predominates above a mix of cytokines to promote the development of 
inflammatory foci around migrating parasites. Although the data described above 
addresses the same questions on the expression of cytokine mRNA as those 
considered in this thesis, these recently published investigations were performed 
60 
concurrently with the analysis reported in this DPhil. Differences between the data 
described above and that detailed in the subsequent chapters will be discussed as 
relevant. 
2.9 Aims of This Study 
From the above two sections it can be concluded that the generation of a Th I 
population in the skin-draining LN, and the recruitment of these cells to the lungs is 
necessary for the production of protective IFN7 in this model. The aims of this study 
were to investigate in detail the response generated following exposure of mice to the 
irradiated Schistosoma mansoni vaccine. The method chosen for this investigation 
was RT-PCR, a very sensitive technique for the detection of mRNA without the need 
for in vitro secondary stimulation as required with cytokine protein detection 
systems. In chapter two a full description of the precise methods chosen and adapted 
for the analysis of cytokine mRNA, both at a semi-quantitative and quantitative level, 
is described. In subsequent chapters these methods are used to investigate the 
cytokine profiles induced in the lungs and LN of mice exposed to various exposure 
regimes. 
Chapter three concentrates on the cytokine patterns detected during the induction 
mechanism in the skin-draining LN following vaccination and challenge. The 
expression levels of the major Thl and Th2 cytokines are described with relevance to 
the type of T-helper subset induced during vaccination. In chapter four the cytokines 
expressed during cell recruitment to the lungs post-vaccination, and the subsequent 
effector mechanism are examined. In addition, at a time of peak response post- 
vaccination, sorted cell populations isolated from the lung airways are analysed to 
define the cell types reponsible for the major cytokine expression at this time. The 
expression of inducible nitric oxide synthase post-challenge is also investigated to 
determine whether the pattern of mRNA transcription has any correlation with peak 
cytokine production. Finally, the kinetics of cytokine expression in the lungs is 
analysed following the arrival of a synchronous pulse of parasites administered by 
intravenous challenge. 
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The consequence of host strain on cytokine production during the induction 
mechanism is studied in chapter five. The cytokine responses occuring in the LN and 
lungs of C57BL/6 and BALB/c mice over a short timecourse are described. The final 
experimental chapter deals with the development of a screening technique for the 
segregation of homozygous gene-disrupted mice from heterozygous and wild type 
littermates. This procedure is applied to the screening of IFN7 receptor-deficient 
animals, with subsequent analysis of a homozygous and wild type population for the 
profiles of cytokine expression induced following vaccination and challenge. 
In conclusion, this thesis provides a detailed analysis of the cytokine profiles 
induced in the LN and lungs of mice exposed to cercariae of Schistosoma mansoni. 
The use of RT-PCR has facilitated the analysis of many cytokines not previously 
detectable by protein assay due to sensitivity problems or the lack of available 
antibodies. 
62 
CHAPTER TWO 
The Development of Semi-Quantitative and Competitive PCR Based 
Techniques for the Analysis of Cytokine mRNA 
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Introduction 
Until recently, the study of cytokine release in immunological research has been 
based on the detection of protein secretion from cultured cells. The main 
disadvantage of this technique is the requirement for in vitro stimulation before 
culture supernatants can be assayed, quite possibly resulting in a distortion of the true 
in vivo response. An alternative to cytokine protein analysis involves the detection of 
cytokine mRNA from fresh tissue without in vitro stimulation. This approach 
provides a snapshot of the immune response occurring in vivo at the time of 
sampling. In addition, analysis of mRNA can detect the presence of a cytokine 
which may be absent in culture supernatants due to uptake and utilisation by cells 
bearing receptors. Thus, mRNA profiles can provide an accurate account of cytokine 
production in any organ from which RNA can be isolated. However, care must be 
taken with the interpretation of results. The analysis of gene expression at the 
message level is problematic if the protein of interest has a constitutively expressed, 
stable mRNA which is always present in the tissue. In these cases, the presence of 
mRNA does not necessarily mean that the active protein is secreted from the cell. 
This problem does not arise when protein expression is regulated at the transcription 
level, with no storage of mRNA or post-transcriptional regulation. The majority of 
cytokine genes fall into the inducible category, and are not constitutively expressed 
(Dallman et al., 1991 a, 1991b). On the whole, cytokine mRNAs are very unstable, 
with short half lives and low copy numbers (Shaw and Kamen, 1986). This means, 
that for successful analysis, sampled tissue must be fixed rapidly to prevent RNA 
degradation once the immunological stimulus for production is removed. 
Previous research has investigated the presence of cytokine mRNA in parasitic 
models of infection by Northern blotting. However, this technique requires large 
amounts of mRNA and lacks the sensitivity essential for the detection of these 
relatively rare messages. Systems in which Northern blotting has proved effective at 
detecting cytokine mRNAs are based on acute immune responses induced by high 
levels of antigen, such as invasion of LN tissue by Leishmania major (Heinzel et al., 
1989), or the granulomatous response to egg antigen during Schistosoma mansoni 
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infection (Henderson et al., 1991,1992). In both these experimental systems, the 
advent of more sensitive techniques has uncovered a more complicated picture than 
originally described based on results from Northern blotting. In addition, Northern 
blot analysis has failed to detect any cytokine expression (IFN7, IL-2, IL-4 and IL-5) 
in LN and spleen RNA isolated from mice infected or vaccinated with cercariae of S. 
mansoni (Constant, 1991, Betts, unpublished observations), even though in vitro 
culture of isolated cells has indicated that at least some of these cytokines can be 
detected at the protein level in this model (Constant et al., 1990, Mountford et al., 
1992, Pemberton et al., 1991, Pemberton and Wilson, 1995). The differences in 
detection seen between the S. mansoni vaccination model and the Leishmania and 
egg granuloma models may be due to the presence of a constant source of 
stimulation in the latter two systems. In contrast, following vaccination of mice with 
irradiated cercariae the parasites only reside transiently in the LN, and there is no 
evidence for parasite presence in the spleen (Mountford et al., 1988). 
Other methods of mRNA analysis include the RNAse protection assay and in situ 
hybridisation. However, these methods also possess drawbacks. RNAse protection 
is more sensitive than Northern blotting, but requires relatively large quantities of 
mRNA and thus is difficult to apply to small organ or biopsy samples. In situ 
hybridisation is incredibly sensitive, detecting mRNA species at the single cell level, 
but is technically very demanding to quantify and requires stringent control measures 
to prevent false positive results. Faced with these less than satisfactory mRNA 
detection systems, the majority of cytokine research was carried out at the protein 
level following in vitro culture. 
The advent of the Polymerase Chain Reaction (PCR) (Saiki et al., 1988, Rapolee 
et al., 1988), once linked to a reverse transcription (RT) reaction, has permitted the 
analysis of cytokine gene expression in systems where traditional methods of 
detection have failed. The PCR procedure amplifies a DNA template sequence up to 
detectable levels using a DNA polymerase enzyme stable at high temperatures, and a 
temperature cycling program to alternate strand denaturing and DNA synthesis. This 
reaction can produce a doubling of template DNA with every round of the 
temperature cycling profile, resulting in reaction kinetics resembling an exponential 
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growth curve. However, by the very nature of the reaction, true quantification is 
difficult to achieve. PCR is a very sensitive technique and makes the detection of 
any rare message or DNA possible. However, this sensitivity can lead to a variety of 
associated problems in that it allows amplification of any contaminating DNA, such 
as previously amplified PCR product, present in the RNA sample or reaction 
components. To prevent these problems arising, all pre-PCR manipulations can be 
carried out in a clean area separate from the product handling area, such as a flow 
hood, and reagents and equipment can be kept as DNA-free as possible. Aliquoting 
of primer and enzyme stocks can also aid the prevention of expensive bulk 
contamination. 
In spite of all the above drawbacks, PCR has become one of the most widely used 
tools for the analysis of mRNA due to the sensitivity and ease of the assay. The 
research described in this thesis is based on RT-PCR detection of murine cytokine 
expression by the application of methods adapted from the many published protocols 
to provide semi-quantitative and quantitative data. For semi-quantitative analysis, 
the majority of protocols described in the literature rely on the comparison of 
products derived from RT-PCR of test and control RNA samples using the same 
primer pair (Murphy et al., 1993, O'Garra and Vieira, 1992, Dallman et al., 1991 a). 
However, to investigate the relationship between the levels of different cytokine 
production within the same sample, a more complicated PCR procedure is required, 
involving the addition of competitive templates as described later. 
To achieve a semi-quantitative result in cytokine mRNA analysis, several methods 
have been described. One of the earliest assesses the PCR product generated after 
increasing numbers of cycles (reviewed by Dallman et al., 1991 a, Montgomery and 
Dallman, 1991, Dallman et al., 1991b). Product from each PCR tube is sampled at 
intervals of five cycles, dot blotted and hybridised with end-labelled probes specific 
for each primer pair. Autoradiographs of the probed products are then inspected 
visually to detect any differences in cytokine expression. This method is especially 
useful in distinguishing variations in cytokine expression in different tissues. 
Analysis at a single cycle number may miss the exponential range of the PCR, with 
some samples having reached saturation, whilst others contain barely detectable 
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product. For semi-quantitative assessment of the mRNA level in a sample, PCR 
product must be examined during the exponential phase of the reaction. Analysis at 
multiple cycle numbers allows the position of this phase to be determined, and 
provides a good estimate of the comparative levels of RNA expression between 
samples. 
A second published method for the analysis of PCR product involves the use of a 
diluted standard RNA sample (Murphy et al., 1993, O'Garra and Vieira, 1992). 
RNA isolated from cell lines expressing the cytokine of interest is serially diluted to 
give a standard curve against which test samples can be compared. Duplicate test 
samples are expressed as arbitrary units derived from the standard curve. The 
housekeeping gene HPRT (hypoxanthine-guanine phosphoribosyltransferase) is 
amplified to indicate any RNA degradation or loss, and can be used as a correction 
factor for differing levels of starting RNA, since the effect of activation on 
expression of this gene is minimal (Murphy et al., 1993). 
Finally, a quicker, although less accurate, way to analyse mRNA by RT-PCR is by 
single cycle number PCR with detection of probed products by autoradiographic 
densitometry (Svetic et al., 1991, Wynn et al., 1993,1994a, 1995a). The values 
obtained in this way are often presented as fold increases over baseline, or percentage 
of the maximum value obtained. This approach is now emerging as the most popular 
method for rapid analysis of gene expression at the RNA level. However, data 
displayed in this way provides no information on the baseline level of expression of 
different cytokines. 
The semi-quantitative analysis of mRNA in this thesis is based on the multiple 
cycle number PCR described above, modified to quantify the amount of radioactive 
probe bound to the PCR product obtained for each cycle number. Furthermore, the 
application of regression analysis to the data obtained has been used to determine an 
accurate value for the level of cytokine mRNA across an infection time course. This 
extra manipulation allows the PCR amplifications to be monitored for uniform 
efficiency using a given primer pair. 
The expression of different cytokines in a single RNA sample can be analysed by 
quantitative, competitive PCR. Several methods have been published describing 
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PCR in the presence of control templates, each with some advantages and drawbacks. 
One of the disadvantages common to most techniques of quantification is the large 
number of tubes required for each sample under test, limiting analysis to a few 
specific samples of special interest. In order to quantify products derived from PCR, 
a competitive control template can be incorporation into the same tube as the test 
sample. In this way all reaction variables, except for the amount of starting material, 
are kept identical. Differences between methods lie in the type of internal control 
added to the mixture, and whether these constructs control for the RT reaction and 
PCR, or only for the PCR itself. 
One of the most complex original quantitative PCR methodologies was based on 
the incorporation of an RNA competitor at the start of the RT-PCR analysis (Wang et 
al., 1989). A synthetic gene was constructed containing a tandem array of cytokine 
primer pairs designed to generate a product differing in size to that derived from 
sample RNA. The artificial gene was transcribed with RNA polymerase, and the 
synthesised RNA collected, purified and quantified by spectrophotometry. The 
artificial and sample RNA were then added together, serially diluted, and PCR 
carried out. This procedure generated a standard curve of the construct RNA PCR 
product against which the test sample could be correlated. A correction factor for the 
differences in product length was also applied to account for the increased 
incorporation of ethidium bromide or radioactivity into longer products during the 
detection step. The end result gave the level of test RNA in molecules at the start of 
the amplification procedure. This procedure accounts for all components of the RT- 
PCR reaction, and because the same primers are used to amplify the test and 
competitive templates, primer efficiency is constant. However, the reaction is 
complex and requires the construction of a completely novel template for analysis of 
the RNA of interest. In addition, the test and control samples possess different 
sequences internal to the two primers, and thus it might be argued that amplification 
may proceed at different rates for each template, although this could be tested by 
examining the efficiency of the PCR for the sample and competitive templates 
independently from each other. 
Subsequent methods have tried to strike a balance between accuracy and ease of 
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setting up the system. For example, the use of genomic DNA as the competitor 
molecule provides a product naturally different in length which also partly controls 
for differences in DNA synthesis efficiency, but does not incorporate the RNA 
reverse transcription step (Gilliland et al., 1990, Carding et al., 1992). Genes with no 
small introns can be altered by the insertion of a unique restriction site into the 
genomic competitor so that product can be distinguished by digestion (Gilliland et 
al., 1990). The genomic DNA is then added in a dilution series to constant amounts 
of test sample cDNA, and the dilution at which both products are equal in band 
intensity after probing and densitometry correlates to the point at which both starting 
templates are equal in concentration. This method can be further quantified by 
applying a correction factor for the addition of double stranded DNA competitor 
compared to single stranded sample cDNA (Carding et al., 1992). However, the 
synthesis of unique competitors for each gene of interest can make the procedure 
time-consuming to establish. 
A more recent competitive PCR protocol combines the convenience of a single 
artificial competitor for all genes under test, with the accuracy of both templates 
containing the same sequence for amplification (Reiner et al., 1993,1994). PCR 
primers are designed to span a small intron; thus competitive control templates 
derived from genomic DNA can be separated by size from the test cDNA following 
PCR. For genes with no appropriate introns, the primers are chosen so that sequence 
internal to the primers contains a unique restriction site to allow distinction between 
gDNA- and cDNA-derived PCR products after digestion. All competitive templates 
are cloned into a single vector and purified to a known concentration. This generates 
a single competitor which can be used for all the cytokines of interest. The 
competitor DNA is coamplified in a dilution series with constant amounts of test 
cDNA and the different size products analysed by gel electrophoresis. Alternatively, 
to reduce sample number, the competitor can be added at a single, previously 
determined concentration and the relative intensity of the sample band compared 
with that of HPRT, which is used as a control for equal amounts of RNA in each 
sample under test. This method does not control for the reverse transcription step, 
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but reduces the cost of quantitative PCR considerably. Thus a variety of methods are 
now available for the accurate analysis of cytokine mRNA by RT-PCR. 
In conclusion, PCR has increased the possibilities, and sensitivity of cytokine 
mRNA analysis over that previously available through Northern blotting (Gilliland et 
al., 1990, Wang et al., 1989). The ftill potential of this method is still evolving with 
the adaptation of non-radioactive ELISA-type assays to increase sample throughput 
without decreasing accuracy (Tanaguchi et al., 1994). The methods described in the 
following chapter are adapted from the multiple cycle number PCR approach 
(Dallman et al., 199 1 b), and the DNA competitive construct PCR for a more accurate 
quantification (Wang et al., 1989). Many of the more recent RT-PCR methods 
described above (Wynn et al., 1993, Carding et al., 1992, Reiner et al., 1993,1994) 
were not published when this work was initiated, and thus the procedures described 
in the following chapters have been adapted independently throughout the course of 
research. This chapter is designed to provide a detailed account of the methods used 
in subsequent chapters, along with the problems encountered and an overview of the 
use of RT-PCR as a tool for cytokine analysis in the present research climate. 
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Materials and Methods 
Tissue Sampling 
The tissue from which RNA was to be extracted was either snap frozen in liquid 
nitrogen, or submersed directly into homogenisation buffer containing guanidinium 
thiocyanate to inhibit RNAse action (4M guanidinium thiocyanate, 0.1 M Tris HCI 
pH 7.5,1 % P-mercaptoethanol added just prior to homogenisation). Tissues were 
removed from the body using dissection equipment washed and soaked in diethyl 
pyrocarbonate-treated water (DEPC-H20), a treatment which inhibits RNAse 
activity. 
Total RNA Extraction 
RNA extraction was performed using a previously published method adapted for 
the isolation of DNA-free total RNA from small amounts of tissue (Sambrook et al., 
1989). Whole organs were homogenised in 5mls of buffer (as above) with a tissue 
shearer (Ystral, Dottingen, Germany) at ftill speed for 2 minutes. Sodium lauryl 
sarcosinate (tradename Sarcosyl, BDH, Poole, UK) was then added to a final 
concentration of 0.5% and the cell lysate centrifuged at 3500 rpm for 25 mins at 
room temperature in a Beckman bench top refrigerated centrifuge. The supernatant 
was layered onto 3.5 mls of 5.7M CsCl/ 0.01M EDTA (pH 7.5) in a Beckman open 
top tube, and sample tubes were balanced accurately by weight using homogenisation 
buffer. The total RNA was pelleted over the CsCl gradient by centriftigation at 20 OC 
for 24 hours at 32,000 rpm in a Beckman ultracentrifuge with an SW41 swing-out 
rotor. 
The homogenate and CsCl were removed from above the RNA pellet, and the base 
of the tube containing the RNA removed with a hot razor blade. The pellet was 
washed with 70% ethanol and allowed to dry at room temperature. The RNA was 
resuspended overnight at 40 C in 150ýtl TES (Tris EDTA/ 0.1% SDS) by gentle 
shaking, and then transferred to a sterile microfuge tube. Any remaining RNA in the 
base of the centrifuge tube was washed out with 50 ýil TE (Tris EDTA) and added to 
the resuspended RNA. An equal volume, 200 ýd, of phenol/chloroform/ 
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isoamylalcohol mix (25: 24: 1) was added to the RNA, vortexed well and the aqueous 
phase removed to a fresh tube. The interface was back-extracted with 200 [LI of TE 
and the two aqueous phases added together. A chloroform extraction was performed 
to remove any traces of phenol left in the aqueous phase and the RNA was then 
precipitated at -200C overnight with 0.1 volumes of 3M sodium acetate and 3 
volumes of 100% ethanol. 
Finally, the precipitated RNA was collected by centrifugation at 12,000g at 4 OC 
for 30 mins, the pellet washed with cold 70% ethanol, respun, air dried and 
resuspended in 100 ýtl DEPC-H20. The yield of total RNA was estimated by 
spectrophotometry at 260 nm and confirmed, along with the intact nature of the 
RNA, by 1% agarose gel electrophoresis of between 1-3 ýtg of isolated RNA. An 
absorbence reading at 280 nm was performed to monitor the protein contamination of 
the RNA, and for samples with a protein: RNA ratio higher than 1: 1.5, the phenol 
extraction step was repeated. 
Extraction of Total RNA ftom Small Numbers of Cells 
A mini-prep based on the above method scaled down to a 100 ýd CsCl volume, as 
published (Brenner et al., 1991), was used to prepare RNA from small numbers of 
cells ( 10 2 to 10 6 ). However, the carrier ribosomal RNA used in this extraction 
obscured visualisation of the PCR product unless the cDNA generated by reverse 
transcription was first treated with DNAse-free RNAse H. In addition, this method 
could not be relied upon to yield RNA in 100% of extractions performed, and thus 
for further experiments involving small numbers of cells an RNA isolation kit was 
purchased (Micro RNA isolation kit, Stratagene, Cambridge, UK), and used in 
accordance with the manufacturer's instructions. 
Reverse Transcription-PCR 
To avoid problems with contamination all pre-PCR procedures were carried out in 
a laminar flow hood distant from the PCR product analysis area, using filter pipette 
tips and sterile technique. For all RT-PCR methods applied throughout this thesis 
the same basic reaction mix was used and is described below. The annealing 
temperatures and magnesium chloride concentrations were optimised empirically to 
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produce a single product for all sets of primers, and the specific conditions and 
primer sequences are described in subsequent chapters. A standard amount of total 
RNA was reverse transcribed in Ix RT buffer (50 mM Tris HCI pH 8.3,75 mM KCI, 
3mM MgCl2 and I OmM DTT) containing 20OU Molony-Murine Leukaernia virus 
(M-MLV) RT (Gibco BRL, Paisley, Scotland), I mM dNTP mix, 100 ng oligo dT 
primer and 20U RNAsin (Promega, Madison, WI). The reaction was incubated at 
370C for 45 mins to generate the cDNA, and then the RT enzyme heat-inactivated at 
95'C for 5 mins. The product was stored on ice or at -200C until further use. 
The amplification reaction was carried out in Ix PCR buffer (10 mM Tris HCI, 50 
mM KCI, 1.5 MM MgC12), 0.2 mM dNTP mix, 0.5 [tM of sense and antisense primer 
and 2U Taq DNA Polymerase (Promega). The temperature program used for each 
primer pair varied in annealing temperature but in general the profiles used were very 
similar: 92 OC for I min; 55,60 or 65 OC for I min; 72 OC for 2 mins. Primer pairs 
were picked by hand from the published cDNA or gene sequences, or obtained from 
previously published work and are described in the relevant chapters. Where 
possible, primers were positioned to span an intron so that any contaminating 
genomic DNA would not be amplified, or could be distinguished by size from the 
product derived from mRNA. Positive and negative controls, including RT and PCR 
template blanks, were run on each amplification to monitor reagent contamination. 
In addition, controls for contamination during RNA isolation, and the presence of 
genomic DNA in the test RNA, were run at the start of each new experiment. This 
was achieved by RT-PCR of an RNA preparation blank, and amplification of RNA 
without a reverse transcription step respectively. These controls ensured that each 
PCR was specific for the message in the sample under test. 
The analysis of longitudinal time courses was carried out using a multiple cycle 
number approach (Dallman et al., 199 1 b), as discussed in the introduction, to obtain 
accurate estimates of the amount of message present in a sample. In the following 
chapters total RNA for each organ at a time point was pooled, with equal quantities 
donated by each individual sample, and duplicates run for each pool to give a total of 
six PCR tubes per pool per cytokine. The cycle numbers chosen for each primer set 
were dependent upon the abundance of that particular message in the organ under 
test, and were determined empirically. However, sampling was always carried out at 
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intervals of 3 cycles to ensure that the whole analysis took place on the exponential 
phase of the PCR reaction. 
Slot and Southern Blotting 
In order to detect the amount of specific PCR product generated, samples were 
either slot or Southern blotted, and probed with oligonucleotide probes recognising 
sequences internal to the two primer positions. Since slot blotting does not allow the 
distinction of size, product for all new primer pairs was first Southern blotted to 
check for a single product and for probe specificity. After initial PCR optimisation, 
samples from multiple cycle analysis were slot blotted for ease of handling the large 
numbers of products generated, and the grid format permitted accurate quantification 
by phosphorimager. 
Southern blotting was carried out using standard procedures (Sambrook et al., 
1989, Mason and Williams, 1990). Briefly, after separation on a 2% agarose gel the 
PCR product was denatured in IM NaCl / 0.5M NaOH solution for 45 mins and then 
washed and neutralised in IM Tris HCI / 1.5M NaCl for 45 mins. The blotting stack 
was assembled with Zeta probe GT nylon membrane (BioRad, Hemel Hempstead, 
Herts, UK) and the DNA transferred by capillary action in 10 x SSC (standard 
sodium chloride/sodium citrate solution). The membrane was fixed with OAM 
NaOH and washed in 2x SSC before air drying and baking at 80'C for 30 mins 
under vacuum. 
Slot blotting was carried out using a vacuum assisted blotting apparatus (BioRad) 
with methods modified from the manufacturers instructions. Samples of 5 [tl from 
each product were denatured by the addition of a 95 [tl volume of denaturation mix 
to give a final concentration of 0.4 M NaOH /I OmM EDTA, followed by boiling for 
10 mins. After cooling on ice, the DNA was neutralised with an equal volume of 
ice-cold 2M ammonium. acetate and loaded on to pre-wetted nylon membrane. The 
samples were applied to the membrane using a partial vacuum and the wells washed 
through with OAM NaOH to denature the DNA on the membrane. Finally, the 
membrane was washed in 2x SSC and air dried before baking at 800C for 30 mins in 
a vacuum oven. 
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Probe Labelling and Hybridisation 
Blotted PCR products were hybridised with short, specific, radioactively labelled 
oligonucleotide probes. The probes were designed from the published gene/cDNA 
sequences or picked from previously published work (see Chapters Three and Four 
for specific information on sequences and relevant references). The labelling 
reaction was carried out in a 25 ýtl volume containing 10 pmoles of probe, 10 U T4 
Polynucleotide kinase (T4PNK, Promega) and 10 pmoles [y- 32 P]ATP (5 gl of 3000 
Ci/mmol, NEN Dupont). The reaction mix was incubated at 37 OC for 45 mins, and 
the enzyme then heat- denatured at 70 OC for 5 mins. The labelled probe was diluted 
up to a final volume of 100 ýtl and the unincorporated bases removed by spin column 
chromatography over G-50 sephadex packed into aI ml syringe. A 1ýtl aliquot of 
each pre- and post-spun probe solution was added to I ml of scintillant (Ultima Gold, 
Packard, Meriden, CT) and the counts obtained by P-scintillation counting to 
estimate the incorporation efficiency and specific activity for each probe. 
Approximately 10 7 counts per minute (cpm) were required for each probing in 20 mls 
buffer. 
Membranes were prehybridised with an SDS blocking buffer (I mM EDTA, 7% 
SDS, 0.5M Na2HP04) at 65 OC for 5 mins and then hybridised at 42 OC overnight in 
20mls of a fresh aliquot of the same solution containing labelled probe at 
approximately 2x 10 5 cpm/ml. The blots were washed twice at room temperature in I 
mM EDTA/ 40 mM Na2HP04 pH 7.2/ 5% SDS for between 3 and 5 mins, and then a 
further wash for a similar period of time at a temperature I OC below the temperature 
of dissociation (Td) was carried out in a solution containing I% SDS. The washing 
temperature was calculated using the following formula: Td = 2(A+T) + 4(G+C). 
Washed blots were wrapped in clear film and exposed to a storage phosphor 
screen for between 0.5 and 24 hours dependent upon the specific activity of the 
probe, and the level of bound radioactivity as assessed by a hand held monitor. The 
screen was scanned on a phosphorimager (SF, Molecular Dynamics, Sevenoaks, 
Kent, UK) and the resulting image analysed to obtain counts for individual blotted 
samples. Rectangles or grids of the correct size were drawn around the band or slots 
in the displayed image. The phosphorimager counts within each cell were obtained, 
corresponding to a known sample and cycle number. 
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Data Analysis and Statistics 
For multiple cycle PCR analysis, the six counts obtained for each sample were 
plotted as a linear regression and estimates for product at a given cycle number 
calculated from this line. The regression equation derived for each time point was 
tested for significance against the slopes of samples amplified in the same PCR and 
primer group by obtaining the standard error of the difference between lines 
(standard statistical test). A lack of significance indicated that all the PCR reactions 
for a given primer pair are amplifying at the same efficiency. Error bars derived 
from the 95% confidence limits for each equation (1.96 x SD, as calculated by 
computer or from standard statistical texts) were added to the estimated value of a 
specific cytokine at a given cycle number within the analysis range. Error bars that 
did not overlap indicated a significant difference with p:! ý 0.0025 (0.05 2 ). 
For simple comparisons at a few time points, PCR was carried out for a single 
cycle number and the mean of the individual samples plotted. All time courses were 
adjusted for differences in the housekeeping gene, HPRT, expression to account for 
variations in the amount of starting material added to each RT-PCR. 
Competitive PCR 
The above methods can only be used to compare the amount of a single cytokine 
present in different samples across a time course. For analysis of different cytokines 
within a sample, an internal control template of known concentration must be co- 
amplified in the same tube as the test sample using the same primer pair. 
Quantitative PCR analysis in subsequent chapters involves the incorporation of a 
competitive template into the PCR reaction. This artificial construct (kindly 
synthesised and donated by Mr Kevin Page, Glaxo Group Research, Stevenage, after 
a method first described by Wang et al., 1989) contained a tandem array of primer 
sequences and was designed to result in generation of a product different in size from 
that derived from cytokine mRNA. Primer sequences incorporated into the construct 
included IFN7, IL-2, IL-4, IL-5, IL-10 and HPRT. The competitor was serially 
diluted between I ýtg and 10 fg, and 5 [tl of each dilution added to a constant amount 
of test template, derived from I [tg or 0.25ýtg of total RNA for lung and LN tissue 
respectively. PCR was carried out as described previously. However, the construct 
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was designed with primer sequences different to those already in use for the semi- 
quantitative PCR and thus the amplification conditions were slightly different, 
requiring an annealing temperature of 55'C and a cycle number of 30 or 35 depending 
on the sample and cytokine under test. 
All test RNA was pooled to reduce tube number, and initially titrated using a 1: 10 
dilution series of plasmid DNA, followed by a 1: 4 range if a finer degree of accuracy 
was required. The products were separated by 2% agarose gel electrophoresis in the 
presence of ethidium bromide, and the point at which product derived from test 
cDNA equaled that from plasmid determined by visual inspection. At the point of 
equivalence, the amount of plasmid incorporated into the PCR mix pre-amplification 
provides an estimate of the initial amount of cDNA (derived from specific cytokine 
mRNA) present before amplification. 
Naive Baseline Values 
Naive SPF animals maintained in isolator conditions were sampled at days 0,14, 
21,35 and 50 post-delivery. RNA was extracted from the lungs and LN and analysed 
by semi-quantitative PCR for the basal level of cytokine expression. The results from 
this experiment demonstrated that no discernible drift in baseline values could be 
detected across the standard duration of the vaccination and challenge period. Thus 
in subsequent experiments naive mice were only sampled at day 0 and 35 to coincide 
with the vaccination and challenge procedures. The average naive value obtained for 
these mice is depicted as a dotted line in chapters three and four. 
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Analysis of Results 
Extraction and Analysis of Whole Tissue Total RNA 
Total RNA was isolated from whole tissue with careful consideration for the 
prevention of contamination with DNA. Furthermore, procedures were maximised 
for recovery of RNA from small quantities of tissue. Fig. I shows a typical agarose 
gel stained with ethidium bromide and the corresponding autoradiograph obtained 
following hybridisation. For each new primer pair, the PCR conditions were 
optimised and the amplification of a single product confirmed using gel 
electrophoresis and Southern blotting. The latter detection system was used to assess 
primer and probe specificity; in this example it can be seen that only one clean band 
is obtained after RT-PCR of a dilution series of LN total RNA using HPRT primers. 
In addition, the greater sensitivity of Southern blotting over ethidiurn bromide 
staining can be seen. Once the specificity of the primer and probe sequences had 
been verified, analysis could be carried out by slot blotting to increase sample 
throughput (Fig. 2). This blotting method allowed easy visualisation of the multiple 
PCR products derived in each experiment, whilst providing a time-saving, cost- 
effective alternative to Southern blotting. In addition, many samples could be blotted 
onto a small piece of membrane, so increasing the number of blots probed with one 
labelling reaction. In this example of the HPRT analysis of LN RNA, differences in 
the product amounts detectable at each increasing cycle number can be seen. For 
each cycle number, duplicates of each sample are run to give a total of six PCR 
products per sample per cytokine. 
The counts obtained for each slot by phosphorimager analysis were analysed by 
linear regression. As demonstrated in Fig. 3a, the phosphorimager count for each 
slot- blotted product was transformed (loglo), and a regression line fitted to the six 
values per RNA sample. The equation was plotted and the 95% confidence limits 
determined (Fig. 3). These limits increase toward the ends of the value range; thus 
the best estimate from the regression equation is obtained near the centre point. All 
regression lines derived for samples to be compared to each other were tested for 
significant differences between slopes by calculating the standard error of the 
difference between the slopes. This ensured that the PCR efficiency was comparable 
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between samples. The error bars added to each point on the final graph (Fig. 4) were 
derived from the 95% error value associated with the corresponding regression line 
used to estimate the values. Table 2 shows the two errors added on to each 
regression parameter in order to obtain the 95% error bar. Where possible, all 
cytokines within an experiment were shown at the same estimated cycle number, for 
example by substituting x =25 or 27 the estimated values should be in the linear 
range for all cytokines under test. An example of a final graph of data subjected to 
ftill statistical analysis is shown in Fig. 4. The vertical axis is read as 
phosphorimager counts (ie. units of energy released from the phosphor screen as 
electrons excited by P-emissions from the radioactive probe return to ground state 
upon laser scanning), and is shortened to counts in subsequent experimental chapters 
and should not be confused with radioactivity counts. This data for HPRT is 
estimated at 25 cycles from the day 0 regression (Fig. 3). In addition, values for days 
2 and 5 post-vaccination (derived in the same way) are plotted in this example. The 
95% confidence limits on these bars overlap and thus the vertical position of the 
regression equations, and hence estimated values, are not significantly different from 
each other. This is not unexpected with the analysis of HPRT which is constitutively 
expressed. Although correction factors were small (Fig. 4), the corresponding 
cytokine data from the same RNA samples was adjusted for completeness. For RNA 
samples displaying variable amounts of HPRT, an adjustment must be made to the 
relevant cytokine data to ensure that any differences reported are due to cytokine 
expression and not total RNA content of the original samples. HPRT adjustment was 
carried out for all samples in each experimental time course. 
Competitive PCR 
The inclusion of a competitive template into the reaction tubes allows the actual 
level of cDNA derived from the cytokine mRNA under test to be determined. An 
example of a competitive PCR result is shown in Fig. 5. At the higher concentrations 
of plasmid added to the test cDNA the only product generated is derived from 
construct DNA (lanes I and 2). As the serial dilution continues along the test 
samples, PCR product derived from cytokine cDNA becomes evident and eventually 
becomes the only visible product (lanes 6,7,8 and 9). The dilution at which both 
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product bands are of equal intensity (lane 4) provides the point of equivalence at 
which both templates have consumed approximately equal amounts of PCR reagents 
and thus are in equal abundance in the reaction. However, this value in pg cannot be 
related back to the exact level of mRNA in the sample due to the lack of control for 
the RT reaction, and differences in the sequence length between the 3' and 5' primers 
in the test and control templates. In addition, the estimate obtained by visual 
inspection is somewhat crude without access to a gel scanner. Differences in band 
intensity, as judged by ethidium bromide staining, could be seen easily with a ten and 
four fold dilution series. However, the ability to convert band fluorescence into a 
numerical figure would allow a more accurate cross-over point to be determined 
graphically. Samples cannot be hybridised with labelled probes and analysed by 
densitometry or phosphorimaging due to the differing internal sequences situated 
between the primer pair in the test and competitive templates. 
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Fig. 1. An example of an agarose gel stained with ethidium bromide, showing HPRT 
PCR product derived from a doubling dilution series of LN total RNA. Directly 
below is the corresponding autoradiograph. PCR was carried out for 30 cycles and 
the products run on a 2% agarose gel followed by Southern blotting and 
hybridisation with a 32 P-end-labelled oligonucleotide probe. 
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Fig. 2. A typical slot blot layout, after hybridisation and autoradiography, showing 
the differences in product obtained with increasing cycle number. Each RNA sample 
was subjected to amplification in duplicate for 3 cycle numbers. 
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Fig. 3. A worked example of the derivation of a regression line from counts obtained 
by phosphorimager analysis of a probed slot blot. 
a) Table 1. Regression analysis of the phosphorimager counts obtained from slot 
blotted HPRT PCR product derived from day 0 LN RNA. 
Day 0 
Autoradiograph 
Cycle 
number 
Counts Loglo Counts Regression Equation 
21 264200 5.4219 
24 996861 5.9986 
27 1779475 6.2503 log y=0.1567x + 2.146 
21 230146 5.3620 (±SE) 
24 963652 5.9839 
27 2576006 6.4109 
b) The regression line derived from the above equation, demonstrating the position 
of the 95% confidence limits for the day 0 sample. 
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Table 2. Breakdown of the equation errors for the regression line shown above, 
demonstrating the standard error and 95% confidence limit values added to each 
parameter. The addition of confidence limits to each estimated point permits the 
significance of that point compared to other samples to be determined. 
Using the regression equation, and errors shown below, the estimated HPRT count 
value for the day 0 sample at 25 cycles is 1,149,145 ± 141,427. 
Equation 
Component 
Basic Value SE 95% Confidence 
Limits 
In 0.1567 0.0161 0.0448 
c 2.146 0307 1.081 
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Fig. 4. Final data presentation of the estimated values of HPRT derived as above for 
days 0,2 and 5. The 95% error bars overlap for these values, and thus the estimated 
values are not significantly different from each other. However, the small correction 
factors (see table below) are applied to all cytokine data from LN samples at days 0,2 
and 5. These factors are worked out for all samples under test from the same pool of 
RNA, and used to adjust all cytokine assay data derived from that pool. Thus data in 
subsequent chapters is shown corrected for differences in HPRT mRNA levels. 
Day 0 Day 2 Day 5 
RPRT Estimated 
Value 
1,149,145 1,307,149 1,558,056 
Correction Factor 1 0.88 0.74 
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Fig. 5. An example of competitive PCR for IFNy on naive C57BL/6 lung RNA. The 
smaller plasmid product decreases in intensity as the larger sample cDNA-derived 
product increases. The PCR was carried out as described in materials and methods, 
and the products separated by 2% agarose gel electrophoresis alongside a DNA 
ladder (ST). The point of equal band intensity in this sample is at the I ng/ml dilution 
(lane 4), corresponding to the addition of 5pg of competitive construct, added in 5ý0, 
to the reaction mix. 
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In lofg 
Discussion 
This chapter describes the basic RT-PCR protocols applied to the analysis of 
cytokine mRNA profiles following vaccination and challenge of mice with S. 
mansoni, as detailed in the following experimental chapters. The study of the 
cytokine profiles induced in vivo after exposure to parasites required the use of a 
sensitive technique like RT-PCR, which is able to detect rare events without 
distortion of the immune response by in vitro secondary stimulation. However, the 
sensitive nature of PCR makes this detection system vulnerable to the problems of 
contamination. This is especially relevant with regards to the immune status of the 
mice under test, since specific schistosome responses cannot be amplified above 
background cytokine production by in vitro culture with parasite antigen, and RT- 
PCR will detect even small increases in cytokine expression due to any pathogen 
present in the host. The problems of reagent contamination and 'unclean' mice have 
both been addressed during the period of research, with the result that all animals 
used in this thesis were specified pathogen free (SPF), and housed in isolator 
conditions to prevent non-specific infection. Furthermore, all pre-amplification 
manipulations were carried out in a sterile environment spatially separated from the 
product handling area to maintain a clean cytokine mRNA detection system. 
The semi -quantitative PCR method used in the following chapters allows direct 
comparison of the cycle number at which product for various samples can first be 
detected, and thus distinguishes those samples which contain higher levels of starting 
template (Dallman et al., 1991 a, 199 1 b, Montgomery and Dallman, 199 1). This 
method was chosen over others published (see introduction) because it did not 
require the generation of standard curves using cell lines constitutively expressing the 
cytokine of interest, a potential source of contamination. In addition, this technique 
permitted easy comparison between samples for the same cytokine. As research 
progressed, the method was adapted to provide a more accurate estimate of the 
amount of product generated from the cytokine mRNA content of a sample by the 
inclusion of phosphorimager counting and regression analysis. In early experiments 
four tubes per sample were used to generate the regression line. However, analysis 
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carried out in this way often required repeating due to this minimum of points 
resulting in regression lines of varying efficiency. Later experiments were carried 
out by amplifying duplicates of each sample at 3 different cycle numbers to give six 
regression points. This resulted in more accurate data presentation, with additional 
statistical tests performed to incorporate the 95% confidence limits of the regression 
analysis. Due to the expense of the PCR technique, sample repeat size could not be 
as large as initially hoped. 
Exposure to a storage phosphor screen and scanning by phosphorimager was 
preferred to autoradiography and densitometry due to the high sensitivity and 
increased linear detection range obtained with the former. Autoradiographic film 
darkens in a linear relationship over two orders of magnitude, thus samples may 
appear saturated at the top cycle number, and barely detectable at the lowest. The 
phosphorimager can detect radioactivity with a linear relationship over five orders of 
magnitude, allowing accurate detection of the product over the nine rounds of 
amplification covered by the three cycle numbers sampled during analysis. With 
PCR working at 100% efficiency on the exponential phase of the reaction, product 
can potentially increase eight fold per three cycles, giving an overall increase of 512 
fold over nine cycles. This range cannot be accurately quantified from densitometry 
of autoradiographs. Moreover, due to the increased sensitivity of phosphorimager 
analysis compared to autoradiography, membranes need only be exposed for one 
tenth the time of autoradiographic film increasing sample throughput. 
RNA analysis by RT-PCR in this way required the application of careful practical 
handling and control measures. This method cannot provide reliable data on the 
relative levels of cytokine expression across a time course if the PCR has reached the 
plateau phase, where amplification is limited by lack of reaction components and the 
accumulation of inhibitors. Thus careful assessment of the linear range of the 
reaction must be carried out before semi-quantitative analysis is undertaken. 
Furthermore, the regression analysis is only valid if the slopes derived from the 
equation for each sample do not differ significantly from each other. 
To ensure that as many as possible of the parameters involved in this analysis are 
kept constant, RNA samples to be compared to each other were run on the same RT- 
PCR amplification, using the same master mix and heating block. In addition, 
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samples were slot blotted and probed together to control for DNA denaturation, 
probe labelling and hybridisation efficiency. Where the number of samples under 
investigation exceeded available equipment, RT-PCR was carried out with the same 
batch of enzyme on consecutive days and the membranes probed together in a single 
hybridisation. Controls for PCR and blotting efficiency were included on each run 
where two or more blots contributed to a single graph. However, these controls only 
allow comparisons to be made between samples probed in a single hybridisation. 
Due to markedly different end-labelling efficiencies resulting in probes with different 
specific activities, no comparisons can be made between the phosphorimager count 
values obtained for the same cytokine (e. g. IFN7) in different experiments. 
Competitive PCR involves the inclusion of a control template of some description 
into the same reaction tube as the sample under test so that both DNAs are amplified 
in exactly the same conditions. Early attempts at quantifying PCR involved the 
addition of a primer pair for a housekeeping gene into the test reaction (Chelly et al., 
1988). However, this method utilises distinct primer and target template sequences, 
with all test samples related back to the expression of the housekeeping gene. Thus a 
strict comparison between the expression of different cytokine genes cannot be made. 
In general, more recent methods have developed templates with primer sequences 
identical to those of the test sample, and consisting of either an artificial RNA/DNA 
construct or modified genomic DNA. The competitive template used throughout this 
thesis consists of a tandem array of cytokine primer sequences cloned into a pGEM 
plasmid. The primers were inserted in an order designed to generate products of 
different sizes than those derived from cytokine mRNA. The theory behind the 
generation and use of the competitive template are similar to those previously 
described (Wang et al., 1989, Gilliland et al., 1990, Reiner et al., 1993), with a 
drawback in that product cannot be easily detected other than by visual inspection 
under UV illumination. This Problem could be addressed by the inclusion of 
radioactivity into the PCR reaction, either as labelled bases or via the use of 
radiolabelled primers. Alternatively, a gel scanner could be used to quantify the 
bands seen directly from the gel. However, these options were not available at the 
time of analysis and thus all competitive PCR data is derived from human 
judgement, and hence is also subject to human error. Therefore, due to the 
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limitations of this technique at present, the increases in cytokine expression derived 
by competitive PCR do not necessarily correspond to the fold increases observed for 
the same samples following semi-quantitative PCR analysis. 
Although many published competitive PCR methods claim to allow absolute 
quantification of product by relating the competitive template quantity to the number 
of cytokine mRNA molecules in the test sample, very few actually take into the 
consideration the reverse transcription reaction and the differences in product length. 
The quantification of cytokine expression down to the exact number of mRNA 
molecules present was deemed unnecessary in this study, thus results from the 
competitive PCR in the experimental chapters are displayed in picograms of control 
template required to attain equivalence with the test sample. In addition, the 
relationship between the message for a certain cytokine and the relative potency of 
the active protein remains unclear (Trinchieri, 1993), hence accurate quantification at 
the mRNA molecule level has limited relevance to understanding the in vivo 
situation. In spite of the limitations, if handled with care, competitive PCR provides 
a valuable tool for comparing the expression level of different cytokines in samples 
from a variety of situations. 
The following four chapters describe the application of the RT-PCR technique in 
the analysis of the in vivo cytokine responses induced in mice after various 
vaccination and challenge exposure regimes. The results obtained provide a detailed 
description of the cytokines expressed during the induction and effector mechanisms, 
in the skin draining LN and lungs respectively, which constitute a protective 
response (Chapters Three and Four). In addition, the differences in these responses 
caused by variations in genetic background, such as those occurring naturally in 
different strains of mice or artificially induced by gene deletion, are investigated 
(Chapters Five and Six). 
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CHAPTER THREE 
Responses in the Skin-Draining Lymph Nodes Following 
Vaccination and Challenge of C57BL/6 Mice 
with Cercariae of S. mansoni 
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Introduction 
Vaccination of C5713L/6 mice with 500 radiation-attenuated cercariae of 
Schistosoma mansoni leads to the generation of high levels of resistance against 
challenge infection (Dean, 1983). This immunity is CD4+ T cell mediated, with little 
input from CD8+ T cells, as determined by in vivo ablation studies (Vignali et al., 
1989). The importance of the skin draining lymph nodes in the induction of 
protection has been established by lymphadenectomy (Mountford and Wilson, 
1990), and vaccination with irradiated parasites by intravenous injection (Coulson 
and Mountford, 1989), both of which treatments bypass this site and result in reduced 
resistance. The slower, truncated migration and persistence in the LN of a proportion 
of the irradiated parasites (Wheater and Wilson, 1979, Mountford et al., 1988), 
results in prolonged exposure of antigen presenting cells to intact parasites and 
related antigens during a vaccinating, compared to normal, infection. It is thought 
that this increased exposure leads to the generation of a Thl population and 
establishment of a protective immune response (Mountford et al., 1988,1992). 
Following both normal infection and vaccination, the number of schistosomula in 
the LN peaks at day 5, with I 1- 16 % of infecting parasites detectable in that location 
(Mountford et al., 1988). However, although irradiated larvae persist in the nodes of 
vaccinated mice for up to two weeks, 10.4% still being present after day 7, under 3% 
of healthy parasites remain after normal infection. 
The effectiveness of vaccinating parasites at inducing an immune response is 
demonstrated by cell population studies. In vitro proliferation of cells isolated from 
axillary LN peaks at day 5 post-vaccination (Pemberton et al., 1991, A. Finlay, 
unpublished observations) and is of similar magnitude in both normal and 
vaccinating infections. However, the proliferative response is more persistent after 
vaccination than that observed after exposure to normal parasites (Pemberton et al., 
199 1). There is also a significant elevation in total cell number in the LN of 
vaccinated mice, with a 13.5 fold increase over naive controls detectable at day 14 
(Constant et al., 1990). In comparison to the eight fold increase in T cell number, the 
number of B cells present in the LN dramatically increases by twenty eight fold, thus 
effectively reducing the ratio of T: B cells from a naive value of 4: 1, to almost 1: 1 
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(Constant and Wilson, 1992). In spite of this large increase in the B cell population 
of the LN, T cells still slightly exceed B cells in absolute numbers over the extent of 
the time course. The elevation in B cells appears to be due to selective retention of 
this cell type in the nodes, since no preferential recruitment or proliferation can be 
detected (Constant and Wilson, 1992). However, there is an absence of B cells in the 
efferent lymph flow, possibly accounting for the accumulation of these cells from 
day 7 post-vaccination onwards. These increases in B cell number and T cell 
proliferation coincide with parasite residence, and increased levels of released 
antigenic material, in the LN (Mountford et al., 1988). In vaccinated mice the cell 
number remains elevated above background until day 35, whereas after normal 
infection the LN cell population starts to decline at day 14 and reaches naive levels 
again by day 21 (Constant et al., 1990, Mountford et al., 1992, Pemberton and 
Wilson, 1995). 
The rise in cellular activity is matched by upregulation of cytokine expression by 
LN cells stimulated in vitro. The Thl cytokine interferon-y (IFNy) dominates 
cytokine protein secretion profiles at all times post-vaccination (Pemberton et al., 
1991), with higher and more prolonged expression than cultured LN cells from mice 
exposed to normal parasites (Pemberton et al., 199 1, Mountford et al., 1992). Two 
main peaks of IFNy protein production occur, one at day 5 and the other at day 18 
post-vaccination. The first corresponds to the residence of maximum numbers of 
parasites in the nodes, the second to the release of large amounts of parasite antigen, 
presumably from dying parasites which have failed to exit the LN and continue 
migration (Pemberton et al., 1991). Anti-CD4 ablation in vitro has an almost total 
inhibitory effect on IFN7 release upon secondary stimulation, indicating that this 
cytokine is produced predominantly by the CD4+ cell population with very little 
secretion attributable to CD8+ T cells (Pemberton et al., 1991). Production of the 
other typical Thl cytokine, IL-2, after vaccination is low at all time points, and 
similar to levels detected after a normal infection. Th2-type cytokines have also been 
detected at elevated levels after vaccination, indicating the mixed Thl/Th2, or ThO, 
characteristics of the response in the sdLN. IL-4 protein is released at low levels at 
day 4 and increases at day 10 post-vaccination, whereas IL-10 secretion displays the 
opposite kinetics, peaking at day 4 and decreasing by day 10. In general, cytokine 
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levels detected after exposure to normal infection are similar to those following 
vaccination, but of lower magnitude and a more transient nature (Pemberton and 
Wilson, 1995). 
Analysis of events after challenge of vaccinated mice has demonstrated the 
importance of the secondary exposure site in determining the type of immune 
response generated upon infection with normal parasites. However, this secondary 
response seems unable to alter the effector mechanism operating in the lungs, since 
whole body irradiation performed prior to challenge infection has no influence on 
resistance (Aitken et al., 1987, Vignali et al., 1988). If mice are vaccinated and 
challenged on the same site, and thus through the same LN, reduced cell proliferation 
is observed with no indication of an anamnestic response displaying Th I 
characteristics (Pemberton and Wilson, 1995). In fact the opposite is true, with 
culture supernatants exhibiting variable reductions (73-96%) in the post-vaccination 
level of IFN7 secretion, and an increase in IL-4 secretion (Pemberton and Wilson, 
1995). This reduction in IFNy levels is less evident if challenge is performed on a 
site remote from the vaccination area (Pemberton and Wilson, 1995, Caulada- 
Benedetti et al., 1991). IL-2 production is slightly raised above background levels in 
mice challenged on a remote site, or in control groups. However, LN cells from mice 
receiving challenge infection on the same site as vaccination exhibited almost 
undetectable IL-2 levels, again emphasising the lack of an anamnestic Thl response 
in the LN which have already seen parasites. In contrast to the Thl cytokines, IL-4 
protein secretion is higher post-challenge than that observed post-vaccination in 
groups of mice challenged on a remote or the same site. Furthermore, IL-4 reaches 
maximal levels more rapidly than in challenge control supernatants, indicative of an 
anamnestic Th2-type response. The dominance of IL-4 in LN cultures from mice 
vaccinated and challenged on the same site implies that the priming vaccinating 
infection induces anergy, or an inhibition in the development of Th I IFNy-secreting 
cells after vaccination. Alternatively, any Th2 cell precursors remaining in the LN 
from after vaccination may expand upon secondary stimulation in the absence of 
inhibitory levels of IFN7 protein and, once established, the Th2 response will then 
prevent expression of any developing Th I cytokines (Mosmann and Moore, 199 1, 
Tanaka et al., 1993). 
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In both same and remote-site exposure regimes, IFNy production from cultured 
cells can be restored, and IL-4 secretion reduced, by the in vitro neutralisation of 11- 
10 (Pemberton and Wilson, 1995). The level of IL- 10 protein expression post- 
challenge is similar to that induced after exposure to irradiated parasites (Pemberton 
and Wilson, 1995). This protein can be released by macrophages and some types of 
B cells (Mosmann et al., 199 1, Moore et al., 199 1, O'Garra et al., 1990, Murphy et 
al., 1993), and may act along with IL-4 to enhance the development of a stronger 
Th2 response post-challenge via the inhibition of macrophage and Thl cytokine 
release (Fiorentino et al., 1989,1991 a, 1991b, Flores Villaneuva et al., 1993). At 
day 6 post-challenge, the LN from mice receiving a vaccination on the same site 
displayed a two-fold increase in B cell numbers compared to challenge control 
animals (Pemberton and Wilson, 1995). This factor may also influence the bias of 
challenge infection towards a Th2 type response if B cells can act as the primary 
APC for Th2 cell populations (Gajewski et al., 1991, Janeway et al., 1987). 
Multiple vaccination regimes have been shown to downregulate Thl and increase 
Th2 cytokine production in the sdLN with increasing exposure to the same site 
(Caulada-Benedetti et al., 1991). Multiple vaccination results in little or no increase 
in the resistance generated by a single exposure. Moreover, protection is 
transferable to naive recipient mice with immune serum indicating that soluble 
factors such as antibodies are now involved, an effect not seen with single 
vaccination serum (Kelly and Colley, 1988, Mangold and Dean, 1986). However, 
the resistance in recipient animals is not comparable to the levels seen in donor mice, 
indicating that the mechanism responsible for resistance is not entirely hurnoral . In 
contradiction to this, hyperimmunized mice treated with anti-CD4 antibody do not 
display reduced resistance, implying that CD4+ T cells are not essential for resistance 
(Caulada-Benedetti et al., 1991). In combining the above two observations, a more 
plausible explanation for these discrepancies could be that ablation of the circulating 
CD4 + population does not necessarily deplete those T cells already resident in the 
lungs awaiting the arrival of challenge parasites (Caulada-Benedetti et al., 1991). In 
summary, the above experiments indicate that upon multiple exposure to S. mansoni 
parasites a Th. 2-like response, involving antibodies, develops and the Thl response 
seen with a single vaccination is reduced, but not completely switched off. 
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Based on previously published reports, a more complete investigation of the 
cytokine profiles following vaccination and challenge was designed. To minimise 
any artifacts induced by in vitro stimulation, analysis of cytokine gene expression 
was performed using Reverse Transcriptase-PCR (RT-PCR). This method allows 
detection of cytokine mRNA ex vivo, providing an accurate characterisation of the 
immune status of the LN at the time of excision. The resulting cytokine mRNA 
profiles detected across the time course supported earlier findings of a dominant Thl 
response post-vaccination with a sharp increase in Th2 cytokines message following 
challenge. Apparent reductions in some cytokine messages below the naive baseline 
values were investigated to determine if B cell accumulation in the LN may act to 
dilute messages detectable from other, less abundant, cell populations. 
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Materials and Methods 
Experimental Animals and Parasites 
A Puerto Rican isolate of Schistosoma mansoni was routinely passaged through 
MF I outbred mice and albino Biomphalaria glabrata snails. Female C57BL/6 
specific pathogen free (SPF) mice, purchased from B&K Universal (Grimston, Hull, 
UK), were housed in isolator conditions to maintain SPF status throughout the 
experiment. 
Exposure Regimes 
Mice weighing 17 to 20g were vaccinated percutaneously on the left flank with 
500 20 krad 60 Co gamma-irradiated cercariae (radiation source provided by the 
Department of Radiobiology, Cookridge Hospital, Leeds) and then 35 days later 
challenged with 200 normal cercariae on the opposite flank. The axillary and 
inguinal LN draining the exposure site were excised at days 0,2,5,10,14,21 and 35 
post-vaccination, and at days 5,10 and 15 post-challenge. LN were removed directly 
into an RNAase inhibitor (4M guanidinium thiocyanate solution) or snap frozen in 
liquid nitrogen and stored at -80 OC until use. A second time course sampling at 
days 0,1,2,5,10,14,21 and 35 post-vaccination was carried out for repeat 
analysis. 
Resistance data was calculated using the worm burdens obtained by hepatic portal 
perftision of groups of 5 vaccinated (VC) and 5 naive (CC) mice from the first 
experiment at 35 days post-challenge. Resistance was calculated from the respective 
worm burdens as follows: %R = [(CC-VC)/CC]x 100. 
Total RNA Isolation 
Axillary and inguinal LN from groups of 3 mice sampled at each time point were 
pooled and homogenised in guanidiniurn thiocyanate solution (4M guanidiniurn 
thiocyanate, 1% 2-mercaptoethanol) using a tissue shearer, and the total RNA 
extracted as previously described in chapter two (Sambrook et al., 1989). The RNA 
yield was measured spectrophotometrically and verified by I% agarose gel 
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electrophoresis in the presence of ethidium. bromide (0.5 mg/ml), which also 
confirmed the intact nature of the preparation. 
Semi-Quantitative RT-PCR Detection of Cytokine mRNA 
Analysis of the levels of cytokine mRNA in samples from the longitudinal time 
course was adapted from a previously published method (see Chapter Two and 
Dallman et al., 199 1, Montgomery and Dallman, 199 1). A titration series of RNA 
dilutions was carried out to determine the optimal amount of starting material for the 
RT-PCR. Based on these results, 0.25[tg of total LN RNA was subjected to reverse 
transcription and PCR as previously described. Briefly, total RNA was reverse 
transcribed and the resulting cDNA amplified in duplicate for three different cycle 
numbers previously determined to lie in the exponential phase of the reaction. The 
cycle numbers chosen for each cytokine were dependent on the individual kinetics of 
the primer pairs, and were spaced at intervals of three cycles. Thus amplification for 
the cytokines assayed in LN RNA was carried out for the following number of 
cycles: HPRT, 21,24,27 ; IFN7,24,27,30; IL-2,27,30,33 ; IL-4,27,30,33 
IL-5,27,30,33 ; IL-10,24,27,30 ; IL-12,24,27,30 ; IL-13,27,30,33. An 
annealing temperature of 600C proved optimal for all the cytokine primers except IL- 
10, where annealing was performed at 550C. Positive and negative controls, 
including PCR and RT-PCR reagent blanks, and a control for the presence of 
genomic DNA in the sample, were run on each amplification to control for the 
potential contamination of reaction components and RNA samples with PCR 
products from previous experiments. Furthermore, where possible, primer pairs were 
designed to span an intron to distinguish product derived from any contaminating 
genomic DNA. Primer sequences for HPRT, IL-5 and IL-13 were based on 
previously published work (Murphy et al., 1993, Montgomery and Dallman, 1991, 
and Wynn et al., 1993 respectively). Primers for additional cytokines were designed 
from published gene/cDNA sequences and were as follows: IL-2 sense GTCAACA 
GCGCACCCACTTCAAGC, antisense GACAGAAGGCTATCCAATCTCCTCAG 
(Kashima et al., 1985); IL-4 sense GCTAGTTGTCATCCTGCTCTTC, antisense 
GCTCTTTAGCTTTCCAAGGAAGCT (Noma et al., 1986); IL- 10 sense 
GAAGCTGAAGACCCTCAGGA, antisense TCCCTGGATCAGATTTAG (Moore 
98 
et al., 1990) ; IL- 12 p40 chain sense CCATCTCCTGGTTTGCCATCGTT, anti- 
sense GGAGCAGCAGATGTGGAGTGGC (Schoenhaut et al., 1992). The 
housekeeping gene HPRT was reverse transcribed and amplified for each set of 
samples to ensure equal quantities of starting total RNA were used in each reaction. 
In order to determine the contribution of B cell RNA to the total LN RNA content 
RT-PCR was carried out with primers specific for the IgM ýt chain constant region, 
as designed from the published cDNA sequence (Auffray and Rougeon, 1980) as 
follows: sense, CGACATCTTCCTTAGCAAGTCCGC, anti-sense, CAGCAGGT 
ACACAGCAGGTGGATG. Due to the high level of expression of this message, the 
cycle numbers used for semi-quantitative PCR were 18,21 and 24, with an annealing 
temperature of 600C. In addition the T cell marker CD4 was amplified as an 
indication of the number of T helper cells present in the LN, with the following 
primers designed from the published cDNA sequence: sense, CTGGTTCGGC 
ATGACACTCTCAGTG, antisense, ACACTGCCACAGCCCTGTCTCAGG 
(Tourvieille et aL, 1986). 
Detection and Analysis ofPCR Product 
The amounts of specific PCR product obtained for each sample were determined 
by slot blotting 5ýil aliquots onto nylon membrane (Zeta Probe, Bio Rad). Baked 
membranes were hybridised with 32 P-end-labelled oligonucleotide probes specific for 
regions of the PCR product internal to the two primer sequences. Probe sequences 
were either adapted from previously published work (IFN7 from Gray et al., 1983, 
IL-4 and IL-5 modified from Montgomery and Dallman, 1991, IL-10 and HPRT 
modified from Murphy et al., 1993, IL- 13 modified from Wynn et al., 1993) or 
designed from the published cDNA sequences as follows: IL-2, TCCAAGTTC 
ATCTTCTAGGCACTG (Kashima et al., 1985); IL-12, TCAGGCGTGTCAC 
AGGTGAGGTT (Schoenhaut et al., 1992); IgM, GGAATCTGCCTTCACCACAG 
(Auffray and Rougeon, 1980); CD4, GTTGCCAGAACCAGCAAACTGAAG 
(Tourvieille et al., 1986). Hybridised membranes were washed at I OC below the 
dissociation temperature of the probe, and exposed to a storage phosphor screen for 
subsequent phosphorimager analysis of bound radioactivity. 
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At each time point a linear regression was performed with the six repeats for each 
sample (two for each cycle number), and the amount of product at a given cycle 
number estimated as previously described (Chapter Two). Values obtained for the 
cytokines were normalised for differing RNA content using the estimated HPRT 
values. The adjusted values were then plotted to give a profile of cytokine 
expression with time post-exposure to irradiated and normal parasites. The 95% 
error bars of the estimated values were plotted by analysing the confidence and 
standard error limits of the regression line. The regression line slope value was also 
analysed for significant differences to confirm that comparable samples had 
undergone PCR amplification of the same efficiencies. 
Competitive PCR 
The above method permits only the comparison of given cytokine differences 
between samples and not the relative levels of different cytokines with respect to 
each other. To achieve this objective, a competitive construct, comprising of primer 
sequences for a set of cytokines, of known dilution must be amplified 
simultaneously, in the same tube as the sample under test. Such a template (kindly 
constructed and donated by Mr. K Page, Glaxo Research, Greenford, Middx) 
consisting of primer sequences in tandem array was used to provide a more accurate 
estimate of the amount of mRNA present in naive mice, and at two peak response 
time points following either vaccination or challenge (as described in Chapter Two). 
Briefly, test LN RNA was reverse transcribed and then amplified in the presence of a 
dilution series of competitive template. Cytokines analysed included IFNy, IL-4 and 
IL-10. The mixture of different sized products was separated by 2% agarose gel 
electrophoreisis in the presence of ethidium. bromide, and the point of equivalence at 
which both products gave equal band intensities determined by visual inspection 
under UV light. 
LN Total RNA Content Determination 
The total weight and RNA content of the LN draining the exposed flank were 
investigated in a third vaccination time course sampled at similar time points to the 
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second experiment. The axillary and inguinal LNs draining the left flank were 
harvested and processed as a pair for each of the 3 animals per time point. Analysis 
was carried out on pooled pairs of LN from each mouse so that the total weight and 
RNA increase could be assessed without small discrepancies in vaccination site 
favouring parasite migration through one node over the other. The nodes were 
weighed, teased apart and the RNA content estimated by a reaction with orcinol 
reagent, eliminating the need for any isolation and purification stages during which 
RNA might be lost (Cerotti et al., 1954). The CsCl isolation procedure for total 
RNA extraction, as used in the above section, produces high yields of intact, DNA- 
free RNA. However, the extraction is not quantitative between sampling days. The 
orcinol reaction provides an estimate of the RNA present in an organ, but the RNA 
preparation is crude and of no further use. The system detects the RNA pentose 
present in a sample by an orcinol/HCI/CUC12 colour reaction measurable by 
spectrophotometry. The teased LN were extracted twice with absolute alcohol and 
twice with diethyl ether. The dried residue was then incubated in cold 2% perchloric 
acid at 40C for 20 minutes. The residue was centrifuged down, the supernatant 
discarded, and the incubation repeated. The LN residue was then incubated in 250ýtl 
10% perchloric acid at 700C for 20 minutes, the supernatant collected and the 
procedure repeated. The supernatants were pooled and boiled for 40 minutes with an 
equal volume of 0.004M CUC12. H20 in conc. HCI/20 mg/ml orcinol. The colour was 
extracted twice with 500[d isoarnyalcohol and an optical density reading taken at 
675nm with a reaction blank and a set of RNA standard dilutions at known 
concentrations. A regression line was plotted using the standard RNA OD readings 
and from this the RNA content of the LN samples estimated. 
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Results 
Cytokine Profiles Observed in the Axillary and Inguinal LN Following Vaccination 
and Challenge. 
Previously published work indicated the predominance of Th I type cytokines in 
supernatants obtained by in vitro culture of leucocytes from the skin draining LN 
after vaccination (Pemberton et al., 1991, Pemberton and Wilson, 1995, Mountford 
et al., 1992). Although the analysis of cytokine protein after secondary stimulation 
of isolated cells provides information on the potential cytokine secretion upon 
exposure to antigen, it does not reveal the true immune response occurring in the LN 
at the time of sacrifice. To address this problem, the more sensitive technique of RT- 
PCR was applied to investigate the in vivo responses occurring in the skin draining 
LN following exposure to S mansoni. However, although RT-PCR analyses the 
cytokine mRNA present in the tissue ex vivo, this molecule is not the final active 
form of the cytokine and thus care should be taken when extrapolating data to the in 
vivo secretion of protein. 
The data shown are representative of two experimental time courses. For all data, 
the values shown are estimates at 25 cycles, derived from regression analysis, with 
error bars showing the 95% confidence limits attributable to the regression equation. 
The slopes of all the regression lines for each cytokine were not significantly 
different from each other. All data points for which the error bars do not overlap are 
significantly different (p:! ý 0.0025) from each other. 
The profiles of the classic Thl cytokines, IFNy and IL-2, can be seen in Fig. 1. 
Both these cytokines rise sharply after vaccination, peaking significantly (p:: ý 0.0025) 
above baseline at day 2, and falling almost to baseline levels by day 5. For IFNY 
there is a second peak around day 14 post-vaccination; however, the level of message 
detected at this time point is lower than that seen at day 2. Both cytokines show no 
increase above naive values after challenge at day 35 in vaccinated and challenged 
animals (VC). Thus there is no anamnestic Thl activity in the axillary and inguinal 
LN upon challenge of previously vaccinated mice. It should be stressed that the 
challenge parasites exit the skin through nodes on the opposite flank to those exposed 
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to vaccinating larvae, and that both sets of nodes (left and right) exhibited similar 
cytokine levels at day 35 for IFNy, IL-2 and IL-4, reflecting the general immune 
status of the mouse rather than a localised response due to previous exposure. But 
insufficient RNA was recovered from the challenge flank LN at day 35 post- 
vaccination to carry out RT-PCR analysis for all the cytokines under investigation. 
Thus, data is plotted with the naive baseline indicated with a dotted line and no direct 
connection can be made between day 35 post-vaccination and day 5 post-challenge 
samples due to the switch to nodes on the other side of the body. 
In challenge control animals (CC) there is a very slight, but not significant, 
increase in IFNy and IL-2 mRNA above baseline values on day 5 after infection (day 
40 on Fig. 1). In fact, after challenge, these cytokines are higher in CC mice than the 
VC group, but neither group reaches the elevated level of Thl expression observed 
following vaccination. 
The Th2 cytokines, IL-4 and IL-5, exhibit a completely different pattern of 
expression compared to the Th I cytokines (Fig. 2). Post-vaccination, IL-4 mRNA 
shows no early increase, only peaking at day 10 and declining to a relatively uniform, 
but still elevated, level until challenge at day 35. Upon exposure to normal parasites, 
levels of IL-4 message rise sharply in both vaccinated and naive mice, peaking at day 
10 post-challenge and then falling by day 15 (days 45 and 50 respectively of Fig. 2). 
The response in the VC group is of higher magnitude than that for CC animals, 
indicating a strong anamnestic response for this cytokine, and in both groups IL-4 
levels peak 2-3 fold higher than following vaccination. After an initial lag, IL-5 
message falls sharply below the naive baseline after vaccination and remains low up 
to day 35, an effect also seen for several other cytokines and discussed in detail 
below. Following challenge infection, IL-5 mRNA increases above background at 
day 5 in VC animals, before falling again at days 10 and 15. CC mice also show a 
rapid fall in IL-5 expression similar to that observed following vaccination. 
However, by day 15 values have recovered to above baseline and reach levels 
comparable to those seen in VC mice at day 5 post-challenge. 
The other cytokines assayed, IL- 10, IL- 12 and IL- 13, all display a sharp decrease 
in expression post-vaccination, with message levels falling below those obtained for 
naive LN (Figs. 3 and 4). IL- 10 mRNA peaks briefly, although not significantly, at 
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day 5 after vaccination and falls gradually below the naive background level for the 
remainder of the post-vaccination time course. Furthermore, mRNA levels remain 
below the naive value after challenge, with both VC and CC animals displaying a 
slight decline in IL-10 expression with time. A similar response is seen for IL-12 
expression, although the peak is earlier at day 2, corresponding with peak IFNy 
expression, and the fall sharper than that observed for IL- 10. Finally, the sharpest 
decline after vaccination is seen for IL- 13 mRNA, with no peak before the message 
drops below the baseline. The same decrease is observed in both treatment groups 
following challenge. 
Competitive PCR 
A more accurate estimate of the amount of cytokine message for IFNy, IL-4 and 
IL- 10 was obtained for day 2 post-vaccination and day 10 post-challenge samples by 
quantitative PCR (Table 1). The point of equivalence for IFNy product derived from 
the competitive plasmid and the sample cDNA was over 100 fold higher (5 0-5 OOpg) 
at day 2 than the values obtained for IL-4 and IL-10 (0.5 and 5 pg respectively). 
However, after challenge of vaccinated mice the pattern is reversed with IL-4 
message approximately 10 fold higher, at 5 pg, than IFNy and IL- 10 mRNA, both of 
which had points of equivalence corresponding to 0.5 pg of competitive template. 
Perhaps surprisingly, IL- 10 displayed slightly higher levels of expression post- 
vaccination, with a 10 fold decrease following challenge. This is in contradiction to 
the increase in the other Th2 cytokine, IL-4, observed at this time. Lack of time and 
reagents limited this analysis to a 1: 10 dilution series, and thus some cross-over 
points are expressed as a range of values if the exact point of equivalence was not 
covered by a single dilution. 
Total RNA Content of the LN Following Vaccination 
The production of cytokines by a minority of cells in an organ could lead to any 
message produced being swamped by the proliferation or influx of a more common 
cell type. To test this hypothesis two investigations were carried out involving the 
quantification of total RNA present in the nodes, and the analysis of the proportion of 
this RNA relating to B and T cells. Using a vaccination regime similar to that used 
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for cytokine mRNA analysis, the axillary and inguinal LN draining the vaccinated 
flank were excised and pooled for weighing and RNA content measurement. 
Following vaccination, the weights of the combined LN increased sharply at days I 
and 2, reaching a peak around days 10-14 before falling to near naive values at day 
35 (Fig. 5). Surprisingly the total RNA content followed a similar pattern initially, 
but then reached a plateau and remained elevated with no decrease observed even at 
day 35 post-vaccination. 
B and T Helper Cell Contribution to mRNA in the LN 
RT-PCR data for the constant region of the ýt chain of the IgM antibody indicates 
that there is an increase in the amount of IgM message detected in the LN following 
vaccination (Fig. 6a). The significant increase in expression observed at day 2 post- 
vaccination falls rapidly at day 5 and then remains slightly elevated until day 35, at 
which point a second, smaller peak occurs. After exposure to challenge parasites, no 
increase in IgM expression is observed in either VC or CC groups. In fact, the levels 
detected are below the naive baseline. Analysis of CD4 mRNA demonstrated an 
initial rise up to day 5 post-vaccination, followed by a steady decline until day 21 
(Fig. 6). Similar to IgM expression, CD4 mRNA then increases at day 35. There is 
no detectable increase in CD4 expression above background post-challenge in 
previously vaccinated or control animals. 
Resistance Data 
Mice previously vaccinated with 500 irradiated cercariae were highly protected 
against a challenge infection compared to naive controls, demonstrating a resistance 
of 73%. The resistance was calculated from the worm burdens (CC = 46.75 ± 5.36, 
VC = 12.6 ± 1.86) using the equation given earlier. This result confirms data 
obtained previously by left flank vaccination followed by right flank challenge in 
which resistances of 66.8% and 79.3% were obtained (Pemberton and Wilson, 1995). 
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Fig. 1. The levels of IFN7 and IL-2 cytokine mRNA expression in combined axillary 
and inguinal. LN tissue following percutaneous vaccination and challenge (E) or 
challenge alone (0). Values shown are estimates obtained at 25 cycles from 
regression equations derived using multiple cycle number PCR, and are adjusted for 
differences in HPRT levels between samples. The naive baseline level is represented 
by a dotted line determined as the average cytokine expression in uninfected mice 
sampled at days 0 and 35 of the vaccination time course. 
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Fig. 2. Levels of IL-4 and IL-5 mRNA expressed in combined axillary and inguinal 
LN tissue following vaccination and challenge (M) or challenge alone (0). Values 
shown are as described for Fig. 1. 
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Fig. 3. Expression of the regulatory cytokines, IL-10 and IL-12, in combined 
axillary and inguinal LN tissue following vaccination and challenge (M) or challenge 
alone (0). Values shown are as described for Fig. 1. 
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Fig. 4. Expression of the Th2 cytokine IL- 13 in LN tissue following vaccination and 
challenge (0) or challenge alone (0). Values shown are as described for Fig. 1. 
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Fig. 5. Profiles of combined axillary and inguinal LN weight (a), and total RNA 
content (b), following vaccination on the left flank with 500 radiation attenuated 
cercariae. After weighing, the LN were teased apart, extracted in organic solvents 
and boiled with orcinol to give a colourmetric reading of the ribose content of the 
tissue. Values shown are the mean ± SE for three animals per sampling time. 
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Fig. 6. The expression mRNA for the ýt heavy chain constant region (a) and CD4 (b) 
mRNA in combined axillary and inguinal LN tissue following vaccination and 
challenge (0) or challenge alone (0). Values shown are as described for Fig. 1. 
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Table. 1. The quantity of competitive plasmid DNA added to naive, day 2 PV and 
day 10 PC samples in order to obtain PCR products of equivalent band intensities, as 
determined by visual inspection, when co-amplified with the cDNA under test. 
Values shown are pg of plasmid DNA added in a 5gl volume to a PCR tube 
containing cDNA derived from 0.25 ýtg total LN RNA. 
IFNy IL-4 IL-10 HPRT 
Day 0 (Naive) 0.5 pg 0.05 pg ND 50 pg 
Day 2 post- 
50-500 pg 0.5 pg 5 pg 50 pg 
vaccination 
Day 10 post- 
0.5-5 pg 5 pg 0.5 pg 50 pg 
challenge 
ND = not detectable 
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Discussion 
The cytokine messenger RNA profiles presented above provide an interesting 
overview of the events occurring in the skin draining LN following vaccination and 
challenge with S. mansoni. These results support data previously published on the in 
vitro secretion of cytokine protein following secondary stimulation (Pemberton et al., 
1991, Pemberton and Wilson, 1995). However, this chapter also highlights 
differences between the profiles observed at the protein and mRNA level, especially 
with cytokines such as IL- 10, which can be produced by non-T cells (Mosmann and 
Moore, 1991). These discrepancies may be due to a variety of factors. Secondary 
stimulation in vitro does not account for cells utilising released cytokine protein, thus 
low levels of a protein detected by ELISA may not reflect actual production. In 
addition, this study involves the analysis of a wider variety of cytokines than already 
assayed by cell stimulation in culture. Thus RT-PCR provides a more complete 
picture of the Th I and Th2 responses occurring in the sdLN, with the analysis of IL- 
12 and IL- 13 which cannot be readily measured at the protein level at present. 
Following vaccination with 500 irradiated cercariae of S mansoni, mRNA levels 
for the Th I cytokines IFNy and IL-2 in the sdLN are elevated at day I and peak at 
day 2 post-exposure. This is earlier than the previously reported increase in IFNy 
protein at day 4 (Pemberton et al., 199 1, Pemberton and Wilson, 1995); although no 
earlier time points were sampled in the above report, and thus an early peak may 
have been overlooked. In addition, the differences in the kinetics of mRNA 
transcription and protein secretion may account for any small differences in timing of 
peak expression. The rapid increase in IFNy at day 2 coincides with a small increase 
in IL- 12 message at this time point. IL- 12 has been shown to induce IFNy secretion 
from NK and T cells (Seder et al., 1993), and this early elevation in expression may 
be responsible for inducing Th I cytokine production in the LN soon after parasite 
stimulation of resident antigen presenting cells. IFNy message remains elevated 
above background until day 21 with a another, smaller, peak at day 14, closely 
matching data obtained on protein production (Pemberton et al., 1991). The 
magnitude and persistence of IFNy expression may reflect the prolonged residence of 
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parasites in the LN for at least 2 weeks after vaccination (Mountford et al., 1988, 
1992). An early peak of IL-2 expression coincides with elevated levels of IFNY 
mRNA, and has not been reported before, again possibly due to the absence of early 
sample points. The negligible levels of IL-2 seen across the remainder of the post- 
vaccination time course correspond to protein data as reported above (Pemberton and 
Wilson, 1995). This high expression of Thl cytokines is in conflict with published 
data indicating that prolonged antigen exposure can lead to Th2 dominance in the 
skin draining LN after vaccination with irradiated cercariae of S mansoni (Caulada- 
Benedetti et al., 1991). However, this discrepancy may be explained by differences 
in sampling times and exposure regimes, the above published study having assayed 
cytokine levels at 4 weeks post-vaccination, long after migrating parasites have left 
the nodes. In addition, an in vitro antigen presentation system has demonstrated the 
development of Th2-like clones with increasing antigenic load (Gajewski et al., 
1989). 
Th I cytokine response detected in the LN coincides with the arrival of the first 
migrating parasites in this organ. Irradiated larvae can be detected in this tissue from 
day I onwards, peaking in numbers at day 5 (Mountford et al., 1988). Furthermore, 
parasite-released material can be detected from day 2 after vaccination. The first 
peaks in mRNA for IL-4 and IL- 10 correspond to the peak in parasite numbers 
resident in the nodes, occurring later than the very early expression of Thl cytokines. 
A delay in IL-4 protein release, compared to IFNy, has been demonstrated in cultured 
LN cells (Pemberton and Wilson, 1995, Mountford et al., 1992) and is supported by 
the mRNA data presented here; IL-4 peaks at day 10 post-vaccination, 8 days later 
than IFNy. The increase in Th2 cytokines after levels of Thl cytokines have started 
to subside indicates that IFNy, and also elevated IL- 12 expression, may have an 
inhibitory effect on the expression of Th. 2 cytokine genes during the initial response. 
Alternatively, it may be the stimulation of IL-4 production which acts to suppress 
further Th I secretion, although later increases in IFNy tend to indicate that Th2 
inhibition does not occur. The downregulation of IL-4 and IL- 10 by IFNy and IL- 12 
has been demonstrated in both in vitro and in vivo systems (Gajewski and Fitch, 
1988, Gajewski et al., 1989, Heinzel et al., 1993a; 1994, Manetti et al., 1993), and 
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thus the complex counter-regulatory mechanisms existing between the T helper 
subsets may be exerting an effect in this parasitic model. 
The sharp decline in the level cytokine message detected after day 5 post- 
vaccination may be due to a dilution effect caused by a retention of B cells in the LN 
after day 7 (Constant et al., 1990, Constant and Wilson, 1992). This cell 
accumulation might result in a relative increase of non-T cell RNA in the nodes and 
consequently, the proportion of cytokine transcripts from T cells or macrophages 
sampled in the 0.25 ýtg added to the RT-PCR reaction would be reduced. In 
addition, if the B cells present in the LN were activated and producing high levels of 
antibody then the dilution factor caused by this increase would have a significant 
effect on the detection of non-B cell messages. To test this hypothesis the weight 
and total RNA content of the combined axillary and inguinal LN were analysed, and 
a marker for B cell presence assayed by RT-PCR. As expected, LN weight increases 
with time post-vaccination, peaking at days 10 to 14. This is indicative of an 
increase in cell number. The RNA content of the LN also increased after 
vaccination, but in contrast to the LN weights, remained elevated until the end of the 
experiment at day 35. This may indicate an increase in cell activation and 
transcription, possibly attributable to Ig production, since the reduction in LN weight 
indicates that the number of cells in the nodes is actually falling around this time. 
The sustained increase in total RNA detected in the nodes coincides with the decline 
in cytokine message observed until day 35. 
The sharp increase in IgM expression observed at day 2 post-vaccination, followed 
by a rapid decline, does not explain the steady decrease seen in IL-5, IL- 10, IL- 12 
and IL-13 expression. Thus this marker may represent the activation of young and 
resting B cells already present in the LN rather than the accumulation of this cell type 
into the nodes. IgM expression switches to the IgG isotype upon cell activation, 
possibly explaining the apparent fall in expression. The profile obtained in this PCR 
would seem to indicate that B cell retention in the LN is not the cause of the 
downward trend observed in the mRNA levels for IL-5, IL- 10, IL- 12 and IL- 13. 
However, upon further investigation, a fall in CD4 message was detected from day 
10 post-vaccination onwards, even though the CD4+ T cell population has been 
reported to stay elevated in the nodes for up to 28 days following exposure (Constant 
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et al., 1990). This indicates that a dilution effect of the proportion of T helper cell 
mRNA in the LN may occur. Alternatively, cytokine expression may be turned off 
after stimulation during vaccination, and inhibition of cytokine release can be caused 
by factors such as TGFP. However, the downregulation of expression for certain 
cytokines to below naive baseline values would tend to indicate that these genes are 
constitutively expressed, and this is thought not to be the case (Dallman et al., 199 1 a, 
1991b). The true nature of the apparent reduction in some cytokine gene expression 
remains undefined. Moreover, decreases in IL- 10 expression of up to 5 fold below 
baseline have also been observed in the LNs of mice infected with Leishmania major 
(Reiner et al., 1994). The analysis of the LN cell populations by RT-PCR using 
primers for a more constitutive B cell marker, such as the kappa light chain expressed 
for all antibody class production, may highlight an increase in RNA from this cell 
type. However, in order to investigate the precise cytokine expression levels 
generated by the LN cell compartments, cell populations could be sorted and 
assayed individually by RT-PCR. In this way, compensation can be applied for any 
dilution effects attributable to large increases in cell types not responsible for the 
majority of cytokine expression. 
In conclusion, the presence of both Th I and Th2 cytokine mRNA in the LN 
following vaccination defines the presence of a mixed, or ThO, cell population. 
However, the Th I cytokine expression occurs earlier, and is of higher magnitude 
than Th2 cytokine expression, as determined by competitive PCR. Although this 
early expression of IFNy confirms data obtained by protein analysis, the presence of 
some of the other cytokines described by this study (IL-2, IL-5, IL- 12) has not been 
reported previously. 
Challenge with 200 normal parasites on the opposite flank to vaccination, through 
nodes which have not previously seen migrating parasites, induces strong IL-4 and 
IL-5 cytokine responses with very little increase in IFNy or IL-2 mRNA. A possible 
explanation for the low Th I cytokine values obtained in primed and control animals 
following challenge is that the day 5 sample point is on the downward slope of an 
earlier peak, similar to that seen after vaccination. The early increase in Thl subset 
cytokine mRNA observed post-vaccination is replaced by IL-4 expression after 
challenge. Thus it would seem that there is no anamnestic Th I response, but a strong 
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IL-4 anamnestic effect leading to the establishment of a predominantly Th2 profile 
upon multiple exposure. This type of Th I inhibition has been reported previously 
when mice are multiply-vaccinated, or when challenge and vaccination have been 
applied to the same site (Caulada-Benedetti et al., 199 1, Pemberton and Wilson, 
1995, respectively). The above data, and that presented here, indicates that repeated 
exposure to intact parasites can lead to the downregulation of the initial Thl response 
and an increase in Th2 cytokine gene expression. 
The absence of Thl cell activity following challenge may be attributable to the 
anergy of this cell subset. The ability of Thl type cells to become anergized has been 
reported to be related to the stimulation of this subset in the absence of any 
costimulatory signals, such as B7/CD28 (Gajewski et al., 1990,1994, Jenkins, 1994). 
The increased presence of B cells in the LN after vaccination may lead to this cell 
type acting as the predominant APC for cell stimulation following challenge. 
Resting B cells lack high levels of B7 expression (Croft and Swain, 1995). Hence 
activation in the absence of this molecule may lead to the induction of anergy in the 
Th I population, resulting in preferential stimulation of the Th2 population and a 
subsequent increase in IL-4 release (Gajewski et al., 1994, Jenkins et al., 1990). Th2 
cells can resist anergy to a higher extent than Thl cells; in fact stimulation of ThO 
cell populations in the absence of costimulatory molecules can lead to an increase in 
Th2 characteristics (Zubiaga et al., 1991, Gajewski et al., 1994) and a corresponding 
decrease in Thl-like cells. However, the role of costimulatory factors is not well 
established, and in contradiction to the above reports memory T cells of both subset- 
type have been reported as requiring lower levels of costimulation than naive cells 
(Croft et al., 1994, Croft and Swain, 1995, Yi-qun et al., 1996). Thus the mechanism 
by which Thl cytokine expression is reduced post-challenge remains to be defined. 
An alternative explanation may be simply that the absence of IFN7 and IL-12, both 
of which can have an inhibitory effect on the proliferation and cytokine production of 
Th2 cells, allows the expansion of any residual Th2 population remaining in the LN 
after vaccination. 
The lower expression of IFN7 post-challenge has been confinned by the analysis 
of day 2 post-vaccination and day 10 post-challenge RNA by competitive PCR. 
IFN7 message levels are approximately 100 fold higher following exposure to 
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irradiated parasites than on secondary infection. Interestingly, IL-10 also has 
reduced expression post-challenge, corroborating data obtained by multiple cycle 
number PCR analysis. The patternof IL-10 gene expression in lung tissue has been 
reported previously to follow that of IFN7 (Wynn et al., 1993,1994a), an observation 
possibly caused by the increase in Th2 cytokines exerting an inhibitory effect on 
macrophage activation and cytokine release (Fiorentino et al., 1991 a). This 
mechanism may result in a decrease in macrophage-derived IL- 10 by a form of self- 
regulation. In contrast, IL-4 profiles are opposite in nature, with a 10 fold increase in 
mRNA levels observed following challenge similar to that seen in data obtained from 
the longitudinal RNA analysis. Thus the competitive PCR method allows detailed 
analysis of the level of expression of mRNA for a given cytokine, and comparison 
between different cytokine messages within the tissue. However, this method cannot 
account for possible differences in potency of the cytokines under analysis. Hence 
caution must be applied when interpreting data where comparisons are made between 
cytokines, since although IFN7 dominates the post-vaccination responses, naive 
C5713L/6 mice also show a much higher basal level of expression of this cytokine 
compared to IL-4 and IL- 10. 
The increase in the typical Th2 cytokines post-challenge does not appear to have 
any effect on the resistance mechanism. This is further demonstrated by the 
administration of sub-lethal whole body irradiation prior to challenge (Aitken et al., 
1987, Vignali et al., 1988), a treatment which prevents the development of a new T 
cell response but has no effect on the existing memory T cell population resident in 
the lungs of previously vaccinated mice; following challenge of irradiated mice the 
effector mechanism is left intact. Thus it can be inferred that the predominant Th I 
response generated after vaccination is sufficient for protection, and any other 
immune responses generated upon challenge are superfluous. 
In conclusion, vaccination with irradiated cercariae of S. mansoni promotes the 
development of a dominant, but not exclusively, Thl population with some 
expression of Th2 cytokines at later time points post-vaccination. These data 
demonstrate that the vaccinating dose of 500 irradiated parasites results in higher 
Thl cytokine responses than an infection with 200 normal cercariae. Furthermore, 
previous exposure to vaccinating parasites appears to downregulate Thl and IL-10 
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cytokine expression upon challenge infection, with the result that challenge control 
animals display slightly higher levels of cytokine mRNA than previously primed 
mice. Although this may appear surprising, the profiles detected in control mice do 
not seem capable of inducing resistance. Indeed the factors characteristic of 
irradiated cercariae responsible for altering the LN responses to a Thl dominated 
profile remain unknown, but the altered kinetics of migration may play a role in 
induction of protection. The high expression of IFNy in the LNs mirrors the high 
expression of this cytokine in the lungs upon subsequent parasite arrival in this organ 
(Mountford et aL, 1992, see also Chapter Four). It has been shown that the 
development of a predominantly Th I population in the LN, and the recruitment of 
this schistosome-specific population to the lungs, where vaccinating parasites 
terminate migration, are two major stages in the induction of immunity. The 
presence of IFNy producing cells in the lungs is vital to the protection mechanism 
(Smythies et aL, 1992a, 1992b). A detailed analysis of the cytokine profiles induced 
in the lungs during the next stage of migration and the effector mechanism are 
reported in the following chapter. 
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CHAPTER FOUR 
Responses in the Lungs Following Vaccination and Challenge of 
C57BL/6 Mice with Cercaria of S. mansoni 
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Introduction 
It is well documented that a single vaccination of C57BL/6 mice with optimally 
irradiated cercariae of Schistosoma mansoni results in resistance to reinfection of up 
to 70% (Dean, 1983). Furthermore, the lungs have been identified as the major site 
of parasite attrition following a challenge infection (Wilson et al., 1986, reviewed by 
Wilson and Coulson, 1989). Early studies on migration indicated that normal 
parasites traversing the lungs undergo a period of transition involving elongation, by 
rhythmic contraction and lengthening, which is thought to aid passage through the 
narrow capillaries (Wilson, 1987). Once through the lungs, normal parasites can 
continue migration to the hepatic portal system where mating and egg laying begins. 
However, vaccinating irradiated parasites migrate no further than the lungs (Mastin 
et al., 1983, Mangold and Dean, 1984), and it is possible that the radiation dose 
disrupts neuromuscular coordination, so preventing the adaptations necessary for 
successftil passage through the capillaries (Harrop and Wilson, 1993). 
The persistence of worms in the lungs post-vaccination leads to the recruitment of 
a cell population with Th I properties to that organ. A proportion of migrating 
parasites get trapped in the alveolar spaces, presumably by disrupting the delicate 
blood/air barrier as they try to traverse the capillary beds (Mastin et al., 1985b). 
These larvae attract foci of cells, and appear unable to return to the vasculature to 
continue migration once in the alveoli. The majority of cellular recruitment into the 
lungs occurs between days 10 and 16 post-vaccination (Ratcliffe and Wilson, 199 1) 
and consists predominantly of CD4+ T cells, which are capable of producing high 
levels of IFN7 upon in vitro culture, but not IL-2 or IL-4 as detectable by T cell assay 
(Smythies et al., 1992a, Mountford et al., 1988). This cytokine profile is indicative 
of a short term memory/effector phenotype and, in support of this, the cell population 
recruited to the lungs displays high levels of CD44 and low levels of CD45RB cell- 
surface markers (Coulson and Wilson, 1993). A transient eosinophilia around day 21 
post-vaccination accounts for 30% of the leukocyte influx (Menson and Wilson, 
1989), but rapidly decreases in comparison to the CD4+ population which resides in 
the lungs for up to 10 weeks after exposure (Aitken et al., 1988). In summary, 
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exposure of mice to a vaccinating infection results in the recruitment to the lungs of a 
predominantly Th I -like, schistosome-specific, cell population, rich in short term 
memory cells and capable of high IFN7 secretion upon stimulation. 
Following challenge, normal parasites arriving in the lungs become the target of 
focus formation involving the cell populations recruited there after vaccination. The 
cellular aggregates act as a blockade, preventing parasite exit from the lungs and 
hence maturation into adult worms (Coulson and Wilson, 1988, Kambara and 
Wilson, 1990). The immunological mechanisms responsible for focus formation 
have been investigated at the cytokine protein and histological level (Smythies et al., 
1992b). The focus of cells around each migrating parasite consists mainly of CD4+ T 
cells and macrophages (Kambara and Wilson, 1990), and produces high levels of 
IFN7 at day 14 post-challenge, but with little other cytokine protein detectable and an 
absence of proliferation in response to IL-2 (Smythies et al., 1992a). In fact the 
importance of IFN7 in the effector mechanism has been shown by in vivo ablation 
with anti-IFN7 antibody, the effects of which result in a 90% abrogation of resistance 
(Smythies et al., 1992b, Sher et al., 1990a). Furthermore, vaccination of IFN7 
receptor gene-deleted mice gives lower, but not completely abrogated, levels of 
protection than observed in wild type animals (see Chapter Six, and Wilson et al., 
1996). 
The role of toxic nitrogen intermediates, released by macrophages, in the cell- 
mediated effector mechanism is not clear at present. IFN7 can act to upregulate 
inducible nitric oxide synthase mRNA expression in macrophages (Liew et al., 1990, 
199 1, Oswald et al., 1994c), and hence the production of NO, which in turn can 
mediate in vitro cytotoxic killing of newly transformed schistosomes (James and 
Glavem, 1989, Oswald et al., 1994a). However, this mediator appears unable to 
harm lung stage parasites in vitro (Pearce and James, 1986). In contradiction to this 
finding, a recent study has implicated NO as an important factor in the effector 
mechanism, with iNOS mRNA readily detectable at elevated levels at day 2 post- 
challenge in vaccinated and challenged mice, compared to challenge controls (Wynn 
et al., 1994a). Furthermore, ablation of the effects of NO by the administration of the 
inhibitor aminoarginine hemisulphate (AMG) leads to a 33% reduction in protection 
(Wynn et al., 1994a). The importance of nitric oxide in parasitic infections has 
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already been demonstrated by the infection of iNOS-deficient mice with Leishmania 
major (Wei et aL, 1995). In this model, mice normally resistant to lethal infection 
with L. major become susceptible to visceral progression of the disease, and display 
reduced inflammatory responses compared to wild type animals . 
Recent reports on human diseases involving DTH reactions have highlighted the 
importance of the chemokine RANTES in Thl responses (Rathanaswami et al., 
1993, Devergne et al., 1994). The findings reported for humans may also be 
applicable to murine models of parasitic infection. This molecule has been shown to 
play an important role in the recruitment of memory T cells in the human model of 
rheumatoid arthritis, and can be produced by many different cell types including 
macrophages and endothelial cells (Devergne et al., 1994, Rathanaswami et al., 
1993). The cell types responsible for RANTES production in humans are similar to 
those present in the lung foci formed in mice upon challenge infection (Smythies et 
al., 1992b). In addition, the cytokines necessary for RANTES upregulation in 
humans, namely IFNy, TNFoc and IL- I P, are also elevated in expression following 
vaccination and challenge of mice with S. mansoni (Wynn et al., 1993). Thus, based 
on extrapolation from human studies, the expression of murine RANTES may 
contribute, at least in part, to the recruitment of cells into the lungs in the irradiated 
vaccine model. 
The following experiments were carried out to investigate further the interplay of 
the cytokines released after exposure to both vaccinating and challenge parasites. 
Whole lung tissue was analysed by RT-PCR for the presence of various cytokine 
mRNAs along an extensive timecourse. Furthermore, the kinetics of RANTES and 
NOS mRNA expression in this model were determined. The cell types responsible 
for the main cytokine release during the peak recruitment following vaccination were 
examined by analysis of cell populations recoverable from the lung airways by 
broncho-alveolar lavage. In addition, lung tissue from an intravenous challenge 
infection was investigated to determine the kinetics of cytokine expression following 
the arrival of the majority of parasites in the lungs as a synchronous pulse. 
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Materials and Methods 
Experimental Animals and Parasites 
Parasites of a Puerto Rican strain of Schistosoma mansoni were routinely passaged 
through LACA or MF I outbred mice and albino Biom halaria glabrata freshwater 
snails. Specified pathogen free (SPF) female C57BL/6 mice weighing between 18 
and 209 (B&K Universal, Grimston, Hull) were used for all experiments and housed 
in flow cabinet or isolator conditions to maintain SPF status throughout all exposure 
regimes. 
Exposure Regimes 
The vaccination and challenge experimental plan has been previously outlined in 
chapter three. The following analyses and results concentrate on the lung tissue 
harvested from the same two timecourses analysed for the LN responses. Whole 
lungs were removed from three mice per timepoint and the RNA extracted 
immediately, or the tissue snap frozen in liquid nitrogen and stored at -800C until 
required. Lung tissue was sampled at days 0,5,10,14,21 and 35 post-vaccination, 
and at days 5,10 and 15 after percutaneous challenge. Ten extra mice, vaccinated at 
the same time as the above experiment, were sacrificed at day 21 post-vaccination to 
determine the lung cell populations responsible for the production of various 
cytokines at this timepoint. The mice were anaesthetised and the perfused lungs 
lavaged to obtain the airway populations. The recovered cells were then sorted as 
described below. The broncho alveolar lavage (BAL) was performed as previously 
described (by A Finlay using a method from Holt, 1979). 
Additional post-challenge analysis was carried out on lung tissue removed from 
mice exposed to an intravenous challenge with 120 lung stage parasites derived from 
donor mice previously infected with 1000-2000 normal cercariae (challenge 
procedure carried out by Prof. RA Wilson, and Drs. LE Smythies and PS Coulson, 
using a technique previously described by Miller and Wilson, 1978 and Wilson and 
Coulson, 1986). This method allows the kinetics of cytokine expression to be 
investigated due to the synchronicity of parasite arrival in the lungs following 
injection into the exposed femoral vein. In order to make a direct comparison 
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between previously vaccinated and naive animals, a limited sampling program was 
designed to allow challenge of both groups of mice on the same day, using the same 
pool of parasites. The small right lobe of the lung from these animals was removed 
for RT-PCR analysis at days 0,2,4 and 12 post-challenge, either directly into 
guanidinium isothiocyanate solution, or snap frozen in liquid nitrogen for storage. 
Resistance data for both exposure regimes was calculated from the worm burdens 
obtained by hepatic portal perfusion at 35 days following challenge of groups of 5 
mice from each of the treatments above. Resistance was calculated from the 
respective worm burdens as follows : %R = [(CC-VC)/CC]x 100. 
Total RNA Isolation 
Lungs from each of 3 mice per timepoint for the percutaneous challenge, or 5 mice 
for the intravenous challenge, were treated individually using an RNA extraction 
procedure (as described in Chapter Two). For all samples the yield was measured 
spectrophotometrically and confirmed, along with the intact nature of the RNA, by 
agarose gel electrophoresis in the presence of ethidium. bromide. 
Semi- Quantitative RT-PCR Detection of Cytokine mRNA 
Analysis of the levels of various cytokine mRNAs between samples was carried 
out as previously described in chapter two. After initial trial experiments the 
optimum amount of total lung RNA to be used in each PCR was determined as I [tg. 
A fixed amount of RNA was taken from each lung sample (3 per timepoint for the 
percutaneous challenge, and 5 per timepoint for the i. v. experiment) and pooled to 
give a combined total RNA sample for RT-PCR analysis in an attempt to reduce 
experimental cost. This pool was assayed at three different cycle numbers, with 
duplicated tubes at each cycle number to give a total of 6 tubes per sample per 
cytokine. The cycle numbers and primer sequences used were the same as described 
previously (Chapter Three) with the addition of the following: IL- 1P sense, 
GGCAACTGTTCCTGAACTCAAC and anti-sense, CTCGGAGCCTGTAGT 
GCAGCTG (designed from published sequence, Gray et al., 1986); TNFa sense, 
ATGGCCCAGACCCTCACACTC and anti-sense, GTAGTCGGGGCAGCCTT 
GTCC (adapted from Murphy et al., 1993); RANTES sense, GAAGATCTCTG 
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CAGCTGCCCT and anti-sense, GCTCATCTCCAAATAGTTGA (designed from 
published sequence, Schall et al., 1992). 
Both percutaneous and intravenous challenge timecourses were also analysed for 
the presence of inducible nitric oxide synthase (NOS) mRNA to investigate the role 
of this larvicidal molecule in the effector mechanism. Lung samples from the 
percutaneous time course were analysed individually by RT-PCR for a single cycle 
number. RNA from the intravenous time course were analysed by multiple cycle 
number PCR. The primer sequences were designed from the published cDNA 
sequence (Lowenstein et al., 1992) and were as follows: sense, GCAGCTCCTCAC 
TGGGACAGCAC, antisense, ATGAGGCAGGAGCTCCTCCAGAGG. 
For all RT-PCR products the detection system used was as outlined in previous 
chapters. Briefly, oligonucleotide probes were end-labelled with [ 32 P-7] ATP and 
hybridised with PCR product slot blotted onto nylon membrane. Washed blots were 
then exposed to a storage phosphor screen and scanned on a phosphorimager to 
obtain counts for all samples which could then be processed by linear regression. 
The probes specific for molecules analysed in this chapter were designed from 
previously published sequence data and were as follows: TNF(x, ATGGCCCAGAC 
CCTCACACTC (Caput et al., 1986); IL- I P, GAGCCCATCCTCTGTGACTCA 
(Gray et al., 1986); RANTES, CTGCCTCGTGCCCACGTCAAG (Schall et al., 
1992); NOS, CATGTGACATCGACCCGT (Lowenstein et al., 1992). 
Competitive PCR 
Quantitative PCR analysis of a limited number of samples, representative of peak 
cytokine responses post-vaccination and post-challenge, was carried out as described 
previously (Chapter Two). Samples from day 21 following vaccination, and day 10 
post-challenge, were analysed for the expression of IFNy, IL-4, IL- 10 and HPRT. 
Background differences in the basal levels of these cytokines in naive mice were also 
investigated. 
Sorting and Analysis of Lung Alveolar Cell Populations 
The total BAL cells recovered from each mouse were individually pelleted and 
resuspended in I ml of GMEM (Glasgow minimal essential medium) plus 10% FCS 
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(Globefarm., Esher, Surrey), 200 U/ml penicillin and 100 ýtg/ml streptomycin (Sigma 
Chemical Co., St Louis, MO). The separate samples were then pooled and the total 
cell number estimated using an improved Neubauer haemocytometer. The volume of 
medium was adjusted to give a concentration of 10 6 cells/ml and the cell suspension 
plated out in a 24 well sterile plate at 1 ml per well. The cell suspension was left to 
adhere for 45 minutes at 370C and then the non-adherent populations were washed 
from the plate with ice-cold PBS, collected, and centifuged for 8 mins, 40C at 800 
rpm (Beckman benchtop refrigerated centriftige). The resulting pellet was 
resuspended in I% bovine serum albumin (Sigma), in phosphate buffered saline pH 
7.2 (1% BSA/PBS), at a concentration of 6.25xl 07 cell /ml. 
Three aliquots of 5xlO 6 cells (80[d) were labelled with 6[d of CD4, CD8 or a 
combination of CD4, CD8 and B220 magnetic beads (MACS system, Miltenyi 
Biotec Gmbh, Germany). After incubation at 6-12 OC for 15 mins, the cells were 
washed and centrifuged gently to remove excess label, and then resuspended in 
550ýtl 1% BSA/PBS. A 50 ýd aliquot was taken for flow cytometric analysis and the 
remainder purified over a magnetic cell sorting system (MACS). Both the retained 
and non-retained cell populations were collected from each bead labelling, and the 
recovered cell number estimated by haernocytometer. Samples of 10 5 cells from 
each of the retained and non-retained CD4 and CD8 cell purifications were labelled 
with the appropriate fluorescein-labelled antibody for 30 minutes on ice, washed 
with phenotyping buffer (0.1% BSA in PBS) and resuspended for flow cytometric 
analysis to obtain values for cell enrichment. 
The remaining samples, including the recovered adherent cell populations, were 
pelleted and the RNA isolated using a small scale RNA isolation kit (Stratagene Ltd, 
Cambridge, UK) following the manufacturers instructions. The resulting total RNA 
pellets were resuspended in 100ýtl of DEPC-treated water and 10vtl of each subjected 
to RT-PCR for a set number of cycles dependent upon the cytokine under assay 
(HPRT, 3 0; IFNy, 3 0; IL-4,3 3; IL-5,3 3; IL- 10,3 3; and IL- 12,3 0). The product was 
analysed by Southern blotting followed by detection with specific 32 P end-labelled 
oligonucleotide probes, and exposure to autoradiographic film and phosophor storage 
screen. The product detected for each cytokine in a cell population was scored on a 
scale of three intensities following HPRT adjustment of the phosphorimager count. 
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Results 
Cytokine Production in the Lungs Following Percutaneous Vaccination and 
Challenge 
The expression of cytokine mRNA in whole lung tissue following exposure to 
irradiated and normal cercariae was investigated using semi-quantitative RT-PCR. 
All points for which the error bars do not overlap are significantly different (p:! ý 
0.0025) to each other as described in chapter two. Following vaccination, IFN7, IL- 
2, IL-4, IL-5, IL- 10, IL- 12 and IL- 13 all rise steadily to a peak at day 21 post- 
exposure, with the majority of these cytokines reaching levels between 5 and 10 fold 
over the detectable baseline (Figs. I to 4). Exceptions to this high increase in mRNA 
were the inflammatory cytokines TNFoc and IL- IP (Fig. 5), both of which peak at 2-3 
fold over naive levels. Furthermore, IL- IP peaks earlier, at day 14, than the other 
cytokines tested. There appears to be no real distinction between the Thl and Th2 
cytokine profiles in the lungs following exposure to vaccinating parasites. 
After challenge infection of vaccinated and naive mice, differences can be seen in 
the levels of Thl and Th2 cytokine expression induced in the two experimental 
groups. The message levels for IFN7, IL-2, IL-4, IL-5, IL- 10, IL- 13 and TNFa in 
previously primed (VC) animals following challenge reached a maximum at lower 
values than those detected post-vaccination. IL-12 and IL-lP attain similar levels to 
those observed at day 21 post-vaccination. IFN-y, IL- 12 and IL- IP all peak at day 10 
post-challenge (day 45 on Figs. 1,4 and 5) and show elevated levels of expression 
over the time course studied compared to challenge control (CC) animals, which only 
show slight increases at day 15 (day 50 on Figures). IL-2, IL-4, IL-13 and TNF(x 
mRNA levels continue to rise up until day 15 post-challenge in previously primed 
mice. In contrast, control mice do not attain the same level of IL-4 and TNF(x 
expression seen in VC animals at the time points sampled, although the former group 
display elevated expression of IL-2 and IL- 13 at day 15 following infection with 
normal parasites. Cytokine message for IL-5 and IL-10 is barely elevated above the 
levels detected at day 35 post-vaccination in vaccinated mice. In addition, IL-10 
expression does not increase above naive values in CC mice. In contrast, IL-5 rises 
sharply at day 15 post-challenge in CC mice to become the only cytokine detectable 
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above the levels expressed in vaccinated mice. Similarly, IL- 13 expression in 
challenge controls also rises sharply at day 15 post-challenge, but levels do not 
increase above those detected in vaccinated animals at this time point (Fig. 3). IL-5, 
IL- 10, IL- 12, TNFoc and IL- IP expression in the challenge control mice falls below 
the naive levels detected at day 35 before recovering (in the case of IL-5, IL-12, IL- 
13 and TNFoc) to increase above baseline at day 15 (Figs. 2,3,4 and 5). However, 
IL- 10 mRNA levels remain below baseline throughout the post-challenge time 
course (Fig. 4). It is interesting to note that IL- IP shows a high basal level of 
expression in day 35 naive mice compared to the naive group sampled at day 0 (Fig. 
5), although the reason for this remains unclear. 
In summary, the inflammatory cytokines IFN7, IL- 12, TNFcC and IL- IP display 
strong anamnestic responses post-challenge, with the mRNA levels for these 
cytokines reaching at least 50% of the post-vaccination values. IL-2, IL-4, IL-5 and 
IL- 10 appear to have no anamnestic response compared to levels obtained in the 
lungs after vaccination. However, from day 35 onwards all cytokines in vaccinated 
animals reached higher levels of expression than in naive controls, with only IL-5 
displaying an increased value in control animals compared to vaccinated 
counterparts. On the whole, the mRNA expression profiles induced upon exposure 
of challenge control animals to normal parasites are lower and later than those 
observed in previously vaccinated mice. In addition to the earlier peaks observed in 
primed animals, cytokines are expressed at much higher levels in vaccinated mice 
after challenge compared to naive mice, and are dominated by Thl and inflammatory 
cytokines. 
RANTES Expression in the Lung 
The expression of RANTES mRNA following vaccination reaches peak levels at 
day 21 (Fig. 6), coincident with peak values for all the major cytokines, and known 
inducers of RANTES in human systems, namely IFNy, IL- IP and TNFCC 
(Rathanaswami et al., 1993). 
This chemokine also peaks after challenge, at day 10 post-exposure, before falling 
again by day 15 (days 45 and 50 respectively on Fig. 6). There is no increase in 
RANTES expression in challenge control animals, on the contrary there is a slight 
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decrease from baseline values. In fact the baseline value obtained from day 35 naive 
animals is three fold higher than that detected in day 0 naive mice. Thus, although 
the level of expression falls in challenge control samples from day 35 onwards until a 
slight recovery at day 15 post-challenge (Fig. 6), these levels are still relatively 
higher than RANTES expression at days 0,5,10 and 14 post-vaccination. 
Competitive PCR 
PCR in the presence of a competitive internal constuct was used to determine the 
relative expression levels of IFN7, IL-4 and IL- 10 mRNA in naive mice and at the 
time of peak responses post-vaccination (day 2 1), and post-challenge (day 10) (see 
Table 1). In naive mice IFN7 mRNA is expressed at a level 10 fold that of IL-4, 
whilst IL- 10 is undetectable. Post-vaccination, the IFN7 mRNA level is 100 fold 
higher than that detected in naive samples, equating to 50 pg of plasmid DNA. IL-4 
expression was detectable at 10 fold above the naive baseline, but at an overall level 
lower than IFN7, equivalent to 0.5 pg of construct. A similar level of IL-10 mRNA 
was detected at day 21 post-vaccination. Post-challenge, IFN7 mRNA levels are 
lower than after vaccination at between 5 and 50 pg. IL-4 and IL-10 expression was 
also lower, showing a similar drop to the levels of IFN7 mRNA. The level of HPRT 
expression equated to 50 pg of plasmid DNA for all samples under test. 
The Cytokine mRNA Profiles ofSorted Cell Populations 
Magnetic bead sorting of the BAL cell population resulted in high enrichment of 
the CD4+ population (from 46% to 92%), the CD8+ population (from 12.5% to 87%), 
and granulocytes (from 48% to 76%). However this last sample contained 15% 
contamination from macrophages and 10% from T lymphocytes. The adherent cell 
population, purified by attachment to a sterile plate, was only enriched to 
approximately 50% of the recovered cells. 
The cytokine production from each enriched and depleted sample is shown in Fig. 
7 and summarised in Table 2. RNA isolated from the adherent population gave 
positive results for IFN7, IL-4, IL-5, IL- 10 and IL- 12 (Lanes 1,2 and 3 on Fig. 7, 
first column of Table 2). The production of IL- 12, IFN7 and IL- 10 by the adherent 
cell population is not surprising in that these cells are probably activated by the 
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surrounding cytokine environment. However, the production of IL-4 and IL-5 by the 
adherent cell population is unexpected and possibly due to the presence of 
contaminating T cells. The main T cell population expressing cytokines appears to 
be the CD4+ subset, with high levels of IFNy, IL- 10 and IL-5 and low levels of IL-4 
and IL-12 message detectable in this sample (lane 4). In addition, all the cytokines 
under test could also be detected in the CD8- and granulocyte-depleted samples 
(lanes 7 and 8). The CD8+ cell sample does not appear responsible for major 
cytokine production this model, with no PCR product detected for IFNy, IL-4, IL-5, 
IL-10 or IL-12 in this cell population. Granulocytic cells also test positive for all 
cytokines (lane 9), although contamination in this cell sample is a possibility due to 
only 76% enrichment. Two cytokines that this cell population appears to express 
above the contamination level are IFNy and IL-12, both of these being detectable at 
higher levels in the granulocyte-enriched sample that flowed through the column, 
compared to the CD4+, CD8+ and B cell sample retained by the magnetic field. 
These cytokines can be expressed by macrophages, and a small contaminating 
population of these cells could account for the detection of IFNy and IL-12 in the 
granulocyte sample. 
Cytokine Expression in Lung Tissue Following Intravenous Challenge 
The cytokine message profiles of whole lung tissue after a synchronous pulse of 
lung stage worms were analysed by the semi-quantitative RT-PCR method described 
for the percutaneous challenge. IFN7 expression is higher in previously primed mice 
throughout the time course. A main peak occurs in VC mice at day 4 post-challenge 
after rising over 2 fold from day 2, and before falling again by day 12. IFNy 
expression in the lungs of CC mice barely rises over baseline values (Fig. 8). The 
other Thl cytokine, IL-2, shows an increase at day 2 in VC mice followed by a fall at 
day 4 before increasing again at day 12. As observed for IFNy, CC levels of IL-2 
mRNA only increase slightly above the naive level at day 12 post-exposure. 
The Th2 cytokines also display elevated expression in previously primed animals 
compared to the control group (Fig. 9). IL-4 mRNA peaks at day 4, before declining 
again by day 12. Expression of this cytokine in the challenge control group does not 
rise above baseline until later, at day 12, by which time it is slightly higher than the 
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IL-4 mRNA level detected in VC mice. In vaccinated animals, IL-10 message is 
elevated dramatically over baseline at day 2, and then falls gradually over the 
remainder of the time course, whereas challenge controls show very little increase 
above background throughout. TNF(x expression in vaccinated mice rises above 
baseline values only at day 4 post-challenge, and is not expressed at elevated levels 
in CC mice at any of the time points sampled (Fig. 10). In contrast, CC mice express 
higher levels of IL- IP at day 2 than VC mice (Fig. 10). However, at days 4 and 12 a 
similar pattern of IL- IP expression is observed for both groups of mice, with levels 
slightly higher in the vaccinated group. In general, the cytokine message detected 
related well to that reported for the percutaneous exposure. The values obtained for 
previously vaccinated mice were higher than those in control animals for almost all 
timepoints. The cytokine expression observed in control animals, for the most part, 
remained at basal levels (Figs. 8,9 and 10), as seen following percutaneous 
challenge. 
Expression ofInducible NOS mRNA in Whole Lung Tissue 
Elevated expression of NOS mRNA was only detected above baseline at day 10 in 
lung tissue from percutaneous challenge (Fig. 11 a). The RT-PCR analysis carried 
out on individual mice gave high variation at this time point, making the observed 
increase insignificant, although highly reproducible. Consequently, analysis of 
RNA from tissue exposed to intravenous challenge was carried out to see whether 
this variability was due to the staggered arrival of parasites in the lungs following 
percutaneous challenge. The results, obtained by semi-quantitative PCR, indicate a 
peak at day 4 post-challenge exposure in previously primed mice (Fig. II b). This 
peak was highly significant (p:! ý 0.0025 as calculated by 95% confidence limit 
overlap) over levels detected in challenge control animals, which remained at base 
line throughout the time course. Furthermore, values remained elevated in 
vaccinated and challenged mice until day 12. 
Resistance Data 
The levels of protection obtained in the percutaneous vaccination and challenge 
regime gave good agreement with previously reported data at 73% resistance. The 
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worm burden in vaccinated mice was 12.6 ± 1.9, compared to 46.8 ± 5.4 in the 
control group. The intravenous challenge timecourse induced a resistance of 43.5% 
which correlates with measurements obtained previously using this method (Menson 
et aL, 1989, Smythies et aL, 1996a) and is possibly lower than the protection 
observed with percutaneous challenge due to the developmental state of the injected 
worms. 
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Fig. 1. The levels of Th I -type cytokine mRNA expression in whole lung tissue 
following percutaneous vaccination and subsequent challenge (0), or challenge alone 
(0). Values shown are estimated phosphorimager counts at 25 cycles derived from 
regression analysis as described in materials and methods 
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Fig. 2. The levels of Th2-type cytokine, mRNA expression in whole lung tissue 
following percutaneous vaccination and subsequent challenge (0), or challenge alone 
(0). Values represented as described in Fig. 1. 
135 
05 10 14 21 35 40 45 50 
IL-13 
7500 
6000 
4500 
0 
3000 
1500 
0 
05 10 14 21 35 40 45 50 
tt 
Vaccination Challenge 
Days Post-exposure 
Fig. 3. The levels of IL- 13 mRNA expression in whole lung tissue following 
percutaneous vaccination and subsequent challenge (0), or challenge alone (E) 
Values represented as described in Fig. 1. 
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Fig. 4. The levels of regulatory cytokine mRNA expression in whole lung tissue 
following percutaneous vaccination and subsequent challenge (0), or challenge alone 
(EI). Values represented as described in Fig. 1. 
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Fig. 5. The levels of inflammatory cytokine mRNA expression in whole lung tissue 
following percutaneous vaccination and subsequent challenge (0), or challenge alone 
(11). Values represented as described in Fig. 1. 
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Fig. 6. The profile of RANTES mRNA expression in whole lung tissue following 
percutaneous vaccination and subsequent challenge (M), or challenge alone (EI). 
Values shown are estimates of phosphorimager counts at 25 cycles, obtained from 
linear regression analysis of multiple cycle number PCR as described in materials 
and methods. 
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Fig. 7. Southern blot analysis RT-PCR product amplified from total RNA isolated 
from sorted lung cell populations, recovered by BAL, at day 21 post-vaccination. 
Lanes 1-9 represent: the adherent cell population (lanes 1-3); the positively selected 
CD4+ population (lane 4); the population depleted of CD4+ cells (lane 5); the 
positively selected CD8+ population (lane 6); the population depleted of CD8+ cells 
(lane 7); Population enriched for CD4+, CD8+ and B cells (lane 8); and the cell 
population enriched for polymorphonuclear cells (lane 9). 
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Fig. 8. The levels of Thl cytokine mRNA expression following intravenous 
challenge of previously vaccinated, and naive mice, with 120 lung stage worms. 
Values shown are the estimated phosphorimager counts at 25 cycles derived from 
regression analysis of 4 data points per sample. The dashed line represents the 
baseline level obtained from analysis of naive animals. 
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Fig. 9. The levels of Th. 2 cytokine mRNA expression following intravenous 
challenge of previously vaccinated, and naive mice, with 120 lung stage worms. 
Values shown are as described in Fig. 8. 
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Fig. 10. The levels of inflammatory cytokine mRNA expression following 
intravenous challenge of previously vaccinated, and naive mice, with 120 lung stage 
worms. Values shown are as described in Fig. 8. 
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Fig. 11. The expression of NOS in whole lung tissue following a) percutaneous 
challenge, and b) intravenous challenge. Values shown for a) are the mean of 
phosphorimager counts obtained for three mice per timepoint ± SE, there are no 
significant differences between samples. Values shown for b) represent estimates of 
phosphorimager counts at 30 cycles ± 95% confidence limits, as derived from 
regression analysis of 6 points per sample. Peaks at d2 CC, and days 4 and 12 VC are 
significantly increased over the day 0 naive sample (p< 0.0025). 
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Table. 1. The values obtained by competitive PCR analysis of naive, day 21 post- 
vaccination and day 10 post-challenge whole lung RNA pooled from 3 mice. The 
values shown represent (in pg) the amount of plasmid DNA spiked into each test 
PCR tube to gain a point of equivalence with the unknown sample cDNA derived 
from cytokine mRNA. All analysis was carried out on I [tg of total RNA and 
amplification for 35 cycles, with the band intensities of the separated products judged 
by visual inspection under UV illumination. 
IFNy IL-4 IL-10 HPRT 
Day 0 Naive 0.5 pg 0.05 pg ND 50 pg 
Day 21 post- 
vaccination 
50 pg 0.5 pg 0.5 pg 50 pg 
Day 10 post- 
challenge I 
5-50 pg 0.05 pg 0.0005 pg 
I 
50 pg 
ND = not detectable 
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Table. 2. The presence or absence of cytokine mRNA in sorted BAL cell 
populations as determined by RT-PCR followed by Southern blot analysis. Product 
was scored on a scale of 3 intensities, designated by + to +++, depending on the 
counts obtained by exposure to a phosphorimager screen (see below). Samples with 
no detectable product are marked ND. 
Adhere. CD4 + CD4- CD8 + CD8- Poly- Poly+ 
IFN7 ... ... ND ND +++ + ++ 
IL-4 ... ++ ++ ND ++ ++ + 
IL-5 ... ++ + ND ++ + + 
IL-10 ... ... ND ND ... ++ + 
IL-12 ... ++ + ND ++ ++ ++ 
> 150,000 counts 
50,000 - 150,000 counts 
5,000 - 50,000 counts 
ND < 5,000 counts 
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Discussion 
The data presented above illustrates the cytokine profiles induced following 
vaccination with 500 irradiated cercariae and subsequent challenge with 200 normal 
parasites. The peaks observed in cytokine expression at day 21 post-vaccination 
correlate well with previously published data on the timing of parasite arrival in the 
lungs, macrophage activation, and the recruitment of leucocytes and focus formation 
around worms trapped in the alveolar spaces (Mastin et al., 1985b, Aitken et al., 
1988, Menson et al., 1989, Menson and Wilson, 1989). 
IL-12 was the only cytokine message with an earlier, smaller peak in expression, at 
day 10 post-vaccination, in addition to the main peak at day 2 1. This cytokine has 
been shown to play a pivotal role in the generation and expansion of Th I 
populations, both in vitro and in vivo, (Gazzinelli et al., 1993, Hsieh et al., 1993, 
Manetti et al., 1993,1994). Recent data describing the administration of IL- 12 with 
the irradiated vaccine model demonstrated that this cytokine can increase the 
resistance to challenge infection (Wynn et al., 1995a). Coincident with enhanced 
protection, a corresponding increase in IFNy and IL-12 p40 mRNA expression and a 
reduction in the level of IL-4, IL-5 and IL-13 message was reported. 
The exact role of IL-12 in the lungs is unclear, since it has been demonstrated that 
cells recovered from the lung airways post-challenge are incapable of proliferation in 
vitro (Smythies et al., 1992a, Mountford et al., 1992), even in response to IL-2 
stimulation. This would indicate that these cells are of the memory phenotype, an 
observation confirmed by the analysis of the memory markers on the cell surface 
post-vaccination (Coulson and Wilson, 1993). It is also believed that the T helper 
population in the lungs is recruited after primary stimulation in the skin draining LN 
(Pemberton et al., 199 1, Pemberton and Wilson, 1995, Ratcliffe and Wilson, 199 1). 
Thus it is difficult to envisage the role of a cytokine able to aid the development of 
naive cell populations in the direction of a Thl response, in an organ already armed 
by an established Thl cell-dominated population. It may be that this cytokine is 
released by alveolar macrophages as these cells become activated by the arrival of 
the first parasites in the lungs around days 7-10 (Mangold and Dean, 1984, Menson 
and Wilson, 1990). Alternatively, early IL- 12 might stimulate the development of 
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any naive T cells present in the area. However, it has been shown that rIL- 12 can 
decrease the IL-4 and IgE production upon secondary in vitro stimulation of human 
cells isolated from helminth-infected patients (King et al., 1995). Thus it appears, at 
least in human infections, that this cytokine can have an effect on a fully 
differentiated response to modulate the IL-4 and related IgE production. Hence IL- 
12 may play a role in maintaining the Thl response via inhibition of IL-4 and Th2 
cytokine production in this murine model. In vivo neutralisation of IL- 12 in the 
irradiated vaccine model might result in an increase in IL-4 message, and therefore 
demonstrate a regulatory role for this cytokine in the ongoing immune response. 
To some degree this work supports data previously published on the kinetics and 
patterns of cytokine secretion in the lungs following exposure to the irradiated S 
mansoni vaccine (Wynn et al., 1994a, 1995a). However, the fold increases in 
cytokine expression above baseline values detected in these published reports are far 
in excess to those described in this chapter, and although the same cytokines are 
elevated, the timing is dissimilar to that reported here. In addition, the comparison 
between normal and vaccinating infection in the literature detects no differences in 
the pattern of the majority of cytokine production at the mRNA level, except for an 
earlier peak in IFNy expression at day 10 post-exposure in vaccinated mice, 
compared to day 22 in normally infected animals (Wynn et al., 1994a). This is in 
contrast to the strong peak of IFNy at day 21 post-vaccination described in the above 
chapter, although differing exposure regimes may account for the variations in 
maximum cytokine expression. 
In conclusion, from the data described above, and that published recently, it 
appears that the response generated after a vaccinating infection is mixed Thl/Th2 or 
ThO in profile, at the mRNA level and not entirely polarised towards a Th I as 
previously thought from cytokine protein studies (Smythies et al., 1992a). However 
the dominance of IFNy mRNA is confirmed by competitive template PCR, with this 
cytokine expressed at almost 100 fold higher levels than both IL-4 and IL- 10. IFNy 
message at day 21 is also expressed at approximately 100 fold that detected in naive 
animals. Moreover, IFNy mRNA levels in naive mice are at least 10 fold above 
those of IL-4 and IL-10, making it difficult to relate the absolute amounts of 
cytokine message detected to the in vivo potency of a cytokine protein. 
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The discrepancies observed in the number of cytokines detectable at the mRNA 
level compared to previous protein analysis might reflect the greater sensitivity of 
PCR compared to protein assays. Alternatively, the secondary stimulation of 
cultured cells in vitro may alter the secreted cytokine profiles by masking low level 
expression. In addition, the analysis of protein secretion was carried out on cells 
recovered from the airways of vaccinated mice, whereas RT-PCR was carried out on 
RNA extracted from whole lung. Although BAL is one of the few ways of removing 
cells from the lungs without damage to cell surface molecules, many of the cell 
populations making up the focus may not be represented in the cells recoverable in 
this way. This has been confirmed by experiments using a collagenase digestion 
technique, which have revealed the presence of an NK cell population not previously 
thought to be resident in the lungs (Wilson and Coulson, unpublished observations). 
However, the RT-PCR analysis of RNA obtained from a total BAL population at day 
21 post-vaccination has detected many of the major cytokines present in RNA 
isolated from whole lung tissue at this time (data not shown). Thus this method of 
sampling would seem to give a representative view of the cell populations trapped in 
the foci, even if the cell types may not be present in the same proportions as those in 
total lung tissue. 
RT-PCR analysis of RNA derived from cell populations recovered by BAL and 
sorted into adherent, CD4+, CD8+ and granulocyte cell types indicated that most of 
the cytokines released during the response following vaccination are derived from the 
adherent/macrophage and CD4+ T cell populations. High levels of IL- 12, IL- 10 and 
IFNy mRNA are all produced by the adherent cell population. Furthermore, this 
sample gave positive results for all cytokines under test, but the impurity of the 
sample makes interpretation of this data difficult. High levels of IL-4, IL-5, IL-10 
and IFNy expression were detectable in the CD4+ sample, confirming the mixed 
cytokine profile induced in lung tissue following vaccination. There appears to be no 
cytokine release from CD8+ T cells in this model, an observation supported by data 
demonstrating that ablation of CD8+ T cells with a monoclonal antibody has no 
effect on resistance generated (Vignall et al., 1989). In contrast, CD4 ablation has 
previously been shown to result in loss of protection and IFNy production (Kelly and 
Colley, 1988, Smythies et al., 1992a). The granulocytic population appeared to have 
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increased expression of IFNy and IL- 12, although this may be due to contamination 
with monocytes, cells known to secrete these cytokines. In addition, there appears to 
be no IL-5 expression in the granulocyte population, contrary to human studies in 
which eosinophils have been shown to produce IL-5 message (Desreumaux et al., 
1992). 
The presence of increased levels of mRNA for IFN7, TNF(x and IL- IP in the post- 
vaccination time course led to the investigation of RANTES mRNA, a chemokine 
upregulated by these inflammatory cytokines and shown to be involved in cellular 
recruitment in human DTH reactions. In human systems, such as rheumatoid 
arthritis, this chemokine plays an important role in recruitment of activated T cells 
and macrophages to the site of inflammation (Devergne et al., 1994, Rathanaswami 
et al., 1993). Thus RANTES can act as a mediator of DTH reactions, and is secreted 
by cells involved in this type of response such as macrophages, fibroblasts, 
endothelial cells and activated T cells (Rathanaswami et al., 1993, Devergne et al., 
1994, Schall et al., 1990). The persistence of parasites, and the release of known 
inducers of this chemokine such as IFN7, IL- IP and TNF(x, in the lungs parallel the 
expression of RANTES observed at day 21 post-vaccination. This in turn might aid 
the recruitment of the memory CD4+ population detected in the lungs post- 
vaccination, a population thought to have been previously activated in the skin 
draining LN (Mountford et al., 1992, Ratcliffe and Wilson, 1991, Coulson and 
Wilson, 1993). Thus this chemokine, along with other upregulated adhesion 
molecules such as ICAM- 1 (Coulson, 1995), may account for the increase in CD4+ T 
cells and macrophages around the trapped larvae. 
There is some evidence to suggest that human RANTES can attract eosinophils in 
vitro and can express mRNA for this chemokine (Alam et al., 1993, Ying et al., 
1996). However, recruitment may not occur in vivo due to the lack of this cell type 
in classical DTH responses. It is interesting to note that eosinophils are abundant in 
the lungs of vaccinated mice, peaking at day 21 (Menson et al., 1989, A. Finlay 
unpublished observations), coincident with elevated expression of RANTES and IL- 
5, both of which may have a positive effect on the recruitment of this cell population. 
The presence of Th2 cytokines in the lungs may possibly override any inhibition that 
a true DTH reaction may have on RANTES attraction of eosinophils. IL-4 and IL-10 
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message levels are elevated following exposure to vaccinating parasites, and both 
these cytokines are capable of downregulating RANTES expression either directly 
(IL-4) or indirectly (IL-10) (Essner et al., 1989, te Velde et al., 1990, Devergne et al., 
1994). Inhibition of this chemokine may be another mechanism by which Th2 
cytokine expression can control the inflammatory response. 
Post-challenge, the cytokine patterns detected in this study are indicative of an 
anamnestic Th I response and agree with previously published protein data 
implicating the importance of IFN7 in the effector mechanism (Smythies et al., 
1992a, 1992b, 1993). The expression of the inflammatory cytokines detected in this 
study peaks earlier, and at higher levels than the message associated with Th2 cells. 
This is consistent with the proposed effector mechanism of inflammatory focus 
formation around migrating parasites, blocking exit from the lungs, and hence worm 
maturation in the liver (Smythies et al., 1993). Furthermore, animals exposed to a 
vaccinating infection prior to challenge produced higher levels of all cytokines than 
challenge control mice. Animals receiving a normal infection displayed cytokine 
mRNA levels barely detectable above the naive baseline, with the exception of the 
Th2 cytokines IL-5 and IL- 13, which are elevated at day 15 post-challenge. 
Interestingly IL- 13, an IL-4-like cytokine and good indicator of the presence of Th2 
cells, also increased in expression post-challenge in primed mice, demonstrating a 
strong anamnestic response. This cytokine has been shown to activate NK cells to 
produce IFN7 early in infection (Doherty et al., 1993). However, the precise role of 
IL- 13 in this model is unclear, since its downregulatory effects on macrophage 
activation might inhibit the effector mechanism to some extent. It is possible that 
ablation of IL-4, IL- 10 and IL- 13 together might increase the effectiveness of the Th I 
response, and thus resistance, by reducing inhibition of macrophage activation. 
The abundant expression of IFN7, IL- I P, IL- 12 and TNF(x post-challenge are 
consistent with reports detailing the activation state of macrophages during the 
effector response (Menson and Wilson, 1990). These cytokines are expressed at 
levels approaching those detected post-vaccination, and peak with the arrival of 
challenge parasites in the lungs (Dean et al., 1984, Wilson et al., 1986). This data is 
in agreement with previously published work demonstrating that Th I cytokines 
dominate at the mRNA level in vaccinated and challenged animals (Wynn et al., 
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1994a). Moreover, high expression of IL-12, TNFcc and IL-lp following challenge 
has been related back to macrophage activation, and thus strong inflammatory 
responses (DTH) (Wynn et al., 1994a). 
All the cytokines required for RANTES expression in human models of disease 
(see above post-vaccination data), are also detected in murine lung tissue post- 
challenge. As found following vaccination, upregulation of this chemokine is 
coincident with influxes of CD4+ T cells and eosinophils into the lungs (Smythies et 
al., 1993, Aitken et al., 1988). A definitive role for RANTES in cell recruitment in 
the effector mechanism could be investigated further by in vivo blocking with anti- 
RANTES antibodies. 
Macrophage activation is a key effect of DTH reactions, and the production of 
toxic nitrogen intermediates as a result of stimulation can lead to killing of parasites 
in vitro and in vivo (Pearce and James, 1986, Liew et al., 1990,1991, Liew and Cox, 
199 1, Oswald et al., 1994a). Expression of IFNy, TNFoc, IL- IP and IL- 12 have all 
been associated with the upregulation of macrophage activation and subsequent NO 
production (Oswald et al., 1994c). These cytokines are readily detected during both 
vaccination and challenge exposures and thus might be expected to correlate with 
increased expression of iNOS, the enzyme responsible for NO production. However, 
the analysis of iNOS mRNA following percutaneous challenge demonstrated an 
insignificant peak at day 10 in vaccinated animals. Further investigation of tissue 
samples from mice challenged intravenously indicated that there is a significant 
increase of iNOS message at days 4 and 12 post-exposure in primed mice but not in 
control animals. Recently published data have suggested the importance of NO in 
the effector mechanism of the irradiated S. mansoni vaccine (Wynn et al., 1994a, 
Oswald et al., 1994a). In these studies the elevated levels of iNOS detected post- 
challenge in vaccinated mice were correlated with IFNy production, ablation of 
which results in abrogation of iNOS expression. In addition, ablation of NO during 
challenge infection lead to a 33% decrease in protection. Taken together, the above 
data imply that parasites trapped by inflammatory foci during migration across the 
lungs are restricted to a toxic microenvironment, resulting in at least some effective 
killing of lung stage worrns (Wynn et al., 1994a, Oswald et al., 1994a). 
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However, in contradiction to the above report, a more recent experiment finds no 
reduction in resistance after the administration of a competitive inhibitor for iNOS 
(Smythies et al., 1996b, manuscript in preparation). Furthermore, in vitro assays 
have been unable to demonstrate the killing capacity of NO against lung stage worms 
(Pearce and James, 1986, James and Glavern, 1989, Oswald et al., 1994a). In 
addition, extraction of trapped worms from the lungs at day 17 post-challenge, the 
time of peak NO production reported above, and injection of these parasites into the 
hepatic portal system of naive recipient mice results in ftill maturation and 
development of a patent infection (Coulson and Wilson, 1988). This would imply 
that, at least up until day 17, the worms are unharmed by focus formation, and that 
the effector mechanism has a blocking action not directly harmful to the migrating 
parasites. In support of this, the presence of even small numbers of red blood cells in 
in vitro larvicidal assays results in complete abrogation of parasite killing, indicating 
that while lung parasites are intravascular it is unlikely that NO has a toxic effect 
(Smythies et al., 1996b). It has been shown, moreover, that no further migration of 
schistosomula from the lungs takes place after day 17, and thus any worms trapped 
there will not mature. It is therefore difficult to elucidate a major role for NO in the 
effector mechanism which will have a direct effect on the number of worms maturing 
in the hepatic portal system. Apparently focus formation alone is responsible for the 
termination of migration in the lungs. Whether trapped parasites die by starvation or 
toxic compound attack is of no real consequence to the levels of resistance generated. 
The vaccination and challenge of iNOS-deficient mice will provide the definitive 
answer as to whether NO plays any role in resistance. 
The investigation of the effector mechanism following a synchronous pulse of 
lung stage parasites permitted kinetic analysis of the cytokine expression profiles 
without distortion resulting from the staggered arrival of migrating parasites into the 
lungs. The resistance measurement of 43% obtained from this time course is 
somewhat lower than those routinely observed following percutaneous challenge. 
This might be explained by the developmental state of the injected worms. A 
proportion of the parasites derived from the lungs of infected mice may have already 
made the morphological changes required to aid passage through the narrow 
capillaries. Thus on arrival in the lungs after injection, these worms can rapidly 
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navigate the capillaries and resume migration to the hepatic portal system, 
accounting for the higher percentage of parasite maturation. 
The patterns of Th I and Th2 cytokines induced by intravenous challenge are 
similar to those observed after percutaneous challenge. However, major differences 
were seen in the timing of cytokine expression; IL- I P, IFN7 and TNF(x all peak at 
day 4 post-challenge, compared to day 10 following percutaneous exposure. This 
can be explained by the rapid arrival of parasites into the lungs following injection 
into the femoral vein. Focus formation in previously vaccinated animals occurs 
between days 2 and 8 following parasite injection (Smythies et al., 1996), whereas 
control animals show only a low level of infiltration at the later time point. The 
expression of IFN7 and TNFcc may account for the upregulation of adhesion 
molecules such as ICAM- I and result in recruitment during effector focus formation 
(Dustin et al., 1986, Coulson, 1995). The recruitment of eosinophils may also be 
explained by the increased expression of IL-4 at day 4 post-challenge. This cytokine 
can upregulate VCAM- I on endothelial cells, and VLA-4, its ligand on eosinophils, 
resulting in the infiltration of this cell type during focus formation (Dobrina et al., 
1991). 
Peak expression iNOS at day 4 post-challenge coincides with IFN7, IL- IP and 
TNFcc mRNA elevation, cytokines which can all act as inducers of this toxic 
mediator. Other in vivo studies of intravenous challenge have described peaks of 
IFN7 and iNOS on days I and 2 post-injection respectively (Wynn et al., 1994a). 
This very early expression was not observed in the data presented above, although a 
day I sample was not taken and there was a slight increase in IFN7 message at day 2. 
These discrepancies could be caused by the differences between challenge 
procedures. The data in this chapter is derived from the injection of 120 lung stage 
worms derived from donor mice, whereas the results reported above are based on the 
intravenous administration of 500,24 hour cultured schistosomula derived from 
mechanically transformed cercariae. The arrival of so many parasites into the lungs 
could result in elevated responses compared to the natural migration pattern. In 
addition these young parasites may more reflect skin stage larvae in morphology, and 
thus be more susceptible to NO attack as demonstrated by in vitro assays (James and 
Glavern, 1989, Pearce and James, 1986). 
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To summarise, it would seem that the induction and effector mechanisms in this 
vaccination model are not optimised for the production of a complete Thl response. 
If the residual Th2 cytokine expression could be eliminated then the effector 
mechanism may give higher levels of resistance. It has already been shown that IL- 
12 administered post-vaccination can boost the Thl response, and partially inhibit the 
Th2-type cytokines, resulting in increased levels of protection (Wynn et al., 1995a). 
However, this still only induces a resistance of 80%. By the detailed analysis of the 
immune responses induced by vaccination, the mechanisms required for greater 
protection can be determined. The importance of certain cytokines in resistance can 
ftirther be investigated by the vaccination of gene-deleted mice (see Chapter Six), 
although more information on the interplay of immune factors is required to optimise 
the effects of this vaccination regime. 
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CHAPTER FIVE 
A Comparison of the Cytokine Profiles Induced Following 
Vaccination of C57BL/6 and BALB/c Mice with Irradiated 
Cercariae of S. mansoni 
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Introduction 
The impact of genetic background on the immune responses observed in murine 
models of parasitic infection has long been known. Many infections display 
dichotomy in disease progression according to host strain; Toxoplasma gondii, 
Trichuris muris and Schistosoma mansoni all show a spectrum of disease pathology 
dependent upon the genetic background of the murine host infected. This variation is 
often associated with differing cytokine expression profiles induced upon infection 
(Scott et al., 1989, Scott and Kaufinan, 1991). However, the most widely researched 
example of strain-specific resistance and susceptibility is Leishmania major 
infection in mice. This parasite provides a parallel model for human leishmaniasis, 
and the ability of some strains to resist development of the visceral form of the 
disease has prompted research into the immune environment necessary to control the 
cutaneous infection and promote self-cure. Infection of susceptible strains, such as 
BALB/c, with L. major results in disease progression and eventual death and appears 
associated with the production of IL-4. In contrast, C57BL/6 and C3H/HeN mice 
can control initial cutaneous lesions and self-heal (Heinzel et al., 1989, Scott et al., 
1989, Scott, 1989). The ability of mice to self-cure has been found to show strong 
correlation with the expression of IFN7, and inducers of the Thl response such as 
IL- 12 (Heinzel et al., 1989,1993a, Scharton and Scott, 1993). 
The investigation into the immunological nature of resistance and susceptibility of 
mice exposed to L. major has uncovered a wealth of information on the cytokine 
secretion of T helper subsets, especially on the course of Thl/Th2 development. The 
production of Thl cytokines by resistant strains, and Th2 cytokines by those 
susceptible to infection (Heinzel et al., 1989), indicates that infection with the same 
parasite can elicit different responses from hosts of the same species but differing 
genetic backgrounds. This phenomenon provides an ideal model in which to study 
the induction of cytokine gene expression and the immune environment necessary for 
control or exacerbation of the disease. In addition, information leading to the ability 
to influence the in vivo development of a cell population obligatory for cure will 
provide a useful tool in the design of vaccine strategies. 
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The exact mechanisms responsible for the development of one T helper subset 
preferentially to the other are not clear as yet, but the involvement of different 
cytokines has been investigated. Indeed, it is known that IL-12, IFNy and IL-4 play 
definitive roles in the development of Th I and Th2 subsets, and hence influence the 
outcome of disease in Leishmania infection (reviewed by Scott, 1991, Scott 1993b, 
Reiner and Locksley, 1995). The ablation or administration of any one of these 
cytokines can result in an altered course of infection. Administration of IL-12 or 
IFNy to susceptible mice can reduce the pathology associated with disease (Scott 
1991,1993 b, Heinzel et al., 1993 a, 1994), and in the case of IL- 12 can induce 
resistance to further infection (Heinzel et al., 1993a, Sypek et al., 1993). Ablation of 
IL-4 in susceptible strains has a similar effect to the administration of IL- 12 
(Chatelain et al., 1992). In contrast, the administration of IL-4 to mice naturally 
resistant to L. major infection can lead to disease progression into visceral 
leishmaniasis. Similarly, ablation of IL-12 or IFNy in these mice leads to 
exacerbation of pathology and an increase in the levels of Th. 2 cytokines (Belosevic 
et al., 1989, Chatelain et al., 1992, Sadick et al., 1990, Scott, 1993b). Initial analysis 
of the differences observed between infected strains detected clear cytokine 
expression dissimilarities (Heinzel et al., 1989). However, it is now apparent that 
most strains of mice can express similar, mixed cytokine profiles at the mRNA level 
during the first week of infection (Reiner et al., 1994). After a period of 7 days the 
relevant Th I /Th2 responses then develop according to the strain, as one or other of 
the cytokine profiles is downregulated. 
The importance of Thl cytokines in the resistance mechanism has been related to 
the induction of cell-mediated responses and macrophage activation (Nathan et al., 
1983). Nitric oxide is a toxic intermediate used for the control of some infections, 
and can be released by activated macrophages in response to cytokines such as IFNY 
(Oswald et al., 1994a, 1994c, Liew et al., 199 1). The production of NO by the action 
of nitric oxide synthase on arginine is blocked by structural analogues such as N G_ 
monomethyl-l-arginine (L-NMMA), resulting in an increase in susceptibility in mice 
naturally resistant to leishmaniasis (Liew et al., 1990, Green et al., 1990). 
Furthermore, the generation of iNOS-deficient mice on a resistant background has 
demonstrated the crucial role NO plays in parasite killing in L. major infection (Wei 
158 
et al., 1995). These mice are completely unable to control cutaneous lesions and 
infection results in the development of fatal visceral pathology. Macrophage 
activation, and thus NO production, is down regulated by IL-4, IL- 10 and IL- 13 
(Fiorentino et al., 1991 a, 1991 b, Doherty et al., 1993, Oswald et al., 1994a, Liew et 
al., 1991). This may account for the inability of mice with Th. 2 characteristics to 
control infection and explain the strain differences observed in leishmanial infection. 
It has been reported that NO has an important role in the effector mechanism against 
S. mansoni (Wynn et al., 1994a, see Chapter Four). However, results are 
inconclusive and the effects of the inhibition of iNOS are less clear than following 
exposure to Leishmania major. 
Investigations into the effects of mouse strain on the outcome of infection with 
Leishmania have highlighted the predisposition of different stains to mount specific 
Thl or Th_2 responses. This effect has also been shown in other models of parasitic 
disease as mentioned earlier. In fact, Schistosoma mansoni infection in different 
strains of mice can result in varying levels of resistance (James et al., 198 1, James 
and Sher, 1983). However, the differences in cytokine production induced in 
different strains have not been described. C5713L/6 mice are typically high 
responders, and a single vaccination with 500 irradiated cercariae routinely generates 
up to 75% resistance (Dean, 1983, Smythies et al., 1992a, 1993). The effector 
mechanism which operates in the lungs is CD4+ T cell-mediated and has an essential 
requirement for IFNy (reviewed by Smythies et al., 1993). The cytokine expression 
induced in less resistant mice after vaccination with irradiated cercariae may be very 
different from the patterns observed following exposure of highly resistant C5713L/6 
mice. Thus the study of vaccination in high and low responders may highlight the 
cytokine profiles necessary for resistance. This chapter aims to describe the 
differences observed between C5713L/6 and BALB/c mice following exposure to 
irradiated cercariae of S mansoni. Semi-quantitative RT-PCR analysis was carried 
out at restricted time points, estimated from previous experiments to be coincident 
with peak cytokine protein responses in the skin draining LN and lungs. In addition, 
the relative basal levels of cytokine expression between the two strains were 
investigated by competitive PCR. 
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Materials and Methods 
Experimental Animals and Parasites 
Parasites for the vaccination procedure were passaged as previously described 
(Chapter Three) through MFl outbred mice and Biomphalaria glabrata snail hosts. 
Strains of mice known to differ in resistance to infection with other parasites, such as 
L. major, were chosen for the study (in collaboration with S. Anderson). SPF 
C57BL/6 and BALB/c female mice were obtained commercially (B&K Universal, 
Hull, UK) and maintained in isolator conditions throughout the vaccination time 
course. 
Exposure Regimes 
Mice were infected with 500 optimally irradiated cercariae percutaneously via the 
shaved abdomen. Unexposed control animals, and groups of 3 vaccinated mice were 
sacrificed at days 6,15 and 20 post-vaccination and the lungs, and 2 of the 4 LN 
draining the exposure site, removed into homogenisation buffer containing RNAse 
inhibitor (4M guanidinium thiocyanate). Alternatively, tissue was frozen in liquid 
nitrogen and stored at -800C until RNA isolation. Axillary and inguinal LN were 
pooled from all three mice per time point for the RNA isolation procedure, whereas 
lung samples were treated individually. Remaining LN were removed for tissue 
culture and protein analysis (S. Anderson, unpublished observations). 
At day 35 post-vaccination, five mice from the vaccinated group and age-matched 
naive controls were infected with 200 normal parasites by tail immersion in a 
cercarial suspension. Mice were restrained in a humane apparatus for the 30 minute 
duration required for maximal parasite penetration of the skin. At day 35 after 
challenge, the groups of mice were sacrificed and the adult worm burdens assessed 
for resistance measurements. Resistance was calculated from the worm burdens 
using the equation previously described (Chapter Three). 
Total RNA Isolation 
Total RNA was isolated from the pooled LN and individual lungs as previously 
described (Chapter Two). The yield of recovered RNA was established by 
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spectrophotometry at 260 nin and confirmed, along with the intact nature of the 
preparation, by I% agarose gel electrophoresis in the presence of ethidium bromide. 
Semi-quantitative RT-PCR Analysis of Cytokine mRNA 
Total RNA isolated from each strain was analysed for the presence of message for 
HPRT, IFNy, IL-4, IL-10 and IL-12 as previously described (Chapter Two). LN total 
RNA was diluted to a concentration of 0.25 ýtg/l 0[tl, and I 0[tl added to each RT- 
PCR test. Equal quantities of lung RNA for each sample were combined in a pool to 
a final concentration of I ýtg/ I 0[d for each time point. Following reverse 
transcription, duplicates for each sample were amplified for 3 different cycle 
numbers at intervals of 3 cycles. The PCR primer sequences, reaction conditions and 
appropriate cycle numbers are described elsewhere (Chapters Three and Four). 
Detection of PCR product was carried out by hybridisation of slot-blotted samples 
on to nylon membrane, followed by hybridisation with 32 P-end labelled, specific 
oligonucleotide probes (sequences as previously described, Chapters Three and 
Four). After stringent washing, membranes were exposed to a storage phosphor 
screen and the counts for each sample repeat obtained by analysis on a 
phosphorimager. The counts collected were analysed by linear regression and an 
accurate value for PCR product at 25 cycles derived. Estimated values were adjusted 
for differences in total RNA added to the RT mix by correction with a factor derived 
from the HPRT content of the samples. 
Competitive PCR Analysis 
The basal level of cytokine expression in naive lung and LN tissue from C57BL/6 
and BALB/c mice was analysed by the addition of a competitive template into the 
PCR of test samples (see Chapter Two). Known dilutions of competitor were co- 
amplified with an unknown constant amount, I ýtg for lung or 0.2 5 Vtg for LN, of test 
RNA using IFNy, IL-4, IL- 10 and HPRT primers. Amplification was carried out for 
35 cycles and the resulting mix of products separated by 2% agarose gel 
electrophoresis in the presence of ethidium bromide. The point at which the sample 
and competitive templates produced products of equal band intensity was judged as 
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the dilution of construct plasmid DNA with an equal concentration to the cDNA 
derived from the test RNA sample. 
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Results 
Events in the Skin-Draining LN Following Vaccination 
Cytokine profiles detected in the LN following exposure of C5713L/6 and BALB/c 
mice to vaccinating parasites are in general very similar for Th I -related cytokine 
mRNA. However, differences are seen with respect to Th2 cytokine expression. 
IFN7 mRNA is detected at equivalent values for both BALB/c and C57BL/6 mice at 
all time points except for day 0, the naive level (Fig. 1). This was much higher in 
C57BL/6 mice, and thus levels after day 0 are below the baseline expression detected 
in naive mice for this strain. IL-12 follows a similar expression profile in each 
group, with values dropping below baseline and not increasing over the sampled time 
course. This fall in LN cytokine expression following vaccination resembles that 
reported previously (Chapter Three). 
The Th2 cytokines, IL-4 and IL- 10, show greater variation between strains than 
the IFN7 and IL- 12 expression decribed above (Fig. 2). Although the basal level of 
IL-4 mRNA is higher in BALB/c, compared to C5713L/6 LN tissue, both strains 
show a peak of IL-4 expression at day 6 post-vaccination. However, the peak in 
C57BL/6 mice is half that observed in BALB/c animals. In addition the levels seen 
in BALB/c mice remain elevated throughout the time course and do not return to 
baseline as rapidly as those in C5713L/6 mice. Perhaps surprisingly, given the 
disposition of BALB/c mice to produce Th2 cytokines after Leishmania infections, 
IL- 10 mRNA levels are higher in C57BL/6 LN tissue over the whole time course. 
Expression of IL- 10 mRNA in BALB/c LNs is much lower in comparison, with 
values rarely rising above the naive baseline detected at day 0. 
Events in the Lung Following Vaccination 
With the exception of IL-12, both C57BL/6 and BALB/c mice display elevated 
expression of all cytokines assayed at days 15 and 20 post-vaccination (Figs. 3 and 
4). The Thl -related cytokines IFNy and IL-I 2 are expressed at higher levels in 
C57BL/6 mice compared to BALB/c animals, especially IL-12 which does not rise 
above baseline in the latter group. The levels of IL-4 mRNA are similar between 
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strains at all time points, with increases of almost four fold above respective naive 
values at days 15 and 20 post-vaccination. Expression of IL-10 is higher in C57BL/6 
compared to BALB/c mice, in agreement with the LN data described above. At peak 
expression, IL-10 mRNA levels in the lungs of C57BL/6 mice were 3 fold greater 
than those of BALB/c samples. This reflects more closely data obtained for IFN7 
expression than that for IL-4, another Th2 cytokine. 
Competitive PCR 
Basal IFNy mRNA expression in the lungs of C57BL/6 mice shows a marked 
difference to the levels detected in BALB/c mice, at 0.5 pg compared to 0.005 pg 
(Table 1). This hundred fold difference is not reflected in the semi-quantitative PCR 
data shown above, which describes only an 2-3 fold difference between the two 
strains. The IFNy level in BALB/c LN was undetectable in this assay. IL-4 message 
is approximately 10 fold higher in all tissues samples for BALB/c mice (0.5 pg) 
compared to C57BL/6 animals (0.05 pg). The values obtained for HPRT indicate 
that equal amounts of starting material were added into each RT-PCR test. 
Resistance Data 
Resistance measurements obtained for the C57BL/6 group were of the level 
routinely obtained for this strain (see Chapters Three and Four). Worm burdens of- 
130.5 ± 7.3 for the CC group, and 49.4 ± 5.08 for the VC group, gave a resistance 
value of 62%. BALB/c mice displayed similar worm burdens to infected C57BL/6 
animals in the CC group (13 3.3 ± 3.19). However, an increased level of maturation 
in the VC animals (worm burden 72.2 ± 7.7) resulted in a lower resistance, at 45.8%. 
These values agree with previously published and unpublished observations (James 
et al., 1981, James and Sher, 1983, S. Anderson unpublished observations). 
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Fig. 1. Expression of IFNy and IL-12 in the axillary and inguinal LN of C57BL/6 
and BALB/c mice following exposure to 500 radiation-attenuated cercariae of S. 
mansoni. Values shown are estimates at 25 cycles derived from regression analysis 
performed on six values from each RNA sample. Correction for variation in HPRT 
mRNA levels has been applied. 
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Fig. 2. Expression of IL-4 and IL-10 mRNA in the axillary and inguinal LN of 
C57BL/6 and BALB/c mice following exposure to 500 radiation attenuated cercariae 
of S. mansoni. Values depicted as described for Fig. 1. 
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Fig. 3. Expression of IFNy and IL-12 mRNA in whole lung tissue of C57BL/6 and 
BALB/c mice following exposure to 500 radiation attenuated cercariae of S. 
mansoni. Values depicted as described for Fig. 1. 
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Fig. 4. Expression of IL-4 and IL-10 mRNA in whole lung tissue of C57BL/6 and 
BALB/c mice following exposure to 500 radiation attenuated cercariae of S. 
mansoni. Values depicted as described for Fig. 1. 
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Table 1. Cytokine expression levels detected in the lungs and skin draining LN of 
naive C57BL/6 and BALB/c mice. Values shown are the amount of plasmid, in pg, 
added to constant amounts of sample cDNA to achieve a point of equivalence after 
PCR amplification. All samples were tested for HPRT values, and no differences 
observed. 
IFN7 IL-4 HPRT 
BALB/c naive ND 0.5 pg 50 pg LN 
C57BL/6 0.5 pg 0.5 pg 50 pg 
naive LN 
BALB/c naive 0.005 pg 0.05 pg 50 pg lung 
C5713L/6 0.5 pg 0.05 pg 50 pg 
naive lung 
ND = not detected 
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Discussion 
Cytokine expression in the LN tissue of C5713L/6 mice reflects profiles obtained 
with vaccination time courses previously described (Chapter Three). The cytokine 
mRNA levels are similar for both IL- 12 and IFN7, in that values obtained at day 0 
are higher than any others across the time course. The exception to this is the basal 
level of IFN7 expression in BALB/c mice, which is no higher than the expression at 
following time points. This drop in cytokine message following vaccination may be 
due to the inhibition of gene transcription to below baseline levels. However, a more 
plausible explanation is the presence of an increasing number of B cells in the nodes 
after day 7 (Constant et al., 1990, Constant and Wilson, 1992). As described in 
chapter three, the accumulation of this cell type in the LN reduces the T: B cell ratio 
from 4: 1 to 1: 1 (Constant et al., 1990), thus in effect diluting the proportion of T cell- 
derived mRNA represented in the 0.25ýtg of total RNA analysed at each time point. 
IFN7 expression is higher in the axillary and inguinal LN of naive C5713L/6 
animals compared with BALB/c mice. This is in agreement with previously 
published data indicating the IFN7 disposition of the C5713L/6 strain, and hence the 
natural default development of Th I cell populations (Hsieh et al., 1995, Reiner et al., 
1994, Morris et al., 1992). In contrast, IL-4 expression is higher in BALB/c mice 
compared to C57BL/6, again in agreement with published data, displaying a natural 
tendency of this strain to polarise toward Th2 cytokine production (Reiner et al., 
1994). The data obtained by competitive PCR supports these findings, suggesting 
that even in the unstimulated mouse, a pre-determined tendency exists towards Thl 
or Th2 cytokine production. 
IL- 10, the other Th2 cytokine analysed, shows only slight differences in 
expression between the LNs of both strains. C5713L/6 mice display slightly higher 
levels of IL- 10 compared to BALB/c animals, even though the same pattern of 
decline in expression below naive values seen for IFNy and IL-12 is also observed 
here. Previous work (see Chapter Three) has demonstrated early peaks of these 
cytokine mRNAs in the LNs of C5713L/6 animals following vaccination, before the 
expression levels fall below baseline at between days 5 and 10. Thus the time points 
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analysed here may sample the cytokine profiles on the downward trend of an earlier 
peak. A repeat time course involving an earlier sampling program could address this 
problem. 
The dominance of IFNy and IL-12 in C57BL/6 mice following vaccination with 
irradiated cercariae may account for the increased resistances observed upon 
challenge of this strain. BALB/c mice are capable of IFNy secretion, but to a lesser 
extent than the more resistant group, and show no increases in IL-12 levels above 
baseline in either LN or lung tissue. The data presented above correlates well with 
similar studies carried out on Leishmania major infection in these strains of mice 
(Reiner et al., 1994). This published data demonstrates that both susceptible 
BALB/c, and resistant C57BL/6, animals can produce IFNy and IL-12 early in the 
induction mechanism. However, in susceptible strains, the synthesis of these 
cytokines is dramatically reduced after approximately 5 days, and the expression of 
IL-4 begins to dominate (Reiner et al., 1994, Reiner and Locksley, 1995). In 
contrast, following infection of resistant mice, IL-4 mRNA is downregulated. A 
similar pattern of differential cytokine production is observed during an S. mansoni 
vaccinating infection. IFNy and IL-12 are the predominant cytokines expressed by 
cell populations in the lungs of C57BL/6 mice. Although IL-4 mRNA is detectable 
at ten fold above the baseline values determined for these mice, it is still present at an 
overall lower level than IFNy, due to the higher naive levels and four fold increase in 
the latter cytokine. Of course, this does not account for the potency of the different 
cytokine proteins, and low expression of IL-4 may in fact be sufficient to induce a 
Th2 response above any inhibitory levels of IFNy. Thus, as deduced in chapter four, 
C5713L/6 mice appear to mount a mixed Thl/Th2 cytokine profile after vaccination, 
with a tendency towards a Thl-like response. BALB/c mice express levels of IL-4 
message similar to those detected in C57BL/6 mice. However, in contrast to the 
latter strain, BALB/c mice do not express high levels of IFNy and IL- 12. Thus the 
IL-4 production in these mice, although similar in intensity to that observed in 
C57BL/6 animals, represents a higher IL-4: IFNy ratio and hence a more polarised 
Th2 response. 
It has been suggested that a genetic defect in BALB/c mice may be responsible for 
the abundant production of IL-4 upon infection (Reiner and Locksley, 1995). The 
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predisposition of BALB/c mice to mount a Th2 response segregates with the CD4+ T 
cell and is not associated with the APC. Furthermore, the inability of IL-12 to 
downregulate the expression of IL-4 might be due to the lack of suppression of IL-4 
transcription in CD4+ T cells from these animals. Recent data has indicated that T 
cells from BALB/c mice become unresponsive to the effects of IL- 12 after the first 
week of infection (Goler et al., 1996, Szabo et al., 1995) and this may account for the 
prominent development of Th2 profiles in this strain. 
To summarise, it would seem that the genetic background of some strains of mice 
affects the ability to respond to the irradiated vaccine, and that this ability is closely 
linked to cytokine production. The polarisation of the T helper responses in 
C57BL/6 and BALB/c mice after exposure to the irradiated S. mansoni vaccine is not 
as clear cut as that seen during L. major infection. This observation is not 
completely unexpected in that infection of these strains with Leishmania results in 
disease pathology at opposite ends of the spectrum, perhaps indicating that cytokine 
expression might exhibit similar diversity. However, following vaccination and 
infection with S. mansoni, both strains display partial resistance in comparison to 
normal infection. The differences in cytokine levels detected between the strains are 
also less extreme, both strains mounting a mixed Thl/Th2 type response. Complete 
ablation of one or other of the T helper responses by anti-cytokine antibody 
administration might be expected to have a more severe effect on the resistance 
generated with vaccination than subtle variations in strain immunology. 
Alternatively, the generation and analysis of cytokine gene-deleted mice may provide 
the ideal system for studying the consequences of infection in the absence of the 
major cytokines such as IFN7 and IL-4 (see Chapter Six). 
A more complete post-vaccination investigation, looking at very early LN 
responses, could clarify the expression profiles of IFN7 and IL-12 in C57BL/6 and 
BALB/c mice during the induction response. Furthermore, analysis of the effector 
mechanism in the lungs following a challenge infection, would highlight any role the 
differences observed post-vaccination might have in blocking parasite migration. 
The increased ratio of IL-4 to IFN7 mRNA expressed in the lungs of BALB/c 
compared to C57BL/6 mice may result in reduced inflammatory responses post- 
challenge, and generate a less efficient blocking mechanism than that seen in the 
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latter strain. Hence, examination of cytokine production and focus formation during 
the BALB/c effector response could provide an explanation for the lower levels of 
resistance observed in these mice. 
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CHAPTER SIX 
The Cytokine Expression Profiles Induced in IFN7-Receptor Gene- 
Disrupted Mice Following Exposure to the S. mansoni 
Irradiated Vaccine 
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Introduction 
Ablation of cytokines with specific antibodies has long been used as a means of 
investigating the role of individual cytokines in an immune response. However, the 
variable efficiency of ablation in vivo can lead to ambiguous results which are 
difficult to interpret; for example, the ablation may not be 100% successful implying 
the cytokine is not important in the response under investigation. The advent of 
gene-deletion technology has allowed the devlopment of 'knockout' mice, animals 
exactly the same as wild type mice except for a disruption in one of the exons 
required for the expression of an active cytokine protein (Capecchi, 1989, Rajewski, 
1992). This technology has lead to the generation of many cytokine-, or cytokine 
receptor-deficient mice (Ktihn et al., 1991, Dalton et al., 1993, Huang et al., 1993, 
Kaufmann, 1994). Thus gene-disrupted mice provide an ideal system in which to 
study the outcome of infection in an animal completely incapable of synthesising or 
responding to the cytokine of interest, and hence leaves no doubt as to the complete 
absence of this component in the immune response. 
Gene-disrupted mice can be generated by the manipulation of embryonic stem 
cells to incorporate a non-ftinctional version of the gene of interest (Capecchi, 1989). 
DNA constructs containing the modified intron, usually disrupted by the insertion of 
a neomycin gene which confers resistance to the drug G418 (Capecchi, 1989), are 
used to transfect embryonic stem cells in culture. The modified DNA can either 
recombine with the target gene exon in a homologous fashion (replacing the wild 
type sequence), or insert at random in the genome resulting in no disruption to the 
cytokine gene. Successful transfectants, which have taken up and incorporated the 
modified DNA, are positively selected by growth in medium containing G418. To 
screen out cells containing random insertion events, a negative selection process is 
then applied, based on the co-insertion of the herpes simplex virus thymidine kinase 
(HSV-tk) gene alongside the neo insert during non-homologous recombination. By 
including the HSV-tk sequence adjacent to the region of homology, cells containing 
homologous recombination events will lose this gene during transformation. 
However, random insertion will not select against the inclusion of the HSV-tk 
sequence, as predicted from the observation that linear DNA integrates into the 
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genome via the ends of the fragment (Capecchi, 1989, Thomas et al., 1986), and thus 
these cells will be killed by the drug gancyclovir (GANC). The selected cells are 
then incorporated into blastocysts and implanted in foster mothers. The resulting 
progeny are chimeric, and those with modified cells incorporated into the germline 
will produce gametes homozygous for the gene-disruption which when crossed with 
wild type (WT) mice produce heterozygous offspring. Selective breeding of the 
progeny can lead to the generation of a population of mice homozygous for the gene- 
disruption. 
Due to the drastic nature of the complete loss of a gene, some mice cannot tolerate 
the deletion of certain genes resulting in abortion, or death soon after birth. For 
example, TGFP knockout mice can die before birth (Christ et al., 1994), and IL-2 
(Sadlack et al., 1993) and IL-10 (Kuhn et al., 1993) gene-disrupted mice can die a 
few weeks after birth if not maintained in isolator conditions. Mice containing other 
cytokine gene-disruptions require careful handling and maintenance to ensure that 
the animals are not exposed to environmental pathogens. The development of mice 
with less severe deletions has lead to the study of the role of many cytokines in 
various infections. 
IFN7 knockout mice have been generated and the immune response to various 
pathogens studied, such as Mycobacterium bovis (Bacillus Calmette-Guerin, BCG, 
strain, Dalton et al., 1993, Cooper et al., 1993). In this infection, which typically 
induces a Thl response, IFN7 gene-disrupted animals display impaired production of 
macrophage antimicrobial agents and are killed by a sub-lethal dose of bacteria. 
Furthermore, exposure of these animals to Leishmania major results in 
downregulation of the protective Thl response and increased expression of IL-4, IL- 
5 and IL- 13 mRNA, leading to disease exacerbation and death in a strain normally 
resistant to this parasite (Wang et al., 1994). 
Development of IFN7 receptor-deficient mice (Huang et al., 1993) has also 
provided valuable information on the importance of this cytokine for the generation 
of a Th I response. Infection of IFN7 receptor knockout mice with Listeria 
monocytogenes or BCG results in death, similar to the outcome observed in IFN7 
gene-disrupted mice. The susceptibility to BCG, and ability to withstand 
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lippopolysaccharide (LPS) induced toxic shock has been correlated with a reduced 
expression of TNFa in these animals (Kamijo et al., 1993, Car et al., 1994). 
Other cytokine-deficient mice to emerge in recent years include IL-2 knockouts 
(Schorle et al., 199 1, KtIndig et al., 1993), although these animals do not survive 
well due to the development of an ulcerative colitis-like disease (Sadlack et al., 
1993). A similar effect is seen in IL-10-deficient mice (Kuhn et al., 1993), but 
careful husbandry and maintenance can reduce disease. IL-4 knockout mice remain 
healthy if housed in isolator conditions and have been shown to develop lower IgG I 
and IgE responses compared to WT animals (Ktihn et al., 1993), correlating with 
much reduced Th2 cytokine production (Kopf et al., 1993). More recently, the 
abrogation of IFNy responses to keyhole limpet antigen, with a corresponding 
increase in IL-4 expression, have been demonstrated in IL-12-deficient mice (Warner 
et al., 1995). Both the p40 and p35 subunits of this cytokine have been disrupted, 
with similar effects seen in each knockout. 
Genetic-deletions resulting in the abrogation of a cell lineage have also provided a 
broader understanding of the requirements of an immune response following 
infection. For example, mutation of the CD4 gene has indicated that this molecule is 
not necessary for the development of single positive CD8 cells from the thymus. In 
addition a TCR(x p+ve, CD4 -Ve cell population capable of cytokine secretion, but with 
resticted B cell help, also develops (Rahemtulla et al., 1991). This CD4 -ve population 
is able to secrete IFNy and mediate protection against L. major infection (Locksley et 
al., 1993). Mice homozygous for a deletion in the Ig ýt chain develop no mature B 
cells, indicating the importance of this isotype splicing event in the B cell 
developmental pathway (Kitamura et al., 199 1). These mice provide a model for 
human patients exhibiting immunodeficiency disease resulting from an absence of 
functional B cells. 
This chapter will describe the screening system used to derive a homozygous 
breeding colony of IFNy receptor-deficient mice (Huang et al., 1993). Groups of 
these mice were subsequently vaccinated and challenged with cercaria of 
Schistosoma mansoni to investigate the effect on resistance of the inability to 
respond to IFNy during the induction and effector responses. Vaccination of 
C57BL/6 mice routinely results in the generation of up to 75% resistance (Dean, 
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1983, Smythies et al., 1992a, 1992b, 1993). The protection relies heavily on the 
induction of a Th I cytokine producing CD4+ cell population in the LN draining the 
exposure site, and the recruitment of this population to the lungs (Smythies et al., 
1992a, 1992b, Mountford et al., 1992). Upon challenge infection, the schistosome- 
specific CD4+ population forms inflammatory foci around migrating parasites which 
block larval exit from the lungs (reviewed by Smythies et al., 1993). This effector 
mechanism is dependent on the production of IFN7, as demonstrated by the ablation 
of this cytokine with in vivo administration of anti-IFN7 antibody (Smythies et al., 
1992b, Sher et al., 1990a) which results in the abrogation of up to 90% resistance. 
The mechanisms involved in focus formation are not fully understood as yet. 
Through the use of gene-disrupted mice, the roles of individual cytokines in the 
protective response can be analysed without the doubt involved in in vivo anti- 
cytokine antibody ablations. Initial results from the vaccination of IFN7-R-/- mice 
confirm that IFN7 plays an important role in the generation of resistance in the 
irradiated schistosome vaccine model. The technology is now in place to breed and 
test animals of various deficiencies to pinpoint the conditions necessary for effective 
protection against infection with S. mansoni. 
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Materials and Methods 
Mice and Parasites 
Breeding pairs of homozygous IFNy receptor-deficient (IFNy-R and wild type 
(WT) 129 Sv/Ev mice were obtained from the University of Zurich (Prof. M Aguet, 
Huang et al., 1993) and bred and maintained in isolator conditions throughout all 
procedures. The breeding stock and all progeny were screened by DNA extraction of 
2cm tail snips followed by PCR as described below. 
Specified pathogen free C57BL/6 mice were purchased from B&K Universal and 
maintained in isolator conditions throughout all experiments. All infected groups 
were exposed to a Puerto Rican strain of S. mansoni obtained by routine passage 
through albino Biomphalaria glabrata snails and MF I outbred mice. 
Genetic Screening of Gene-Disrupted Mice 
After initial unsuccessful attempts at DNA amplification from peripheral blood 
samples obtained by tail bleeding, genomic DNA was isolated from tail snips excised 
under anaesthesia (method modified from a protocol kindly provided by R Kuhn, 
University of Cologne, Germany). Tail tissue was digested in buffer (50 mM 
TrisHCl pH8,100 mM EDTA pH8,100 mM NaCl, I% SDS) containing 0.4 mg of 
proteinase K (Sigma) at 550C overnight. The DNA was then extracted with 
phenol: chloroform at a 1: 1 ratio by gentle mixing for 10 minutes. The aqueous layer 
was removed to a clean tube with a cut pipette tip, to prevent DNA shearing, and the 
DNA precipitated by the addition of 0.2 volumes of I OM ammonium acetate and 2 
volumes of 100% ethanol. The resulting stringy precipitate was collected and 
washed in 70% alcohol, pelleted and dried at room temperature and resuspended in 
300 ýtl of TE (Tris-EDTA pH 7.5). A 1-2 [tl aliquot of a 1: 100 dilution of this stock 
DNA was used in each screening PCR. 
Amplification of test DNA was carried out using primers designed to span the 
neomycin insert in the appropriate exon. For detection of the IFNy-R gene, primers 
were designed to span exon 5 as follows: 5', AGATCCTACATACGAAACAT; 3', 
TTTCTGTCATCATGGAAAGGAGGG (modified from Huang et al., 1993, ). A 
neomycin- specific oligonucleotide, designed to act as a 3' primer in PCR for the 
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detection of heterozygous and homozygous DNA samples containing the disrupted 
exon, was designed from the published gene sequence as follows, CCTGCGTGCA 
ATCCATCTTG (Beck et aL, 1982). The PCR was optimised to generate a single 
product with DNA isolated from WT and homozygous mice of 189 and 500 base 
pairs respectively. The different sized PCR products obtained by PCR in the 
presence of the cytokine primer pair and the neomycin 3' primer could be used to 
distinguish wild type, heterozygous and homozygous mice. 
Products were separated by 2% agarose gel electrophoresis in the presence of 
ethidium bromide and the gel viewed and photographed under UV illumination. For 
reactions yielding ambiguous results, the PCR was separated into IFNy receptor 3' 
and 5', and IFNy receptor 5' and neomycin 3' amplifications for clarity. 
Exposure Regimes 
Various vaccination and challenge exposure time courses were carried out on 
IFNy- R -/_ mice bred in house. These mice were generated on the 129 Sv/Ev 
background, a sub-strain related to the 129/01a strain shown previously to be 
susceptible to portal shunting. 129/01a mice display a seemingly resistant phenotype 
to infection with S. mansoni, with parasites accumulating in the lungs instead of the 
portal system (Wilson et al., 1983, Coulson and Wilson, 1989, Wilson, 1990). 
Before vaccination, the WT 129Sv/Ev mice were analysed for portal shunts by the 
injection of microspheres and found to be free of this defect (carried out by Prof. 
Wilson and Dr. Coulson) and were therefore suitable for the study of the irradiated 
vaccine. Three experimental timecourses were designed (in collaboration with Dr L 
Smythies, Dr P Coulson and S Anderson) to analyse different stages of the induction 
and effector responses. Due to the small numbers of animals available from breeding 
stock at any one time, each time course concentrated on sampling at limited time 
points. Thus separate exposure regimes sampled lung and skin draining LN tissues 
at day 16 post-vaccination, and lung tissue at day 14 post-challenge. An extended 
time course further analysed the induction response at days 5 and 20 post- 
vaccination, and day 14 post-challenge. At days 5 and 16 post-vaccination both 
IFNy-W /_ and WT 129 mice were sampled. At days 20 post-vaccination and 14 post- 
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challenge IFN7R-/- 129, corresponding WT, and C57BL/6 mice were analysed in 
parallel. 
At day 35 post-vaccination five mice from each experimental group were 
challenged percutaneously with 200 normal cercariae on the tail. Five weeks after 
challenge infection portal perfusion was performed on groups of vaccinated and 
corresponding naive mice to determine wonn burdens and the resistance calculated. 
RT-PCR Analysis of Cytokine Message Generated upon Exposure of IFNY-R-ý- Mice 
At each time point groups of 5 mice were sacrificed and the total RNA isolated 
separately from lung tissue or as a pool for LN samples. RT-PCR analysis was 
carried out for a single cycle number using the basic protocol as previously described 
(Chapter Two). Each individual RNA preparation was tested for the following 
cytokines (at a previously determined appropriate cycle number): HPRT (25), IFN7 
(27), IL-4 (27), IL-10 (30), and IL-12 (30). The primer sequences and cycling 
temperatures were as previously described (Chapters Two and Three). PCR products 
were slot or Southern blotted and hybridised with short oligonucleotide probes end- 
labelled with 32 7P-ATP. The radioactivity associated with each sample was 
quantified by exposure to a storage phosphor screen and scanning by 
phosphorimager. Values obtained for the lung tissue of each mouse were plotted as a 
mean ± SE for the group. 
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Results 
Screening of Gene-Disrupted Mice 
A typical agarose gel depicting the products from a genotyping PCR of IFNy-R-/- 
breeding stocks is shown in Fig. 1. From initial protocols of DNA isolation, it was 
deduced that the PCR reaction with three primers was extremely sensitive to 
contaminating inhibitors, such as iron from the haernoglobin in blood DNA 
isolations. The preparation of genomic DNA by tail digestion provided a clean 
source of test sample which yielded more reproducible PCR products. 
The PCR was designed to yield products of two sizes, with a possible longer, third 
product obtainable under certain reaction conditions. The smallest product of 189 
base pairs corresponded to amplification of the WT gene for the IFNy-R with the 5' 
and 3'receptor primers. A product of approximately 450 base pairs was obtained 
from DNA containing the neomycin insert using the 5' receptor and Yneomycin 
primers. In some reactions (not shown) containing the receptor 5' and Yprimers a 
large product of over 1000 bases was observed, corresponding to amplification of 
DNA containing the neomycin insert. However, this product was not produced in a 
reproducible fashion, hence the introduction of the neomycin 3' primer, the screening 
having been initially designed to comprise of PCR with the receptor gene primers 
only. The presence of only the 189 base pair product was taken to represent WT 
DNA. The detection of both the smallest and 450 base pair, and possibly the 1000 
base pair, products indicated a sample of heterozygous nature. Samples displaying 
only the 450 and 1000 base pair products were classed as homozygous for the gene- 
deletion. In this way, many samples could be screened for the presence of gene- 
deletions with a single PCR test. Samples producing ambiguous results were 
analysed by separate PCR reactions for the 5' and 3' IFNy receptor, or 5' IFNy 
receptor and 3' neomycin primer pairs. 
Cytokine Profiles in LN Tissue Following Vaccination offNy-R-ý- Mice 
At day 5 following vaccination, IFNy mRNA levels in the WT LN are 
approximately 3 fold higher than in knockout animals (Fig. 2). An even greater 
difference is seen with IL-12 message, with WT mice displaying product at almost 6 
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times the level detected for knockout (KO) mice. For the Th2 cytokine IL-4, the 
differences are smaller in comparison to the Thl cytokines, WT IL-4 mRNA levels 
only showing an increase of 2 fold over those observed in RNA from gene-disrupted 
mice (Fig. 3). This is perhaps in contrast to the expected patterns, where the lack of 
IFN7 might cause an increase in the levels of Th2 cytokine mRNA. Unfortunately, 
no naive LN tissue was available during this vaccination and thus comparisons can 
only be made between the two test samples 
At day 16 post-vaccination, IFN7 mRNA levels are much higher in LN tissue from 
WT mice than expression in knockout animals (Fig. 4). However, IL-12 expression 
is very similar between the two groups, indicating that IFN7 may not be required for 
production of IL- 12. Although the Th2 cytokines, IL-4 and IL- 10 (Fig. 5), show 
higher levels of expression in WT mice, compared to the knockout group, the fold 
differences seen are not as great as those detected at day 5 post-vaccination. As 
above, the lack of LN naive tissue available in this study makes interpretation of 
these results difficult. 
Cytokine Profiles in Lung Tissue Following Vaccination and Challenge ofIFNy-R-ý- 
Mice 
Lung tissue sampled at day 5 post-vaccination shows little variation between the 
two genetic bacgrounds, with IFNy, IL-4, IL- 10 and IL- 12 mRNA levels displaying 
no significant differences at this time point (Figs. 2 and 3). Furthermore, expression 
levels were low compared to those observed in LN tissue, and no higher than the 
naive background. Naive values were different in knockout and WT animals for 
IFNy, but similar for IL-4, IL- 10 and IL- 12. By day 16 post-vaccination, the levels 
of cytokine expression in the lungs show marked differences between knockout and 
WT animals (Figs. 4 and 5, p:! ý 0.05 in all cases except IL-4 which is n. s). In fact 
IFNy, IL- 12, IL-4 and IL- 10 are all expressed in WT mice at between 6 and 10 fold 
the level detected in gene-disrupted animals. 
Lung tissue extracted at day 20 post-vaccination for WT, knockout and C57BL/6 
groups of mice allowed the comparison of cytokine expression between genetically 
different groups of animals, one of which was known to be highly resistant to further 
infection. IFNy mRNA levels were similar for 129 WT and knockout mice (Fig. 6), 
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however, C57BL/6 mice displayed IFN7 levels significantly higher (p:! ý 0.05) than 
both 129 groups. This pattern was also observed with IL-4 and IL-12 expression, 
with knockout mice showing slightly higher levels of IL-4 than 129 WT animals. 
IL-10 expression was similar in all groups tested. 
Analysis of lung tissue at day 14 post-challenge demonstrated major differences in 
the cytokine expression in WT, knockout and C57BL/6 mice during the effector 
response (Figs. 7 and 8). IFN7 mRNA levels were significantly different between all 
groups, with C57BL/6 mice expressing this cytokine at levels three fold higher than 
those seen in 129 WT mice. IFN7 expression in knockout mice was under one tenth 
of the amount detected in C57BL/6 animals, and one third that of WT mice (p: 50.001 
between all groups). The other Thl-related cytokines, IL-12 and TNFCC were both 
expressed in a similar pattern; the differences between C57BL/6 and both 129 groups 
were not as great (p:: ý 0.05), and there was no significant difference between 129 WT 
and knockout groups. The naive level of expression for the Thl-related cytokines 
were higher in C57BL/6 tissue than in samples from WT and KO mice. 
The patterns of Th2 cytokine expression were less predictable, with C57BL/6 mice 
expressing levels of IL-4 and IL- 10 equivalent to knockout animals, which might 
have been expected to show elevated Th2 profiles. IL-4 expression was significantly 
lower in 129 WT mice than in C57BL/6 and 129 IFNy-R _/_ animals (p! ý0.05), whereas 
IL-10 levels were not significantly different in any group. IL-5 mRNA expression in 
both 129 groups was approximately 2 fold higher than that observed in C57BL/6 
mice (p:! ý0.05), with no differences between the 129 strain WT and knockout animals. 
In addition, the naive level of IL-5 expression was higher in KO mice, although basal 
levels of IL-4 and IL-10 mRNA were similar in all groups. The patterns of 
expression for Thl and Th. 2 cytokines were repeated in a second experiment (Fig. 9), 
with the exception of IL-4 mRNA levels in C57BL/6 animals which were 
significantly lower (p:! ý 0.05) than in 129 IFNyR _/_ mice. 
Resistance Data 
The worm burdens, obtained by portal perfusion of the three types of mice at day 
35 post-challenge, were used to calculate resistance values. The WT 129 animals, a 
strain not routinely used as a host for S. mansoni, displayed resistances of 53% and 
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46% in two experiments (Wilson et al., 1996). This was lower than the values 
obtained for C57BL/6 mice at 69%. In contrast, the resistance levels induced in the 
IFNy-R knockout mice were 20% and 24% in two experiments, an abrogation of 
62% and 48% respectively compared to WT values. 
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Fig. 1. A typical agarose gel, viewed and photographed under UV illumination, 
depicting the different band sizes observed following PCR screening of WT, 
heterozygous and homozygous mice with a disruption in the IFN7R gene. Band sizes 
are expressed in base pairs (bp). 
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Fig. 2. Thl -related cytokine PCR product derived from total LN and lung RNA 
from 129 WT and IFNy receptor gene-disrupted mice at day 5 post-vaccination . 
Values shown represent a pool of RNA for the LN, whereas lung RNA was analysed 
individually for each animal and depicted as a mean of five mice ± SE. Naive values 
for the lung data are indicated by a line. Values have been adjusted for variations in 
HPRT expression. 
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in Fig. 2. 
188 
IFN 
500 
400 
9- 
6 
ý 300 x 
Co 
200 
100 
0 
129 LN 129 LN 
IFN, yR-l- WT 
IL-12 
1200 
1000 
800 
600 - 40 
400- 
200 - 
0- 
"ITZ, 
129 Lung 
IFN, yR-1- 
129 Lung 
WT 
129 LN 129 LN 129 Lung 129 Lung 
IFN, yR-l- WT IFN-y-l- WT 
RNA Sample 
Fig. 4. Th I -related cytokine PCR product derived from total LN and lung RNA from 
129 WT and IFN7 R gene-disrupted mice at day 16 post-vaccination. Values 
depicted as in Fig. 2. 
189 
IL-4 
2000 - 
1500 
1000. 
500 
0- 
1 
129 LN 
IFN, yR-l- 
IL-10 
3500 
3000 
;r 2500 - 
2000 
1500 - 
1000- 
500 - 
0- 
129 LN 
IFN, yR-l- 
129 LN 
WT 
129 LN 
WT 
RNA Sample 
Fig. 5. Th2 cytokine PCR product derived from total LN and lung RNA from 129 
WT and IFNy R gene-disrupted mice at day 16 post-vaccination. Values depicted as 
in Fig. 2. 
190 
2000- 
_IFNy 
1500- 
1000- 
500- 
0 
C57BL/6 129 129 
WT IFN-tR-l- 
750- IL-12 
600- 
450- 
300- 
1 
150- 
10 
0- , 
C57BL/6 129 129 
WT IFN-jR-'- 
RNA Sample 
600 -1 IL-4 
500- 
400- 
300- 
200- 
100- 
I 
0- - E*3 
C57BL/6 129 129 
WT IFN'YR-1- 
90-1 IL-10 
75- 
60- 
45- 
30- 
15- 
0- -iI 
C57BL/6 129 129 
WT IFN'YR-1- 
RNA Sample 
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and 129 IFN7R gene-disrupted mice at day 20 post-infection. Values depicted as in 
Fig. 2. 
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Discussion 
The methods outlined above for the genotyping of mice containing a disrupted 
cytokine receptor gene provide a rapid and reliable way of distinguishing WT, 
heterozygous and homozygous mice without the need for Southern blotting and 
probe labelling. In addition, this method allows simultaneous screening of large 
numbers of samples. Isolation of DNA by tail snip results in the extraction of 
enough material for multiple test reactions, should the need arise. Initial attempts at 
DNA extraction from whole blood resulted in inefficient PCR, even after resin 
purification, presumably due to the presence of iron from the haem group in red 
blood cells. This PCR method is now in routine use for the monitoring of knockout 
colonies both at B&K Universal and the University of York. 
The vaccination of IFN7-R gene-disrupted mice with irradiated cercariae of S. 
mansoni would be expected to result in a much reduced level of resistance. This 
expectation, based on previous evidence demonstrating the abundance of IFN7 
during the protective effector mechanism, and the dramatic effects on protection of 
ablating this cytokine in vivo (Smythies et al., 1992a, 1992b), proved partially true. 
The 55% abrogation of resistance is lower than anticipated from anti-IFN7 antibody 
ablation experiments which resulted in a 90% reduction (Smythies et al., 1992b). 
There are several possible explanations for this difference. The knockout mice are 
based on a 129 background, a strain not previously studied in relation to the 
protection levels generated after exposure to the irradiated vaccine. The resistance 
data of 50% obtained for WT mice from these experiments would tend to indicate 
that this strain is not a high responder, unlike the C57BL/6 strain more routinely 
used. Thus the effector mechanism is not working at optimal efficiency in 129/Sv/Ev 
mice, an observation confirmed by the lower IFN7 expression level detected in 
comparison to vaccinated and challenged C57BL/6 animals. Bearing this in mind, it 
might be reasonable to assume that a lack of IFN7 receptors in animals which do not 
typically produce high levels of this cytokine might have less of an effect than 
ablation of this cytokine in mice undergoing a more polarised Thl response. 
A second explanation for the moderate reduction in resistance involves the concept 
of immune redundancy. Acute ablation of a cytokine with antibodies at a specific 
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point in time allows the animal no time to adapt to the new, imposed conditions. 
Therefore, the sudden loss of the activity of a cytokine may have a dramatic effect on 
the immune response. Mice harbouring a gene-disruption may adapt to the lack of 
one cytokine by compensating with the activity of another, possibly one usually 
redundant in WT animals. The overall effects of the gene-disruption would thus be 
reduced, and the change in the outcome of infection not as drastic as expected. The 
IFN7-R-/- mice vaccinated in these experiments still mount an immune response upon 
challenge infection, albeit one resulting in lower levels of protection. Thus the mice 
are not completely immuno-compromised by the loss of IFN7 receptors, but mount a 
less effective protection mechanism. The cytokine data discussed below support this 
notion of a substitute immune response consisting of predominantly Th2 cytokine 
expression. 
Cytokine expression in the LN of knockout and WT mice following vaccination 
reflects the differing genetic status of the two groups of mice. IFN7 expression is 
very low in receptor-disrupted mice compared to WT animals at both days 5 and 16 
post-vaccination. It is perhaps surprising that IFN7 is detectable at the mRNA level, 
an observation confirmed at the protein level (Wilson et al., 1996), although there is 
no evidence to suggest that these animals cannot upregulate IFN7 expression in 
response to IL- 12. Indeed, IL- 12 is eight fold higher in WT than knockout mice at 
day 5, but at day 16 both groups express similar levels of this cytokine. This may be 
indicative of an early role for IL- 12 in the vaccination response, possibly involving a 
positive feedback loop for IFN7 in early IL-12 induction. The other cytokines 
analysed in LN tissue at day 16 post-vaccination also show a reduction in any 
differences observed between knockout and WT animals at day 5. This is probably 
due to the transient nature of parasite residence in the skin-draining LN following 
vaccination, most of the migrating larvae having moved on to the lungs by day 16 
(Mountford et al., 1988). Thus increases seen in WT animals may be falling by day 
16, although it should be noted that due to the lack of a naive baseline for the day 16 
time point it is impossible to determine whether cytokine expression in knockout 
mice is increasing, or whether expression in WT animals is decreasing, with time. 
On the whole, the cytokine message levels in the WT LN are higher than those 
detected in tissue from knockout mice at both days 5 and 16 post-vaccination. 
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Cytokine profiles induced in the lungs at day 5 following vaccination are 
expressed minimally above baseline, and at similar levels in both WT and knockout 
mice. This observation is explained by the absence of the bulk of migrating 
schistosomula in this organ at this early time point (Mountford et al., 1988). By day 
16 a difference in IFNy mRNA levels can be detected in the lungs, WT mice 
expressing 10 fold the amount detected in gene-disrupted animals. Higher levels of 
expression for IL-4, IL-10 and IL-12 are also detected in WT, compared to knockout, 
mice. There appears to be little difference in T helper cell polarisation between WT 
and knockout groups, but rather a general suppression of cytokine expression in the 
knockout animals at day 16. 
By day 20 post-vaccination, responses have been upregulated in the lungs of 
knockout mice, with both IL-4 and IL-12 showing higher levels of expression in 
gene-disrupted animals than in 129 WT mice. However, the apparent increase in IL- 
12 mRNA is not significant, unlike that for IL-4 message. Significantly higher levels 
of IL-12 and IFN7 expression were detected in C57BL/6 lung tissue compared to 
both the 129 groups, with the Th2 cytokines IL-4 and IL- 10 expressed at comparable 
levels to those observed in the latter strain. Thus both C57BL/6 and 129 strain mice 
appear to mount a mixed Thl/Th2 type response post-vaccination, but with the 
C57BL/6 group showing higher levels of IFNy expression. Indeed, it is the C57BL/6 
strain which mounts the highest cytokine response at day 20 post-vaccination, 
correlating with the induction of high levels of immunity. 
Cytokine expression in the lung during the effector mechanism is much more 
polarised in nature than that observed post-vaccination. Resistant C57BL/6 mice 
express high levels of IFNy, TNFoc and IL- 12 message, cytokines typically associated 
with a Thl-biased response. However, knockout mice show a more Th2-type 
response, with higher levels of IL-5 mRNA, and lower levels of IFNy, TNFa and IL- 
12 expression than C57BL/6 mice. Reduced levels of TNFoc in IFNyR_/_ mice have 
been reported previously following BCG infection (Kamijo et al., 1993, Car et al., 
1994). WT 129 mice have an intermediate cytokine profile, aptly demonstrating the 
intermediate resistance measurements obtained for these animals. It is interesting to 
note that IL-10 and IL-4 levels are equally high in C57BL/6 and knockout mice in 
post-challenge lung tissue. Although this might not be expected from the traditional 
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Thl/Th2 dogma, the presence of IL-4 and IL-10 mRNA in lung tissue expressing 
high levels of IFNy message has been demonstrated previously (Chapter Four), and 
indicates the incomplete polarisation of the Thl response in this model. This 
similarity is not repeated at the protein level, with C57BL/6 mice displaying IL-4 and 
IL- 10 levels much lower than those observed in both knockout and WT 129 mice 
(Wilson et al., 1996). The discrepancy may be due to the sensitivity of the RNA 
versus the protein assays. Alternatively, differences may be induced by in vitro 
culture of isolated BAL cells washed from the airways, compared to detection of 
mRNA extracted from whole lung tissue. Furthermore, analysis of released cytokine 
protein in culture supernatants does not account for any protein that is captured and 
utilised by the cells during the in vitro stimulation period. 
A repeat of the day 14 time point gave similar data to that obtained above. 
Although the level of IL- 10 mRNA detected in this second exposure of C57BL/6 
animals was much higher than that detected in knockout mice, large variations 
between individuals made this result non-significant. In addition, IL-4 levels in the 
knockout mice were significantly higher than those detected in 129 WT and 
C57BL/6 animals, unlike the profile determined during the first time course. 
In conclusion, vaccinated IFN7-R -/_ mice mount a Th2-type response when 
challenged with normal cercariae, unlike C57BL/6 animals which display tendencies 
to polarise towards Th I cytokine production over the challenge period. The effects 
of the inability to respond to IFN7, to all intents and purposes a complete abrogation 
of IFN7, are not as severe as might be expected from previous anti-IFN7 antibody 
ablation studies (Smythies et al., 1992b), as discussed above with relation to 
resistance. However, in disagreement with the above data, infection of IFN7R_/_ with 
Leishmania major results in the induction of an IFNy, Thl response with no 
detectable increases in IL-4 expression (Swihart et al., 1994). These differences in 
cytokine expression between the two parasitic models may be due to the high 
efficiency of L. major in inducing the development of a Thl population (Swihart et 
al., 1994, Wang et al., 1994). 
A more polarised change in T helper response has been detected in IFNy knockout 
mice following introduction of Schistosoma mansoni eggs into the lungs, or infection 
with L. major (Wynn et al., 1995b and Wang et al., 1994 respectively). Infection of 
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IFNy-/- mice with L. major leads to progression of disease in a normally resistant 
strain, correlating closely with the development of a Th2 reponse (Wang et al., 
1994). In addition to increased Th2 cytokine expression, infection of IFNy-/- mice 
with S. mansoni eggs results in the production of IL-12, indicating that IFNy is not a 
prerequisite for the induction of this cytokine in these knockout animals. This result 
contributes to the debate as to whether IL- 12 requires low level IFNy expression to 
initiate production, which then acts in a positive feedback loop to induce higher 
levels of IFNy release (Trinchieri and Scott, 1994, Trinchieri, 1993, Scott, 1993b, 
Hsieh et al., 1993). Further ablation studies with anti-cytokine antibodies might 
reveal the mechanisms responsible for the induction of IL- 12 in the absence of IFNy. 
The reduction in resistance observed following exposure of IFNy-R-/- mice to the 
irradiated schistosome vaccine appears to be due to structural differences observed in 
granulomatous lesions around migrating parasite traversing the lungs (Wilson et al., 
1996). In C57BL/6 mice the effector response comprises of focus formation, rich in 
CD4 +T cells and macrophages, which blocks parasite exit from the lungs, and hence 
prevents worm maturation in the liver (reviewed by Smythies et al., 1993). 
Knockout mice develop elevated pulmonary eosinophilia (Wilson et al., 1996), 
presumably due to increased levels of IL-5 expression. This cytokine can act as a 
potent upregulator of VCAM, a ligand for VLA-4 found on eosinophils (Dobrina et 
al., 199 1). The foci which develop in the lungs of knockout mice are loose in nature 
and contain high numbers of eosinophils, but are apparently ineffective at preventing 
parasite migration. Furthermore, the lack of cohesion between the cells of these 
modified foci may be due to reduced levels of the adhesion molecule ICAM- I 
detected on CD4+ T cells isolated from the lungs of IFNy-R-/- mice (Coulson, 1995). 
Similar loose granuloma formation is seen after infection of these mice with BCG, 
which results in the ineffective containment of this bacterium (Kamijo et al., 1993, 
Cooper et al., 1993). 
The use of knockout mice in the investigation of murine models of parasitic 
infection provides a valuable tool for analysis of an immune response lacking a 
certain component. As demonstrated in the above experiments, vaccination and 
challenge of IFNy-R -/- mice with S. mansoni results in a partial loss of resistance and 
a shift in the cytokine expression profiles compared to 129 WT and C57BL/6 
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animals. However, these data also highlight the ability of IFNy-R-/- mice to adapt to 
the lack of this cytokine receptor. Thus, future experiments should always be 
conducted in parallel with anti-cytokine antibody ablations in WT mice. This should 
ensure that any effects observed in the gene-disrupted animals are related to the 
missing cytokine, and not due to the instigation of a redundant mechanism. In 
addition, the back-crossing of the 129 IFNyR knockout mice onto a C57BL/6 
background would allow a more precise comparison with the established model. 
Finally, the continued investigation of mice deficient in other cytokines and cytokine 
receptors should allow the cytokines necessary for protection to be established. 
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CHAPTERSEVEN 
Concluding Discussion 
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For the last three decades research into schistosomiasis has centred on various 
methods of invoking resistance in animal models. The most successful protocol so 
far is based on percutaneous exposure to radiation-attenuated cercariae, an approach 
now used routinely to generate resistance to challenge infection in the mouse. 
Following initial experiments optimising vaccination strategy, more recent research 
has focused on the immune responses generated during vaccination, and the 
subsequent effector mechanism against challenge parasites. The ultimate goal of this 
research is the definition of the induction and effector mechanisms responsible for 
protection with a view to developing a human vaccine. 
The rationale behind the experiments described in this thesis was the 
characterisation of the cytokines expressed during induction, and execution of the 
protective response. It is now generally accepted that the slower migration of 
irradiated cercariae through the LN during vaccination results in the stimulation of a 
Thl-biased cell population. Upon parasite arrival in the lungs, the schistosome- 
specific CD4+ population is recruited to this organ and resides there for at least the 
following ten weeks. The lungs are thus armed against the arrival of normal parasites 
from any further infection. The effector mechanism consists of focal inflammation 
around parasites in the lung capillaries and prevents larval exit from this organ 
(reviewed by Smythies et al., 1993). The results described in the previous chapters 
encompass the determination of the cytokine profiles expressed during both the 
induction and effector responses. 
The method chosen for cytokine analysis was RT-PCR, a sensitive technique 
which allows the detection of cytokine mRNA without in vitro stimulation. Thus the 
experiments investigate the events taking place in vivo at time of sacrifice, and are 
not subject to artifacts in the way that cytokine protein analysis can be when isolated 
cells undergo secondary stimulation in culture. This type of analysis provides a 
different viewpoint to that obtained from protein detection and each method has its 
own range of advantages and pitfalls. Disadvantages of RT-PCR include the lack of 
true quantitation, and the fact that although RT-PCR provides an incredibly sensitive 
detection system for dissecting cytokine expression, mRNA is not the active form of 
a cytokine and thus message presence does not necessarily relate to in vivo protein 
release and an immunological response. However, the majority of cytokine messages 
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are thought to be inducible and unstable, hence mRNA should be a good indicator of 
protein production. This has been confirmed in part by the similarity between the 
results described in this thesis and previously published work detailing cytokine 
release upon secondary stimulation of LN and BAL cells in vitro (Pemberton et al., 
199 1, Smythies et al., 1992a, 1996a). A further advantage is that many cytokines for 
which protein assay reagents were unobtainable at the time of assay can be analysed 
by RT-PCR, for example IL- 12, IL- 13 and RANTES, since cDNA sequences for 
primer design are more readily available. Described below is a summary of the 
immune responses exhibited by vaccinated and challenged mice with reference to the 
cytokine data reported in this thesis, followed by suggestions for further research and 
possible vaccine strategies. 
The Induction Response 
Previous studies have demonstrated the importance of the generation of a Thl 
cytokine-producing cell population in the LN of vaccinated C5713L/6 mice in order 
to attain resistance. Furthermore, culture of broncho -alveolar lavage cells from 
vaccinated mice results in the secretion of cytokine profiles similar to those detected 
upon culture of LN cells. Thus it seems that the population stimulated to expand in 
the LN is recruited to the lungs upon parasite arrival in this organ. The data 
presented in chapters three and four support these earlier findings describing cytokine 
secretion profiles from LN and lung cells in culture. 
The production of IFNy in the sdLN after vaccination has been demonstrated at 
the protein level by in vitro cell culture. Data presented in chapter three confirms 
that this occurs in vivo with high levels of IFNy expression detected at day 2 after 
exposure. In addition, IL-2, and the Thl-inducing cytokine IL-12, both exhibit 
upregulated expression at this time, coincident with the arrival of the first migrating 
larvae in the LN. Although Th2 cytokines such as IL-4 and IL-10 are also detectable, 
peak levels of these messages occur at later time points compared to Thl cytokine 
expression. These profiles indicate that the Thl cell population may develop and 
expand rapidly upon the arrival of parasite antigen in the LN, with a slight Th2 
response developing later, delayed possibly as a consequence of the high levels of 
Th I cytokine expression at the earlier time points. The decreases observed in the 
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expression of some cytokines, such as IL- 10, IL- 12 and IL- 13, in the LN to levels 
well below naive baselines are inexplicable at present. It is possible that a dilution 
effect of specific cytokine mRNA occurs as a consequence of an influx of B cells 
and their associated mRNA. Although, analysis of Ig ýt chain mRNA failed to show 
this, decreasing levels of CD4 mRNA tend to indicate that a dilution of T cells does 
occur following vaccination. Alternatively, basal expression of these cytokines may 
be turned off by downregulatory factors such as TGFP; indeed the involvement of 
inhibitory cytokines in this model is an area requiring further investigation. 
The immunological factors responsible for the preferential induction and 
expansion of a Thl population by irradiated larvae remain unclear. Antigen load, 
APC-type, the cytokine environment and costimulatory molecules present at the time 
of primary stimulation have all been implicated in the development of T helper 
subsets (reviewed by Mosmann and Sad, 1996, Reiner and Locksley, 1995). One of 
the major advantages of the attenuated S. mansoni vaccine is the self-delivery of 
parasite antigens, as a consequence of migration, to a site where primary T cell 
stimulation and expansion can occur. Thus, although the exact mechanisms required 
to invoke a Th I response are not yet understood, it is known that the LN play an 
important role in the induction of immunity. 
It is well documented that a cellular population bearing Thl characteristics is 
recruited to the lungs upon the arrival of vaccinating parasites (reviewed by Smythies 
et al., 1993). In order to mount a rapid, efficient response against challenge parasites 
as they arrive in the lungs, the cells resident there require a phenotype indicative of 
previous, specific activation. These criteria are met by the CD4+ T cells recoverable 
by BAL following vaccination. Upon secondary stimulation with parasite antigen in 
vitro, these cells can secrete higher levels of IFNy than splenocytes from the same 
individual, demonstrating the recall nature of the response (Smythies et al., 1992a). 
Furthermore, CD4+ cells recovered from the airways bear markers associated with 
the short term memory phenotype (Coulson and Wilson, 1993). Thus previous 
studies have defined the Thl cytokine-secretion phenotype of these cells, with 
profiles consisting predominantly of IFNy production with some IL-3 and little IL-4. 
Building upon established data, RT-PCR analysis of whole lung tissue following 
vaccination revealed a more mixed cytokine response with both Th I and Th2 
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cytokines readily detectable and peaking in unison (Chapter Four). The 
discrepancies observed between this and previously published reports are probably 
due to the differing sensitivity levels of the protein assays and the PCR-based 
technique used in this study. The mixed response peaks at day 21 post-vaccination 
for all cytokines under test, corresponding to maximum focus formation around 
vaccinating schistosomula trapped in the lungs (Mastin et al., 1985a). Analysis of 
RNA from individual cell populations recoverable by BAL and sorted by magnetic 
beading indicates that the majority of cytokine expression takes place in the CD4+ T 
cell population. However, alveolar macrophages also contribute to the detectable 
levels of IFNy, IL- 12 and IL- 10 messages. 
The mechanisms by which the cell population induced in the sdLN is recruited to, 
and becomes resident in, the lungs are still not understood. However, the initial 
signal is undoubtedly the arrival and persistence of irradiated parasites in this organ. 
Presumably antigens from the larvae are able to stimulate the release of specific 
cytokines required for the upregulation of adhesion molecules on the lung 
endothelium. Additionally, chemokines, such as RANTES, may play a role in this 
recruitment. Research into human inflammatory disease has demonstrated a role for 
RANTES in DTH responses due to its ability to recruit memory T cells and 
monocytes (Rathanaswami et al., 1993). Furthermore, this chemokine can attract 
human eosinophils in vitro, possibly offering an explanation for the high level of 
eosinophilia observed in the foci formed around migrating parasites trapped in the 
lungs of vaccinated mice. RANTES expression is upregulated by IFN7, IL- IP and 
TNFa, typical inflammatory cytokines which are all present in the lung tissue of 
vaccinated mice. RT-PCR analysis with RANTES-specific primers has 
demonstrated that this molecule is upregulated in the lungs at the time of peak 
cytokine responses. Thus RANTES may play a role in recruitment to the lungs of the 
CD4 +T cell population generated in the LN, an hypothesis easily investigated by the 
in vivo administration of anti-RANTES antibodies following vaccination. 
Investigation of the induction mechanism in genetically different strains of mice 
can also aid in the understanding of the protective immune response required for 
resistance. This is especially relevant when the strains are known to exhibit different 
levels of resistance upon exposure to the same parasite, presumably via the 
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generation of distinct immune responses. Analysis of the cytokine profiles 
expressed in lung and LN tissue from BALB/c and C5713L/6 mice following 
vaccination with irradiated cercariae of S. mansoni implied a correlation between Th2 
expression and lower resistance levels (Chapter Five). Vaccination of these two 
strains resulted in a similar, albeit less extreme, polarisation of the T helper 
population than that described for Leishmania major (Heinzel et al., 1989, Scott et 
al., 1989, Reiner and Locksley, 1995). The correlation of lower resistance levels 
with Th2 cytokine expression was again demonstrated by the vaccination of mice 
lacking expression of the IFN7 receptor gene; 129 IFN7R-knockout mice exhibited a 
much reduced level of protection compared to C57BL/6 and 129 WT mice. 
Furthermore, following vaccination these animals expressed lower levels of IFN7 and 
IL- 12 mRNA in lung and LN tissue than WT mice. This altered cytokine expression 
can be related to the protection obtained following challenge infection of knockout 
and control mice (see below). 
The Effector Response 
The effector mechanism in mice exposed to the attenuated cercariae vaccine may 
be successful because it operates in a central organ through which all parasites must 
pass before systemic distribution. Similarly, trafficking lymphocytes also pass 
through the lungs on their way around the body, and thus this organ is ideally 
situated for cell recruitment. Consequently, cells resident in the lungs from 
vaccination can attack migrating challenge larvae in a relatively confined space. 
Furthermore, parasites must remain in the alveolar capillaries for some days to 
undergo transformation into lung stage worms in order to continue migration. Hence 
parasites are, in effect, a sitting target for the immune response at this time. 
Analysis of the cytokine profiles induced in the sdLN following challenge has 
highlighted the lack of importance of secondary stimulation in this organ. As normal 
parasites pass through the LN of previously primed mice after a challenge infection 
Thl cytokine expression is much reduced in comparison to the levels detected post- 
vaccination; in contrast Th2 cytokine expression is drastically increased. This 
suppression of any anamnestic IFN7 response has been reported at the protein level 
(Pemberton and Wilson, 1995) and may reflect anergy of a select cell population. 
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This concept is intriguing, and the mechanism by which Thl cells are rendered 
unresponsive, possibly by the expression of inhibitory cytokines such as TGFP or 
costimulatory factors, warrants further investigation. 
Upon investigation of the cytokine profiles induced in the lungs after challenge it 
was found that more polarised Thl expression could be detected compared to that 
observed in the induction mechanism (Chapter Four). This is in agreement with 
published data detailing the dominance of IFN7 in the effector response. In contrast 
to the major Thl and inflammatory cytokine mRNAs, Th2 message levels did not 
approach those attained post-vaccination. This resulted in an overall increase in the 
ratio of Thl: Th2 cytokine expression, and hence a shift towards Thl polarisation. 
As observed post-vaccination, the cytokines required for RANTES expression are 
also upregulated following challenge. The cytokine profiles detected are typical of a 
DTH inflammation, and as described above, RANTES has been shown to play a role 
in cell recruitment during this type of response. However, previous studies have 
implied that no further cell recruitment is required after challenge to mediate 
protection; whole body irradiation prior to challenge has no effect on resistance 
(Aitken et al., 1987, Vignali et al., 1988). Although no additional cell population is 
necessary for the effector mechanism to operate, some reports describe a secondary 
cellular infiltration into the lungs post-challenge, and RANTES may play a part in 
this event. 
It has previously been shown, by the administration of anti-IFN7 antibody during 
the challenge period, that IFN7 plays a pivotal role in the effector mechanism 
(Smythies et al., 1992b). This treatment results in a 90% abrogation of resistance, 
possibly due to the inability of mice to form foci efficient at preventing migration. 
The generation of IFN7 receptor-deficient mice has permitted ftirther investigation of 
the effector response in the absence of this cytokine (Wilson et al., 1996). By 
vaccination and challenge of mice harbouring a disrupted IFN7 receptor gene, it was 
hoped to clarify whether the remaining 10% immunity in anti-IFN7 antibody-treated 
mice was due to suboptimal ablation, or resistance via another mechanism. Although 
cytokine mRNA analysis of lung tissue from IFN7R-/- animals demonstrated higher 
IFNy profiles than expected, an increase in Th2 expression was observed (Chapter 
Six). In addition, resistance levels were reduced to 20% in IFN7R-/- mice, but not 
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completely ablated implying the presence of a normally redundant mechanism which 
can afford limited protection in the absence of the IFNy receptor. Furthermore, the 
IFNyR -/_ mice were generated on a 129/Sv/Ev genetic background, and WT animals 
of this type were found to exhibit higher levels of Th2 expression, and protective 
responses 20% lower, than those achieved after vaccination of C57BL/6 mice. Thus, 
comparisons of vaccination and challenge in gene-disrupted animals based on this 
intermediate-responder strain with the more commonly used high-responder 
C57BL/6 strain are limited. 
In conclusion, it appears that expression of Th2 cytokines in the absence of high 
levels of IFNy can result in lower levels of protection. Suggestions for future work to 
reduce the levels of Th. 2 cytokine expression during the effector mechanism, and 
possible implications for vaccine design are discussed below. 
Vaccination Strategies 
The discovery of I FN7-inducing cytokines such as IL- 12 and the recently isolated 
IGIF (IFNy-inducing factor, Okamura et al., 1995), has resulted in much excitement 
in the field of vaccine research. The incorporation of these cytokines into 
vaccination regimes may boost the IFN7 response, and hence resistance to many 
infections requiring a Th I -based response for cure: for example leishmaniasis, 
schistosomiasis and leprosy. Although IL- 12 administered with the irradiated 
cercariae vaccine can increase resistance to 80% (Wynn et al., 1995a), this is only a 
10% improvement on the values of 70-75% more routinely obtained with parasites 
alone. Coincident with this small increase in protection, a reduction in the Th2 
cytokine expression levels was observed. However, no increase in the already high 
Th I cytokine expression could be induced, implying that Th I responses are already 
maximal and that residual Th2 activity might be responsible for the sub-optimal 
protection obtained in this model. 
When considered together, results from the vaccination of 129 WT mice described 
above and the IL- 12 immunisation protocols, would seem to indicate that the 
presence of even low level Th2 cell activity can reduce protection. Thus, research 
into potential vaccines might benefit from investigation into strategies for reducing 
the residual Th2 cytokine expression, with a view to promoting higher resistance 
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levels. This might be achieved by the study of the irradiated vaccine in IL-4 and IL- 
10 gene-disrupted mice, or the combined ablation of these cytokines using anti- 
cytokine antibodies or double-knockouts. Furthermore, analysis of the effector 
responses in low- and mid-responder strains of mice, such as BALB/c, might 
highlight the effects that any differences seen in cytokine expression post-vaccination 
have on protection. In this way, the vital cytokines and cellular components of a 
protective immune response can be defined and applied to vaccine design. 
Future vaccines for immunising against Schistosoma mansoni infection may 
include the combined administration of a protective antigen and therapeutic cytokine 
to direct the development of a preferred T helper response. This rationale has been 
tested to some extent by the vaccination of mice with IL- 12 and S. mansoni eggs 
(Wynn et al., 1995c). Administration of these two factors results not in a reduction 
in worm and egg burdens, but a significant decrease in the level of tissue fibrosis 
observed in the liver. Thus this vaccine protects against the pathology of the disease 
rather than infection. Although not ideal, since egg and worm burdens can still 
increase in the host and hence no reductions in parasite transmission can occur, a 
vaccine to target pathology may provide an alternative strategy to reduce the 
development of debilitating disease. As with all therapeutic cytokine applications, 
the toxicity of IL- 12 must be thoroughly examined before administration to the 
human population. In addition, predisposition of a population towards a Th I 
response in areas where many infections are dependent upon the generation of a Th2 
response, for example gut nematode infestations, may result in increasing severity of 
another endemic pathogen (Curry et al., 1995). 
It is still not known which Schistosoma mansoni antigens trigger the protective 
Th I response in the LN and lungs of vaccinated mice. Investigations into potential 
protective antigens have been underway for many years, but have failed as yet to 
isolate a strong vaccine candidate able to promote similar levels of protection to 
those seen with the live attenuated vaccine (Richter et al., 1995). A cocktail of 
antigens and cytokines might be required to invoke the same intensity of response 
generated with irradiated cercariae. In addition, any potential vaccine based on the 
current model must be targetted to a site where antigen presentation to CD4+ T cells 
is optimal to promote expansion of a Thl cytokine-secreting population, followed by 
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recruitment of this cell population to the lungs to arm against migrating parasites. 
This requirement may provide problems in administration of a vaccine, although a 
possible solution may lie in intradermal injection of antigen and cytokine followed 
by nasal or oral inhalation via an emulsion of the same mix. Alternatively, the 
antigen and cytokine might be administered with an adjuvent such as an immune 
stimulatory complex (ISCOMS). These complexes have been shown to prime a wide 
range of humoral and cell mediated effector immune mechanisms in vivo (Maloy et 
al., 1995), and administration of antigen via ISCOMS can act to promote both a local 
and systemic response. 
Future Work 
There are still many questions to be answered with regards to the immune 
mechanisms acting in the irradiated vaccine model, and their application to the 
development of a human vaccine. The continued research into the immune response 
generated during the induction and effector mechanisms following exposure to S. 
mansoni cercariae will highlight the immunological parameters essential for 
resistance. In addition, an explanation for the sub-optimal levels of protection 
obtained with the irradiated vaccine at present must be found in order to elevate 
immunity. The scope for future work is therefore extensive. 
Analysis of the cytokine production from sorted LN cell populations will help 
elucidate which cell types are responsible for the cytokine production leading to 
induction of the Thl population. Furthermore, analysis of the LN response following 
challenge might highlight potential downregulatory mechanisms of the Thl cytokine 
production observed in primed mice post-challenge. One such mechanism may be 
stimulation in the absence of the CD28/B7 ligand pair, which has been shown to 
anergise Thl cell clones (Gajewski et al., 1994, Jenkins, 1994, Croft and Swain, 
1995). Alternatively, interaction with a certain APC or costimulatory molecule such 
as 137-2, which is constitutively expressed on B cells and reportedly results in the 
development and expansion of the Th2 subset (Hathcock et al., 1994, Kuchroo et al., 
1995), may be responsible for the high expression of IL-4 post-challenge. Further 
studies on the role of costimulatory and APC factors in the induction mechanism 
may lead to the ability to manipulate the differentiation of a response towards the 
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Th I phenotype. Knowledge of this kind would be of great importance in many 
vaccination strategies aimed at parasitic infection. 
Vaccination of various cytokine gene-disrupted mice may provide an increased 
understanding of the protective response by permitting analysis of the effector 
mechanism in the complete absence of certain key cytokines. Furthermore, selective 
breeding of the gene-disruption on to a C57BL/6 background will allow more 
accurate comparisons between the established model and infection in the absence of a 
given cytokine or receptor. In addition, antibody ablation of the cytokine under 
analysis should be carried out in parallel to confirm that results obtained in knockout 
mice are due solely to the loss of that cytokine, and not to redundant mechanisms 
altering the in vivo pattern normally seen in wild type mice. Further studies are 
required in this area to clarify the key cytokines involved in the generation of optimal 
resistance. 
Final Summary 
The results described in these chapters support the current Th 1 -based theory of 
protection in the irradiated vaccine model. The development of an RT-PCR-based 
technique has allowed the true in vivo cytokine mRNA profiles to be appraised 
during both induction and protection. Research carried out on lung and LN tissue 
following vaccination and challenge has uncovered the presence of a mixed cytokine 
profile during induction, with the dominance of Th I -type cytokines in the effector 
mechanism. Now that the baseline cytokine mRNA levels for this model have been 
established, the foundations are in place for manipulation of the system in an attempt 
to increase resistance. Further research will advance the understanding of the 
immune components necessary for optimal protection. This knowledge may provide 
a significant step towards the development of a successful vaccine, the ultimate goal 
of schistosome research. 
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